.png)
COVID-19 Evidence Reviews
as of 1/15/21
Today's Feature
|
1/15/2021 |
The NIH COVID-19 Treatment Guidelines Panel have been updated to include a statement on the use of ivermectin to treat COVID-19, citing incomplete evidence to support definitive conclusions about its clinical efficacy. Updated guidelines on the use of ivermection should be released in the coming weeks. | |
= living reviewA review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
 latest update date
 |
select |
|
|---|---|---|
|
1/15/21
|
Shareef MA, Bashaiwth HM, AlAkbari AO, et al. | Avicenna J Med
Aim: To review the evidence on SARS-CoV-2 and HIV coinfection.
|
|
|
1/15/21
|
Mohamadi M, Goodarzi A, Aryannejad A, et al. | Med J Islam Repub Iran
Aim: To review the evidence on SARS-CoV-2 infection complications in elderly individuals.
|
|
|
1/15/21
|
What is the evidence for transmission of COVID-19 by children in schools? A living systematic review
 Xu W, Li X, Dozier M, et al. | J Glob Health
Aim: To investigate the extent of SARS-CoV-2 transmission in schools. RECENTLY UPDATED
|
|
|
1/13/21
|
Hassanipour S, Faradonbeh SB, Momeni K, et al. | Int J Reprod Biomed
Aim: To investigate the clinical manifestation include signs and symptoms, laboratory results, and perinatal outcomes in pregnant women with COVID-19. RECENTLY UPDATED
|
|
|
1/13/21
|
Lee DS, Mirmirani P, McCleskey PE, et al. | Dermatol Online J
Aim: To identify case reports and case series characterizing cutaneous manifestations of confirmed COVID-19.
|
|
|
1/11/21
|
Caristia S, Ferranti M, Skrami E, et al. | Epidemiol Prev
Aim: To describe and compare the effectiveness of national and local lockdowns in controlling the spread of COVID-19.
|
|
|
1/11/21
|
Hariyanto TI, Japar KV, Kwenandar F, et al. | Am J Emerg Med
Aim: To evaluate the difference between these parameters in severe and nonsevere disease and to provide the optimal cutoff value for predicting severe disease.
|
|
|
1/11/21
|
Johanna N, Citrawijaya H, Wangge G | J Public Health Res
Aim: To evaluate the effectiveness of mass testing, lockdown, or a combination of both to control COVID-19 pandemic. RECENTLY UPDATED
|
|
|
1/11/21
|
Zhao X, Gang X, He G, et al. | Front Endocrinol
Aim: To compare the impacts of obesity on the severity and mortality of influenza and COVID-19. RECENTLY UPDATED
|
|
|
1/11/21
|
Fan S, Guan J, Cao L, et al. | Asian J Psychiatr
Aim: To investigate and monitor the mental health status of pregnant women during the COVID-19 pandemic.
|
|
|
1/11/21
|
Kahil K, Cheaito MA, El Hayek R, et al. | Asian J Psychiatr
Aim: To synthesize descriptive and analytic evidence of suicide and suicide-related outcomes (ideations, intent, attempt, or completion) during major international respiratory outbreaks (COVID-19, MERS, SARS, and influenza A) in the recent history.
|
|
|
1/8/21
|
Abubakar AR, Sani IH, Godman B, et al. | Infect Drug Resist
Aim: To summarize some evidence-based therapeutic options for COVID-19 infection.
|
|
|
1/7/21
|
Lin C, Tu P, Beitsch LM | Vaccines
Aim: To compare trends and synthesize findings in vaccination receptivity over time across US and international polls, assess survey design influences and evaluate context to inform policies and practices.
|
|
|
1/7/21
|
Cuadra-Martínez D, Castro-Carrasco PJ, Sandoval-Díaz J, et al. | Rev Med Chil
Aim: To conduct a systematic review on psychological behavior in the context of pandemic scenarios during the twenty-first century.
|
|
|
1/7/21
|
Lukito AA, Pranata R, Henrina J, et al. | Diabetes Metab Syndr
Aim: To review the evidence on metformin consumption and mortality in COVID-19 patients. RECENTLY UPDATED
|
|
|
1/6/21
|
Islam MM, Poly TN, Walther BA, et al. | Front Med
Aim: To assess clinical manifestations and neonatal outcomes of pregnant women with COVID-19.
|
|
|
1/6/21
|
Andrade BS, Rangel FS, Santos NO, et al. | Front Pharmacol
Aim: To review the evidence on drug candidates, potentially approved to be used as new options for SARS-CoV-2 prophylaxis clinical trials and medical protocols.
|
|
|
1/6/21
|
Zaffanello M, Piacentini G, Nosetti L, et al. | Transfus Apher Sci
Aim: To review the literature and ongoing clinical trials on convalescent plasma therapy in pediatric patients with COVID-19.
|
|
|
1/4/21
|
Aerobic exercises recommendations and specifications for patients with COVID-19: a systematic review
Alawna M, Amro M, Mohamed AA | Eur Rev Med Pharmacol Sci
Aim: To systematically analyze the effects of aerobic exercise on immunological biomarkers to provide safe aerobic exercise recommendations and specifications for patients with COVID-19.
|
|
|
1/4/21
|
Post N, Eddy D, Huntley C, et al. | PLoS One
Aim: To comprehensively evaluate the evidence describing the antibody response to SARS-CoV-2. UPDATED
|
|
|
1/4/21
|
Rahimi NR, Fouladi-Fard R, Aali R, et al. | Environ Res
Aim: To highlight how the virus is impacted by the environment and how the virus has impacted the environment.
|
|
|
1/4/21
|
Rada G, Corbalan J, Rojas P, et al. | Medwave
Aim: To provide a timely, rigorous and continuously updated summary of the available evidence on the role of cell-based therapies in the treatment of patients with COVID-19. UPDATED
|
|
|
1/4/21
|
Khamis AH, Jaber M, Azar A, et al. | J Formos Med Assoc
Aim: To systematically review all COVID-19 publications to summarize the clinical features, assess comorbidities, prevalence, and disease outcomes. UPDATED
|
|
|
1/4/21
|
Kim MS, An MH, Kim WJ, et al. | PLoS One
Aim: To evaluate the comparative efficacy and safety of pharmacological interventions used in treating COVID-19 and form a basis for an evidence-based guideline of COVID-19 management by evaluating the level of evidence behind each treatment regimen in different clinical settings. UPDATED
|
|
|
1/4/21
|
Han Q, Guo M, Zheng Z, et al. | Front Pharmacol
Aim: To assess the safety and efficacy of anti-IL-6 signaling (anti-IL6/IL-6R/JAK) agents on COVID-19.
|
|
|
1/4/21
|
Choupoo NS, Das SK, Haldar R, et al. | Indian J Crit Care Med
Aim: To test the efficacy of different therapeutic options currently available for treating COVID-19. UPDATED
|
|
|
1/4/21
|
Cascino F, Hoxhaj I, Zace D, et al. | BMJ Glob Health
Aim: To identify healthcare systems interventions, experiences and recommendations that have been used to manage different respiratory viral infections outbreaks in the past. UPDATED
|
|
|
1/4/21
|
Desai A, Gupta R, Advani S, et al. | Cancer
Aim: To assess the overall mortality in this population through a meta?analysis of published data on COVID?19 and cancer. UPDATED
|
|
|
1/4/21
|
Fu L, Liu X, Su Y, et al. | Clin Cardiol
Aim: To investigate prevalence of cardiac injury and its impact on the outcomes in patients with COVID?19.
|
|
|
1/4/21
|
Del Zompo F, De Siena M, Ianiro G, et al. | Eur Rev Med Pharmacol Sci
Aim: To systematically review the prevalence of liver involvement in patients with SARS-CoV-2 infection at their hospital admission, and its correlation with disease severity and clinical outcomes in patients with or without pre-existing chronic liver disease.
|
|
|
1/4/21
|
Lee KH, Kim SJ, Hong SH, et al. | Eur Rev Med Pharmacol Sci
Aim: To analyze the same clinical issues through an improved research method and to find out the differences from the retracted papers.
|
|
|
1/4/21
|
Liu H, Yang D, Chen X, et al. | Cancer Med
Aim: To qualify the potential effects of anticancer therapies on the clinical outcomes, such as mortality, admission to the intensive care unit (ICU), and the severity of COVID?19, in patients with cancer infected with COVID?19. UPDATED
|
|
|
1/4/21
|
Dillman A, Zoratti MJ, Park JJH, et al. | Infect Drug Resist
Aim: To summarize and characterize research efforts with respect to the different stages of disease progression.
|
|
|
12/31/20
|
Chowdhary A, Subedi R, Tandon M | Brain Sci
Aim: To collect, analyze, and summarize the neurological findings in the MRI among patients with COVID-19
CLINICAL CHARACTERISTICS
|
|
|
12/30/20
|
Mehraeen E, Alinaghi SAS, Nowroozi A, et al. | Indian Heart J
Aim: To pinpoint different observed ECG findings and discuss their clinical significance.
CLINICAL CHARACTERISTICS
|
|
|
12/30/20
|
McEwan T, Robinson PC | Semin Arthritis Rheum
Aim: To systematically examine infectious adverse events associated with colchicine usage and the clinical use of colchicine for infectious diseases.
CANDIDATE THERAPEUTICS
|
|
|
12/30/20
|
Lai X, Liu J, Zhang T, et al. | BMJ Open
Aim: To systematically assess the clinical, laboratory and imaging predictors as well as prediction models for severe or critical illness and mortality in patients with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/30/20
|
de Oliveira TF, de Oliveira Rocha CA, dos Santos AGG, et al. | Braz J Cardiovasc Surg
Aim: To systematically review the literature on the use of extracorporeal membrane oxygenation (ECMO) in patients with coronavirus disease 2019 (COVID-19).
CANDIDATE THERAPEUTICS
|
|
|
12/30/20
|
Dorrell R, Dourgherty MK, Barash EL, et al. | JGH Open
Aim: To characterize the prevalence of gastrointestinal (GI) and hepatic involvement in COVID?19 and specifically assess the prevalence of GI symptoms in isolation. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/30/20
|
Verdejo C, Vergara-Merino L, Meza N, et al. | Medwave
Aim: To provide a timely, rigorous, and continuously updated summary of the evidence available on the role of macrolides for treating patients with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
12/30/20
|
Mondal R, Ganguly U, Deb S, et al. | J Neurovirol
Aim: To summarise the clinical profile, investigations and radiological findings among patients with SARS-CoV-2 associated meningoencephalitis. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/30/20
|
Brown WA, Moore EM, Watters DA | ANZ J Surg
Aim: To estimate the effect size of coronavirus disease 2019 (COVID-19) on post-operative mortality.
CLINICAL CHARACTERISTICS
|
|
|
12/30/20
|
Maharaj S, Alvarez MB, Mungul S, et al. | Laryngoscope Investig Otolaryngol
Aim: To describe otologic dysfunction in patients with the novel SARS?CoV?2.
CLINICAL CHARACTERISTICS
|
|
|
12/30/20
|
Al Maqbali M, Al Sinani M, Al-Lenjawi B | J Psychosom Res
Aim: To ascertain the present impact of the COVID-19 outbreak on the prevalence of stress, anxiety, depression and sleep disturbance among nurses. UPDATED
MENTAL HEALTH
|
|
|
12/30/20
|
Panda PK, Gupta J, Chowdhury SR, et al. | J Trop Pediatr
Aim: To provide a pooled estimate of the prevalence of various psychological and behavioral symptoms/disorders in children and adolescents up to 18?years of age during this pandemic.
MENTAL HEALTH
|
|
|
12/30/20
|
SeyedAlinaghi S, Oliaei S, Kianzad S, et al. | World J Virol
Aim: To summarize the recent findings and reports of COVID-19 reinfection in patients previously reCoVered from the disease.
CLINICAL CHARACTERISTICS
|
|
|
12/30/20
|
Verdugo-Paiva F, Acuna MP, Sola I, et al. | Medwave
Aim: To provide a timely, rigorous and continuously updated summary of the evidence available on the role of remdesivir in the treatment of patients with COVID-19.
|
|
|
12/30/20
|
Callus E, Bassola B, Fiolo V, et al. | Front Psychol
Aim: To identify the most effective stress reduction techniques for health care providers dealing with patients infected with severe coronavirus (SARS, MERS, and COVID-19). UPDATED
MENTAL HEALTH
|
|
|
12/30/20
|
Parsay S, Vosoughi A, Khabbaz A, et al. | J Stroke Cerebrovasc Dis
Aim: To investigate the incidence of ischemic CVA and the mortality due to it in the setting of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/28/20
|
Pranata R, Henrina J, Lim MA, et al. | Arch Gerontol Geriatr
Aim: To quantify the dose-response relationship between CFS and mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
12/28/20
|
Hassani NS, Shojaee A, Khodaprast Z, et al. | J Intensive Care Med
Aim: To investigate the echocardiographic features of cardiac injury related to COVID-19 and their prognostic value.
CLINICAL CHARACTERISTICS
|
|
|
12/28/20
|
Polychronis G, Roupa Z | J Public Aff
Aim: To review the evidence on health care workers' knowledge level during the spread of COVID-19 and their perception of the risk related to the COVID-19 pandemic.
INFECTION CONTROL
|
|
|
12/28/20
|
Aziz M, Goyal H, Haghbin H, et al. | Am J Med Sci
Aim: To evaluate the prevalence of “loss of smell” in COVID-19 as well as its utility for prognosticating the disease severity.
CLINICAL CHARACTERISTICS
|
|
|
12/28/20
|
Clement ND, Ng N, Simpson CJ, et al. | Bone Joint Res
Aim: To assess: 1) the prevalence of COVID-19 in hip fracture patients during the first wave of the pandemic; 2) the associated rate and risk of mortality compared to those without COVID-19; 3) the demographics associated with COVID-19-positive patients; 4) the time from the day of admission to diagnosis of COVID-19; and 5) length of follow-up after a diagnosis of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/23/20
|
Prendki V, Tau N, Avni T, et al. | BMC Geriatr
Aim: To examine the participation of elderly patients in therapeutic or prophylactic trials on COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
12/23/20
|
Bhuiyan MU, Stiboy E, Hassan MZ, et al. | Vaccine
Aim: To review the evidence on the epidemiological and clinical characteristics of COVID-19 infection in children under five years. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/23/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the use of ivermectin for prophylaxis or treatment of COVID-19.
|
|
|
12/23/20
|
Kubota T, Gajera PK, Kuroda N | Epilepsy Behav
Aim: To perform a systematic review and meta-analysis to summarize and quantitatively evaluate the electroencephalogram (EEG) findings in patients with coronavirus disease 2019 (COVID-19).
|
|
|
12/22/20
|
Ghazy RM, Almaghraby A, Shaaban R, et al. | Sci Rep
Aim: To review the evidence on the effectiveness and safety of either CQ or HCQ alone or in combination with AZM in treating COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/22/20
|
Sun F, Zhu J, Tao H, et al. | J Psychosom Obstet Gynaecol
Aim: To review the evidence on mental health in pregnant and delivery women during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
12/22/20
|
Luo Y, Chua CR, Xiong Z, et al. | Front Psychiatry
Aim: To review the evidence on the impact of viral respiratory epidemics, including coronavirus disease 2019 (COVID-19), on mental health among different population groups, drawing on their insights for recommendations for the current COVID-19 pandemic.
MENTAL HEALTH
|
|
|
12/22/20
|
Piombino P, Troise S, Vargas M, et al. | Eur Rev Med Pharmacol Sci
Aim: To analyze the scientific literature identifying the indications for tracheostomy and safety precautions to reduce contamination.
CANDIDATE THERAPEUTICS
|
|
|
12/22/20
|
Fiest KM, Krewulak KD, Plotnikoff KM, et al. | BMC Med
Aim: To evaluate the validity of published triage protocols and the mortality prediction embedded within them to help inform health system-decision-making.
|
|
|
12/22/20
|
Oikonomidi T, Boutron I, Pierre O, et al. | BMC Med
Aim: To describe the proportion of evidence on the effect of interventions for COVID-19 from preprints and journal articles and map changes in evidence between and within different sources reporting on the same study.
CANDIDATE THERAPEUTICS
|
|
|
12/22/20
|
Neef V, Buxmann H, Rabenau HF, et al. | Pediatr Neonatal
Aim: To characterize a large number of neonates delivered by rRT-PCR confirmed SARS-CoV-2 positive mothers.
CLINICAL CHARACTERISTICS
|
|
|
12/22/20
|
Wang Y, Huo P, Dai R, et al. | Int Immunopharmacol
Aim: To evaluate the existing evidence and experience related to CP immunotherapy for COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/22/20
|
Fabrizi F, Alfieri CM, Cerutti R, et al. | Pathogens
Aim: To evaluate the frequency of AKI and dialysis requirement in patients who underwent hospitalization due to COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/22/20
|
Rocha APD, Atallah ÁN, Pinto ACPN, et al. | Sao Paulo Med J
Aim: To assess whether patients undergoing pharmacological treatment for IMID present higher risk of worse outcomes when diagnosed with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/22/20
|
Clark M, Loshak H, Farrah K | CADTH
Aim: To review the evidence on the use of COVID-19 mRNA vaccines on patients with cancer or who are immunocompromised.
|
|
|
12/22/20
|
Siemieniuk RAC, Bartoszko JJ, Ge L, et al. | BMJ
Aim: To compare the effects of treatments for coronavirus disease 2019 (covid-19). UPDATED
CANDIDATE THERAPEUTICS
|
|
|
12/22/20
|
Rattka M, Dreyhaupt J, Winsauer C, et al. | Heart
Aim: To assess the mortality of patients with STEMI admitted during the COVID-19 pandemic. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/22/20
|
Bae S, Kim SR, Kim M, et al. | Heart
Aim: To estimate the prevalence and risk factors for CVD among patients with COVID-19 in different age groups. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/22/20
|
Sarkar S, Khanna P, Singh A | J Med Virol
Aim: To evaluate the consequence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with concurrent co-infections based on the publications reported to date. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/22/20
|
Tyrrell CSB, Mytton OT, Gentry SV, et al. | Thorax
Aim: To provide acute insights into the guidance on which patients are treated in ICU and receive ventilation during periods of high demand for ICU capacity during the COVID-19 pandemic. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/22/20
|
Mathioudakis AG, Fally M, Hashad R, et al. | Life
Aim: To describe the outcomes evaluated in 415 RCTs on the management of COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/22/20
|
Rabbani G, Islam SMS, Rahman MA, et al. | Expert Rev Respir Med
Aim: To investigate COVID-19 mortality and severity among patients with pre-existing COPD. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/22/20
|
Rodrigues C, Baía I, Domingues R, et al. | Front Public Health
Aim: To review knowledge on the impact of COVID-19 on pregnancy and describe the outcome of published cases of pregnant women diagnosed with COVID-19, as well as the characteristics of COVID-19 positive women who delivered in Portugal by 31 of March 2020. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/22/20
|
Santabárbara J, Lasheras I, Lipnicki DM, et al. | Prog Neuropsychopharmacol Biol Psychiatry
Aim: To conduct a systematic review and meta-analysis to ascertain the impact of the COVID-19 outbreak on the prevalence of anxiety in the general population.
MENTAL HEALTH
|
|
|
12/22/20
|
July J, Pranata R | Geriatr Gerontol Int
Aim: To discover whether age, sex and other comorbidities might affect the association between dementia and mortality. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/22/20
|
Islam MA, Alam SS, Kundu S, et al. | Front Neurol
Aim: To conduct a comprehensive systematic review and meta-analysis to estimate the overall pooled prevalence of headache in COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/22/20
|
Violant-Holz V, Gallego-Jimenez MG, Gonzalez-Gonzalez CS, et al. | Int J Environ Res Public Health
Aim: To analyze the extent to which engaging in physical activity during the COVID-19 pandemic affected adults’ psychological health.
MENTAL HEALTH
|
|
|
12/22/20
|
West E, Moore K, Kupeli N, et al. | Age Aging
Aim: To explore key factors that influence place of care and place of death decisions in older adults.
|
|
|
12/22/20
|
Lee MMY, Docherty KF, Sattar N, et al. | Eur Heart J Cardiovasc Pharmacother
Aim: To provide summary odds ratio (OR) estimates for associations between treatment with (vs. without) renin-angiotensin system (RAS) blockers and risk of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection and coronavirus disease 2019 (CoViD-19) severity (including case-fatality) in patients with hypertension, and in all patients (irrespective of hypertension).
CANDIDATE THERAPEUTICS
|
|
|
12/22/20
|
Viner RM, Ward J, Hudson L, et al. | Arch Dis Child
Aim: To undertake a systematic review of reviews of the prevalence of symptoms and signs of COVID-19 in those aged under 20 years. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/22/20
|
Subsoontorn P, Lohitnavy M, Kongkaew C | Sci Rep
Aim: To determine the accuracy of nucleic acid point-of-care diagnosis for human coronaviruses, particularly, SARS-CoV, MERS-CoV and SARS-CoV-2. UPDATED
DIAGNOSTICS
|
|
|
12/22/20
|
Salari N, Khazaie H, Hosseinian-Far A, et al. | Hum Resour Health
Aim: To systematically review and determine the prevalence of stress, anxiety and depression within front-line healthcare workers caring for COVID-19 patients.
MENTAL HEALTH
|
|
|
12/18/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the impact of COVID-19 and related public health measures on household food security. UPDATED
|
|
|
12/18/20
|
Yan H, Ding Y, Guo W | Front Psychol
Aim: To quantify the influence of the COVID-19 pandemic on the mental health of pregnant and postpartum women, and to explore the specific vulnerable groups among this population of women. UPDATED
MENTAL HEALTH
|
|
|
12/18/20
|
Wenjing L, Yuanzheng F, Li JY, et al. | Aging
Aim: To review the evidence on the safety and efficacy of CP transfusion in SARS-CoV-2-infected patients.
CANDIDATE THERAPEUTICS
|
|
|
12/18/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the role of daycares and schools in the transmission of COVID-19. UPDATED
|
|
|
12/17/20
|
Johnson BA, Waddimba AC, Ogola GO, et al. | Am J Surg
Aim: To investigate if surgical delays impact survival for breast, lung and colon cancers.
INFECTION CONTROL
|
|
|
12/17/20
|
Zafari M, Rad MTS, Mohseni F, et al. | Hemoglobin
Aim: To determine mortality and morbidity of infected ?-thal patients with coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
|
|
|
12/17/20
|
van Paassen J, Vos JS, Hoekstra EM, et al. | Crit Care
Aim: To evaluate the effect of corticosteroids on mortality, viral clearance and secondary outcomes in COVID-19 patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
12/17/20
|
Wan J, Wang X, Su S, et al. | JGH Open
Aim: To investigate the exact prevalence of digestive symptoms and liver injury in COVID?19 patients and compare the difference between patients with and without digestive symptoms.
CLINICAL CHARACTERISTICS
|
|
|
12/17/20
|
Lewinski AA, Rushton S, Van Voorhees E, et al. | Res Nurs Health
Aim: To review the evidence on the practices that impact the implementation of RT for adults seeking clinical care advice.
INFECTION CONTROL
|
|
|
12/17/20
|
Suh YJ, Hong H, Ohana M, et al. | Radiology
Aim: To conduct meta-analysis of the study-level incidence of PE and DVT and to evaluate the diagnostic accuracy of D-dimer tests for PE from multicenter individual patient data.
CLINICAL CHARACTERISTICS
|
|
|
12/17/20
|
Arieta-Miranda J, Alcaychahua ABS, Santos GMP, et al | Heliyon
Aim: To evaluate the quality of the CPG for the management of paediatric dental emergencies, published in the period 2000–2020 and applicable to the context of pandemic, by using the AGREE II tool. UPDATED
INFECTION CONTROL
|
|
|
12/17/20
|
Silver SA, Beaubien-Souligny W, Shah PS, et al. | Kidney Med
Aim: To determine the pooled prevalence of AKI and KRT among hospitalized patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/16/20
|
Noorimotlagh Z, Jaafarzadeh N, Martínez SS, et al. | Environ Res
Aim: To systematically collect all experimental studies related to airborne transmission of SARS-CoV-2 in indoor air environments.
INFECTION CONTROL
|
|
|
12/16/20
|
Thakkar S, Arora S, Kumar A, et al. | Clin Med Insights Cardiol
Aim: To provide a foundation for understanding the CV manifestations and outcomes of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/16/20
|
Lazarus G, Audrey J, Kharisma Wangsaputra V, et al. | Diabetes Res Clin Pract
Aim: To investigate the prognostic value of admission blood glucose (BG) in predicting COVID-19 outcomes, including poor composite outcomes (mortality/severity), mortality, and severity.
CLINICAL CHARACTERISTICS
|
|
|
12/16/20
|
Madewell ZJ, Yang Y, Longini IM, et al. | JAMA Netw Open
Aim: To examine evidence for household transmission of SARS-CoV-2, disaggregated by several covariates, and to compare it with other coronaviruses. UPDATED
INFECTION CONTROL
|
|
|
12/16/20
|
Liu S, Cao Y, Du T, et al. | J Allergy Clin Immunol Pract
Aim: To investigate the asthma prevalence among COVID-19 patients and compare outcomes between asthma and non-asthma patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/16/20
|
Wu T, Jia X, Shi H, et al. | J Affect Disord
Aim: To provide a comprehensive perspective of the prevalence mental health problems during the COVID-19 pandemic and identify high risk groups of mental health problems related to COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
12/16/20
|
Zhang R, Ni L, Di X, et al. | J Vasc Surg Venous Lymphat Disord
Aim: To identify the prevalence of VTE, PE, and DVT in consecutive hospitalized patients, ICU patients, and non-ICU patients with COVID-19 by a meta-analysis based on currently available clinical studies.
CLINICAL CHARACTERISTICS
|
|
|
12/16/20
|
Samaranayake LP, Fakhruddin KS, Buranawat B, et al. | Acta Odontal Scand
Aim: To evaluate available data on three major measures: rubber dam application, pre-procedural oral rinse, and high-volume evacuators (HVE) aimed at reducing bio-aerosols.
INFECTION CONTROL
|
|
|
12/16/20
|
Liu N, Zhang T, Ma L, et al. | Blood Rev
Aim: To elucidate the association between ABO blood group and increased COVID-19 morbidity and mortality.
CLINICAL CHARACTERISTICS
|
|
|
12/16/20
|
Li X, Xu W, Dozier M, et al. | J Glob Health
Aim: To investigate the role of children in the transmission of SARS-CoV-2.
INFECTION CONTROL
|
|
|
12/16/20
|
Cowling T, Graves E, Loshak H | CADTH
Aim: To explore what we know about virus-neutralizing monoclonal antibodies, their mechanism of action and how they are administered, and which virus-neutralizing monoclonal antibodies are in clinical development for SARS-CoV-2 infection.
|
|
|
12/14/20
|
Maples LS | Int J Nurs Pract
Aim: To determine the effectiveness of quarantine on coronavirus outbreaks to support the WHO quarantine recommendation.
INFECTION CONTROL
|
|
|
12/14/20
|
Gallagher JE, Sukriti KC, Johnson IG, et al. | BDJ Open
Aim: To review the evidence on the pattern of aerosol spread and settle relevant to oral surgery in dental surgery. UPDATED
|
|
|
12/14/20
|
Nobari NN, Seirafianpour F, Mashayekhi F, et al. | Dermatol Ther
Aim: To review the evidence on treatment-related mucocutaneous drug reactions of COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/14/20
|
Ojha V, Verma M, Pandey NN, et al. | J Thorac Imaging
Aim: To assess the important imaging features on CMR in patients diagnosed with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/14/20
|
Piscoya A, Ng-Sueng LF, del Riego AP, et al. | PLoS One
Aim: To evaluate the efficacy and safety of remesdivir for the treatment of COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
12/14/20
|
Kaushal K, Sarma P, Rana SV, et al. | J Biomol Struct Dyn
Aim: To evaluate the role of AI in drug repurposing, novel drug discovery, vaccine and antibody development for the therapeutics of COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/14/20
|
Arevalo Rodriguez I, Buitrago Garcia D, Simancas Racines D, et al. | PLoS One
Aim: To review and critically appraise evidence about the proportion of RT-PCR false-negatives at initial testing for COVID-19. UPDATED
DIAGNOSTICS
|
|
|
12/14/20
|
Liao S, Shao S, Cheng C, et al. | Crit Care
Aim: To review the evidence on the incidence and mortality rates after incident arrhythmia in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
12/14/20
|
Al-Benna S | Ann Burns Fire Disasters
Aim: To identify the optimal protection measures during the COVID-19 pandemic and provide guidance of protective measures for burn surgeons.
INFECTION CONTROL
|
|
|
12/14/20
|
Kaprin AD, Fedenko AA, Polyakov AA, et al. | Khirurgiia
Aim: To review the evidence on surgical management and preoperative screening of cancer patients within the COVID-19 pandemic, as well as prevention of SARS-CoV-2 transmission and resumption of elective surgery.
INFECTION CONTROL
|
|
|
12/11/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on risk factors are associated with COVID-19 outbreaks and mortality in LTC facilities and what strategies mitigate risk. UPDATED
|
|
|
12/11/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on how and by whom COVID-19 is introduced and transmitted within acute care settings.
|
|
|
12/10/20
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
12/10/20
|
Levin AT, Hanage WP, Owusu-Boaitey N, et al. | Eur J Epidemiol
Aim: To assess the age specificity of the infection fatality rate (IFR) for COVID-19 using seroprevalence results from eight national studies (Belgium, England, Hungary, Italy, Netherlands, Portugal, Spain, and Sweden), fifteen seroprevalence studies of specific locations in Europe and the United States, and three countries (Iceland, New Zealand, and Republic of Korea) that have engaged in comprehensive tracking and tracing of COVID-19 infections. UPDATED
|
|
|
12/10/20
|
Liu N, Sun J, Wang X, et al. | J Alzheimers Dis
Aim: To investigate the impact of pre-existing dementia comorbidities on COVID-19.
|
|
|
12/9/20
|
Kondylakis H, Katehakis DG, Kouroubali A, et al. | J Med Internet Res
Aim: To shed light into studies found in the scientific literature that have used and evaluated mobile apps for the prevention, management, treatment, or follow-up of COVID-19.
|
|
|
12/9/20
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
12/9/20
|
El Keshky MES, Basyouni SS, Al Sabban AM | Front Psychol
Aim: To evaluate the impact of COVID-19 on the psychology of sustainability (quality of life), on sustainable development, and on the global economy.
|
|
|
12/9/20
|
Vancsa S, Hegyi PJ, Zadori N, et al. | Front Med
Aim: To evaluate the prognostic value of on-admission liver function tests and pre-existing liver diseases on the clinical course of coronavirus disease 2019 (COVID-19). UPDATED
|
|
|
12/9/20
|
Putko RM, Bedrin MD, Clark DM, et al. | J Clin Orthop Trauma
Aim: To identify risk factors, comorbidities, case characteristics, and treatment strategies to better understand the nature of this disease and its effects on the extremities.
|
|
|
12/9/20
|
Prakash A, Singh H, Kaur H, et al. | Indian J Psychiatry
Aim: To evaluate the efficacy and safety of FPV in published literature.
|
|
|
12/9/20
|
Shamshirian A, Hessami A, Heydari K, et al. | Ann Acad Med Singap
Aim: To examine the effectiveness of hydroxychloroquine in treatment of COVID-19. UPDATED
|
|
|
12/9/20
|
Fligor SC, Tsikis ST, Wang S, et al. | J Thorac Dis
Aim: To synthesize the available literature on time to surgery and its impact on outcomes along with a critical appraisal of the released triage guidelines in the United States.
|
|
|
12/8/20
|
Wilkinson R, Hines L, Holland A, et al. | Harm Reduct J
Aim: To explore what harm reduction interventions and messaging are most effective during a pandemic-type situation. UPDATED
|
|
|
12/7/20
|
Puyat J, Ahmad H, Avina-Galindo AM, et al | PLoS One
Aim: To review the evidence on home-based activities that have potential beneficial effects on mental health. UPDATED
|
|
|
12/7/20
|
Hessami A, Shamshirian A, Heydari K, et al. | Am J Emerg Med
Aim: To study cardiovascular disease burden among COVID-19 patients. UPDATED
|
|
|
12/7/20
|
Rodriguez-Gonzalez M, Castellano-Martinez-A, Cascales-Poyatos HM, et al. | World J Clin Cases
Aim: To summarize the current knowledge about the potential cardiovascular involvement in pediatric COVID-19 in order to give a perspective on how to take care of them during the current pandemic emergency.
|
|
|
12/7/20
|
Kim JS, Lee KH, Kim GE, et al. | Eur Rev Med Pharmacol Sci
Aim: To analyze clinical characteristics and mortality of patients with hematologic malignancies and COVID-19.
|
|
|
12/7/20
|
Vakhshoori M, Emami SA, Heidarpour M, et al. | Iran J Kidney Dis
Aim: To define the frequency of AKI as well as two specific renal biomarkers including BUN and serum Cr among individuals suffering from COVID-19 infection.
|
|
|
12/7/20
|
Hu BS, Hu MZ, Jiang LX, et al. | Eur Rev Med Pharmacol Sci
Aim: To review the evidence on the use of ECMO in patients with COVID-19.
|
|
|
12/7/20
|
Ampuero J, Sanchez-Torrijos Y, Del Rosario Garcia Lozano M, et al. | Rev Esp Enferm Dig
Aim: To assess the impact of the baseline liver function (AST, ALT, and bilirubin) on COVID-19-related outcomes, including on mortality, intensive care unit admission, and non-fatal severe complications.
|
|
|
12/7/20
|
Bandyopadhyay S, Baticulon RE, Kadhum M, et al. | BMJ Glob Health
Aim: To estimate COVID-19 infections and deaths in healthcare workers (HCWs) from a global perspective during the early phases of the pandemic.
|
|
|
12/7/20
|
Berardicurti O, Ruscitti P, Ursini F, et al. | Clin Exp Rheumatol
Aim: To review the evidence on the mortality rate in TCZ-treated patients with COVID-19.
|
|
|
12/7/20
|
Chu Y, Yang J, Shi J, et al. | Eur J Med Res
Aim: To investigate the association between obesity and poor outcomes in patients with COVID-19 pneumonia.
|
|
|
12/7/20
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
12/7/20
|
Jefferson T, Spencer EA, Brassey J, et al. | Clin Infect Dis
Aim: To review the evidence from studies relating SARS-CoV-2 culture with the results of reverse transcriptase polymerase chain reaction (RT-PCR) and other variables which may influence the interpretation of the test, such as time from symptom onset. UPDATED
|
|
|
12/4/20
|
Shuto H, Komiya K, Yamasue M, et al. | Sci Rep
Aim: To review the evidence on the associations between corticosteroid treatment and any type of mortality and/or other clinical outcomes among noncritically ill patients with COVID-19.
|
|
|
12/4/20
|
Zarifkar P, Kamath A, Robinson C, et al. | Clin Oncol
Aim: To review the current evidence base pertaining to the prevalence, presentation and outcome of COVID-19 in cancer patients, in order to inform policy and practice going forwards. UPDATED
|
|
|
12/4/20
|
Mohamed K, Yazdanpanah N, Saghazadeh A, et al. | Bioorg Chem
Aim: To provide an overview of studies that have used computational methods for drug repurposing in COVID-19.
|
|
|
12/4/20
|
da Silva FAF, de Brito BB, Santos MLC, et al. | Rev Soc Bras Med Trop
Aim: To review the evidence on GI symptoms associated with coronavirus disease 2019 (COVID-19) as well as of the serum levels of biomarkers related to liver function and lesion in SARS-CoV-2-infected individuals.
|
|
|
12/4/20
|
Alhumaid S, Al Mutair A, Al Alawi Z, et al. | Trop Med Infect Dis
Aim: To assess the efficacy and safety of lopinavir/ritonavir in COVID-19 patients in the extant published research. UPDATED
|
|
|
12/4/20
|
Pollock A, Campbell P, Cheyne J, et al. | Cochrane Database Syst Rev
Aim: To review the evidence on the effects of interventions aimed at supporting the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic.
|
|
|
12/4/20
|
Komolafe TE, Agbo J, Olaniyi EO, et al. | Diagnostics
Aim: To perform a meta-analysis to evaluate the diagnostic performance of chest CT, common CT morphological abnormalities, disease prevalence, biodata information, and gender prevalence of patients. UPDATED
|
|
|
12/4/20
|
Zuercher SJ, Kerksieck P, Adamus C, et al. | Front Public Health
Aim: To review the evidence on MHP prevalence rates published since 2000, during and after epidemics, including the general public, health care workers, and survivors. UPDATED
|
|
|
12/4/20
|
National Collaborating Centre for Methods and Tools | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the effect of the COVID-19 pandemic on the use and cessation of tobacco and vaping products.
|
|
|
12/4/20
|
Lieneck C, Garvey J, Collins C, et al. | Healthcare
Aim: To evaluate the literature specific to rapid telehealth implementation during the current COVID-19 pandemic.
|
|
|
12/4/20
|
Negrini F, De Sire A, Andrenelli E, et al. | Eur J Phys Rehabil Med
Aim: To report data of a systematic search performed on papers published in July 2020. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/4/20
|
Lo Moro G, Sinigaglia T, Bert F, et al. | Int J Environ Res Public Health
Aim: To describe the main measures planned for the 2020–2021 academic year within the WHO European Region.
|
|
|
12/4/20
|
Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, et al. | Pulmonology
Aim: To determine the prevalence of restrictive pattern, obstructive pattern and altered diffusion in patients post-COVID-19 infection and to describe the different evaluations of respiratory function used with these patients. UPDATED
|
|
|
12/4/20
|
Yifan C, Jun P | Front Endocrinol
Aim: To assess the clinical characteristics of elder patients with COVID-19.
|
|
|
12/4/20
|
Foldi M, Farkas N, Kiss S, et al. | Obesity
Aim: To evaluate the association between the distributions of CT?quantified fat mass and critical condition of patients with COVID?19.
|
|
|
12/3/20
|
Oakman J, Kinsman N, Stuckey R, et al. | BMC Public Health
Aim: To review the impact of WAH on individual workers’ mental and physical health, and determine any gender difference, to develop recommendations for employers and employees to optimise workers’ health.
|
|
|
12/3/20
|
Jain N, Varman R, Tarbox JA, et al. | Auris Nasus Larynx
Aim: To review the current knowledge of biomolecular factors surrounding otorhinolaryngeal illnesses and analyze their presence in COVID-19 virulence.
|
|
|
12/3/20
|
Szarpak L, Adam I, Dzieciatkowski T, et al. | Postepy Nauk Medycznych
Aim: To identify the most frequently observed symptoms in pediatric patients with confirmed COVID-19.
|
|
|
12/3/20
|
Chi J, Gong W, Gao Q | Arch Gynecol Obstet
Aim: To summarize the clinical features and maternal–infant outcomes of 230 pregnant women (154 patients gave birth) infected with COVID-19 and their 156 infants, including the possibility and evidence of vertical transmission.
|
|
|
12/3/20
|
Zhou S, Xu J, Xue C, et al. | Ren Fail
Aim: To review the evidence on kidney-related outcomes of three recent pandemics: SARS, MERS, and COVID-19, which were associated with potentially fatal acute respiratory distress syndrome (ARDS). UPDATED
|
|
|
12/3/20
|
Cai XJ, Tay JCK, Kui SL, et al. | Singapore Med J
Aim: To study in-hospital mortality in COVID-19 patients who were on ACEI/ARB as compared to those not on ACEI/ARB.
|
|
|
12/3/20
|
do Amaral WN, de Moraes CL, Dos Santos Rodrigues AP, et al. | Healthcare
Aim: To investigate pregnant women infected with COVID-19 in terms of signs and symptoms, type of delivery, comorbidities, maternal and neonatal outcomes, and the possibility of vertical transmission.
|
|
|
12/3/20
|
Aburas W, Alshammari TM | Saudi Pharm J
Aim: To provide an overview of pharmacists’ roles in disasters and formulating a definition of expected roles and tasks through which they can perform these roles properly.
|
|
|
12/3/20
|
Mahdi SS, Ahmed Z, Allana R, et al. | Medicina
Aim: To identify additional infection control measures implemented in dental practice globally to prevent cross-infection and evaluate the psychological impacts of the pandemic among dental professionals.
|
|
|
12/2/20
|
Fraiman P, Godeiro C, Moro E, et al. | Front Neurol
Aim: To review the evidence on the cerebrovascular events in COVID-19 infection.
|
|
|
12/2/20
|
Gunn H, McCormack S | CADTH
|
|
|
12/2/20
|
Das RR, Behera B, Mishra B, et al. | Indian J Med Microbiol
Aim: To review the effect of chloroquine and hydroxychloroquine on COVID-19 virological outcomes.
|
|
|
12/2/20
|
Loomba RS, Aggarwal G, Villarreal EG, et al. | Blood Coagul Fibrinolysis
Aim: To compare laboratory results in COVID-19 patients with and without DVT with the aim of identifying risk factors for DVT in this population.
|
|
|
12/2/20
|
Zhou L, Wang J, Xie R, et al. | J Altern Complement Med
Aim: To assess the effects of TCM as an auxiliary treatment for COVID-19 through a systematic review of randomized-controlled trials (RCTs). UPDATED
|
|
|
12/2/20
|
Malas MB, Naazie IN, Elsayed N, et al. | EClinicalMedicine
Aim: To estimate the overall rates of TE of COVID-19 and further determine the association of TE with mortality among patients with COVID-19.
|
|
|
12/1/20
|
Shimabukuro PMS, Duarte ML, Imoto AM, et al. | Sao Paulo Med J
Aim: To identify, systematically evaluate and summarize the best available scientific evidence on environmental cleaning to prevent COVID-19 infection.
|
|
|
12/1/20
|
Yang J, Tian C, Chen Y, et al. | J Med Virol
Aim: To evaluate the impact of obesity on the onset, exacerbation, and mortality of coronavirus disease 2019 (COVID?19); and compare the effects of different degrees of obesity. UPDATED
|
|
|
12/1/20
|
Schunemann HJ, Khabsa J, Solo K, et al. | Ann Intern Med
Aim: To review multiple streams of evidence regarding the benefits and harms of ventilation techniques for coronavirus infections, including that causing COVID-19. UPDATED
|
|
|
11/30/20
|
Graber K, Byrne E, Goodacre E, et al. | Child Care Health Dev
Aim: To review of the impact of quarantine, isolation, or other restrictive environments on children’s play and whether play may mitigate the adverse effects of such restrictions. UPDATED
|
|
|
11/30/20
|
da Rosa Mesquita R, Silva LCF, Santana FMS, et al. | Wien Klin Wochenschr
Aim: To systematize the literature regarding clinical manifestations of patients with confirmed COVID-19.
|
|
|
11/30/20
|
Wang Z, Deng H, Ou C, et al. | Medicine
Aim: To compare the differences in the field of demographic, comorbidities, clinical symptoms, complications and outcomes between severe and non-severe COVID-19.
|
|
|
11/30/20
|
Raja MA, Mendoza MA, Villavicencio A, et al. | Transplant Rev
Aim: To help expand our current limited knowledge base regarding COVID-19 in SOT recipients, especially looking at clinical presentations, treatment modalities and outcomes.
|
|
|
11/30/20
|
Meher BR, Padhy BM, Das S, et al. | J Assoc Physicians India
Aim: To evaluate the currently available data to provide evidence about CPT in COVD-19 patients.
|
|
|
11/30/20
|
Amiri-Dashatan N, Koushki M, Ghorbani F, et al. | Gastroenterol Hepatol Bed Bench
Aim: To determine whether patients with elevated CRP, TNF?, and IL-6 levels may be at increased risk for severe infection and liver damage of COVID-19.
|
|
|
11/30/20
|
Makvandi S, Ashtari S, Vahedian-Azimi A | Gastroenterol Hepatol Bed Bench
Aim: To evaluate the symptoms of COVID-19 in pregnant women with a focus on gastrointestinal symptoms.
|
|
|
11/30/20
|
Bell V, Wade D | Soc Psychiatr Epidemiol
Aim: To estimate the additional burden of working directly with infected patients during epidemic and pandemic health emergencies. UPDATED
|
|
|
11/30/20
|
Hannum ME, Ramirez VA, Lipson SJ, et al. | Chem Senses
Aim: To provide a comprehensive assessment of methodologies currently employed to quantify smell loss in COVID-19–positive patients and examine whether method type affects reported prevalence of smell loss in COVID-19 patients. UPDATED
|
|
|
11/30/20
|
Mousquer GT, Peres A, Fiegenbaum M | Tuberculosis
Aim: To conduct a systematic review on the current literature on TB/COVID-19 co-infection cohorts, evaluating clinical and epidemiological data, focusing on its implications to the immune system.
|
|
|
11/30/20
|
Bekele F, Sheleme T, Fekadu G, et al. | SAGE Open Med
Aim: To summarize the knowledge, attitudes, and practice of COVID-19 among the general population and health workers across the globe.
|
|
|
11/30/20
|
Afra HS, Amiri-Dashatan N, Ghorbani F, et al. | Gastroenterol Hepatol Bed Bench
Aim: To report a pooled analysis of the association of the circulating levels of liver enzymes and total bilirubin with severe and non-severe COVID-19.
|
|
|
11/30/20
|
Bareeqa SB, Ahmed SI, Samar SS, et al. | Int J Psychiatry Med
Aim: To quantify COVID-19 mental health issues and its prevalence in China during the early period of the COVID-19 crisis. UPDATED
|
|
|
11/30/20
|
Thrinuavukkarasu S, Kapoor N, Tina Cao, et al. | Diabetes Obes Metab
Aim: To examine the proportion of newly diagnosed diabetes in COVID-19 patients.
|
|
|
11/30/20
|
Azam M, Sulistiana R, Ratnawati M, et al. | Sci Rep
Aim: To estimate the incidence of recurrent SARS-CoV-2 RNA positivity after recovery from COVID-19 and to determine the factors associated with recurrent positivity. UPDATED
|
|
|
11/30/20
|
Maraolo AE, Grosi A | Immun Inflamm Dis
Aim: To gauge the safety profile of HCQ/CQ in the context of COVID?19 pandemic on the basis of data from RCTs published so far, to highlight the trade?off between pros and cons of HCQ/CQ repurposing to treat or prevent SARS?CoV?2 infection.
|
|
|
11/30/20
|
Jammu A, Chasen M, Lofters A, et al. | Support Care Cancer
Aim: To synthesise the available knowledge regarding the impact of the COVID-19 pandemic. UPDATED
|
|
|
11/30/20
|
Cardwell K, Jordan K, Byrne P, et al. | Rev Med Virol
Aim: To summarise the evidence on non?contact thermal screening as a method through which to identify cases and reduce the spread of coronavirus disease (Covid?19).
|
|
|
11/30/20
|
Allan SM, Bealey R, Birch J, et al. | Eur J Psychotraumatol
Aim: To estimate the prevalence of common mental health disorders in HCWs based in hospitals where pandemic-affected patients were treated. UPDATED
|
|
|
11/30/20
|
Islam N, Salameh JP, Leeflang MMG, et al. | Cochrane Database Syst Rev
Aim: To determine the diagnostic accuracy of chest imaging (computed tomography (CT), X?ray and ultrasound) in people with suspected or confirmed COVID?19. UPDATED
DIAGNOSTICS
|
|
|
11/28/20
|
Pasin L, Navalesi P, Zangrillo A, et al. | J Cardiothorac Vasc Anesth
Aim: To evaluate the effect of corticosteroid therapy in patients with COVID-19 at different severity levels.
|
|
|
11/27/20
|
Arruda AG, Beyene TJ, Kieffer J, et al. | Animals
Aim: To summarize the available literature on swine depopulation methods and to highlight critical gaps in knowledge.
|
|
|
11/27/20
|
Wang Z, Deng H, Ou C, et al. | Medicine (Baltimore)
Aim: To compare the differences in the field of demographic, comorbidities, clinical symptoms, complications and outcomes between severe and non-severe COVID-19. To conclude the potential risk factors to severe COVID-19 patients. UPDATED
|
|
|
11/27/20
|
Zhang X, Yang X, Jiao H, et al. | Aging
Aim: To investigate the role of coagulation dysfunction in the severity of COVID-19 progression.
CLINICAL CHARACTERISTICS
|
|
|
11/27/20
|
Asadi-Pooya AA, Simani L, Shahisavandi M, et al. | Neurol Sci
Aim: To discuss the evidence on the occurrence of de novo seizures in patients with COVID-19, the consequences of this catastrophic disease in people with epilepsy (PWE), and the electroencephalographic (EEG) findings in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/27/20
|
Griffin J, Casey M, Collins Á, et al. | BMJ Open
Aim: To conduct a review of available evidence to advise on appropriate parameter values for serial interval and generation time in national COVID-19 transmission models for Ireland and on methodological issues relating to those parameters. UPDATED
|
|
|
11/27/20
|
Rostami A, Sepidarkish M, Leeflang MMG, et al. | Clin Microbiol Infect
Aim: To estimate the global and regional seroprevalence rates in humans of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and to assess whether seroprevalence is associated with geographical, climatic and/or sociodemographic factors.
CLINICAL CHARACTERISTICS
|
|
|
11/27/20
|
Kuek JTY, Ngiam LXL, Kamal NHA, et al. | Philos Ethics Humanit Med
Aim: To evaluate prevailing accounts of physicians facing dying patients in ICUs through the lens of Personhood.
MENTAL HEALTH
|
|
|
11/27/20
|
Amicucci M, Mastronuzzi A, Ciaralli I, et al. | J Clin Med
Aim: To collect and analyze scientific literature regarding the management, interventions, and strategies to prevent the spread of COVID-19 in children with cancer.
INFECTION CONTROL
|
|
|
11/27/20
|
Dar-Odeh N, Elsayed S, Babkair H, et al. | J Dent Sci
Aim: To highlight COVID-19 pharmacotherapeutic agents that are relevant to dental practice in terms of their clinical indications in COVID-19 and dental practice, as well as their adverse effects as they impact the dental patient.
CANDIDATE THERAPEUTICS
|
|
|
11/26/20
|
Lombardi A, Asahi AM, Gupta A, et al. | Radiol Med
Aim: To review the most common extra-pulmonary manifestations of SARS, Influenza, MERS, and COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/25/20
|
Vakhshoori M, Heidarpour M, Shafie D, et al. | Arch Iran Med
Aim: To analyze the available COVID-19 data on acute cardiac injury, using troponin and brain natriuretic peptide (BNP) levels.
CLINICAL CHARACTERISTICS
|
|
|
11/25/20
|
Yang X, Tian S, Guo H | Int Immunopharmacol
Aim: To gain clarity regarding AKI incidence and renal replacement therapy (RRT) use in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
11/25/20
|
Karabay M, Ç?nar N, Karakaya Suzan Ö, et al. | J Matern Fetal Neonatal Med
Aim: To investigate the available evidence describing neonatal outcomes in newborns who have SARS-CoV-2 infection in order to guide prevention of COVID-19 in newborns. UPDATED
INFECTION CONTROL
|
|
|
11/25/20
|
Chu C, Zeng S, Hasan AA, et al. | Br J Clin Pharmacol
Aim: To review the evidence on the effect of RAAS blockers on the expression of ACE2 and the risk of SARS-Cov-2 infection.
CLINICAL CHARACTERISTICS
|
|
|
11/25/20
|
Sameni F, Hajikhani B, Yaslianifard S, et al. | Front Med
Aim: To provide a systematic review and meta-analysis of various skin manifestations among patients with COVID-19 through case reports/case series and prevalence studies.
CLINICAL CHARACTERISTICS
|
|
|
11/25/20
|
Jindal R, Chauhan P | J Family Med Prim Care
Aim: To describe the cutaneous manifestations of COVID-19 patients from diverse regions with the aim of highlighting any important associations.
CLINICAL CHARACTERISTICS
|
|
|
11/25/20
|
Garg M, Gupta P, Maralakunte M, et al. | Clin Imaging
Aim: To evaluate pooled prevalence, sensitivity, and specificity of chest computed tomography (CT) and radiographic findings for novel coronavirus-2019 (COVID-19) pneumonia.
DIAGNOSTICS
|
|
|
11/25/20
|
Kiss S, Gede N, Hegyi P, et al. | Med Microbiol Immunol
Aim: To review the evidence on the correlation between early changes in the laboratory parameters and the clinical outcomes of COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/25/20
|
Wang KC, Xiao R, Cheung ZB, et al. | J Orthop
Aim: To assess the risk of early mortality in hip fracture patients with COVID-19 infection who undergo surgical intervention.
CLINICAL CHARACTERISTICS
|
|
|
11/25/20
|
Li B, Zhang S, Zhang R, et al. | Front Pediatr
Aim: To evaluate the epidemiological spectrum and clinical characteristics of children infected with SARS-CoV-2. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/25/20
|
Paul D, Gupta A, Maurya AK | PLoS One
Aim: To evaluate research done, prior to COVID-19 pandemic, on various decontamination methods for reprocessing of N95-FFRs. UPDATED
INFECTION CONTROL
|
|
|
11/25/20
|
Nearchou F, Flinn C, Hennessy E, et al | Int J Environ Res Public Health
Aim: To provide a systematic review of the evidence on the COVID-19 pandemic's impact on youth mental health. UPDATED
MENTAL HEALTH
|
|
|
11/25/20
|
Lee Y, Kirubarajan A, Patro N, et al. | Am J Surg
Aim: To assess all research literature related to changes in surgical practice during disease outbreaks and epidemics, especially during the current COVID-19 pandemic.
INFECTION CONTROL
|
|
|
11/25/20
|
Jiménez D, García-Sanchez A, Rali P, et al. | Chest
Aim: To review the evidence on the incidence of VTE and bleeding among hospitalized patients with COVID-19? UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/25/20
|
Saniasiaya J, Islam MA, Abdullah B | Laryngoscope
Aim: To estimate the overall pooled prevalence of olfactory dysfunction in COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/25/20
|
Singh AK, Jena A, Kumar-M P, et al. | United European Gastroenterol J
Aim: To review the evidence on the risk of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infection and clinical outcomes of coronavirus disease (COVID-19) in inflammatory bowel disease.
CLINICAL CHARACTERISTICS
|
|
|
11/25/20
|
Galanis P, Vraka I, Fragkou D, et al. | J Hosp Infect
Aim: To determine the seroprevalence of SARS-CoV-2 antibodies among HCWs, and to find out the factors that are associated with this seroprevalence. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/25/20
|
Katsanos AH, Palaiodimou L, Zand R, et al. | Ann Neurol
Aim: To evaluate the potential impact of coronavirus disease (COVID-19) on the management and outcomes of acute stroke.
CLINICAL CHARACTERISTICS
|
|
|
11/24/20
|
Chang PC, Yang CC, Kao KC, et al | Aging
Aim: To compare clinical outcomes in patients hospitalized for COVID-19 with those of patients hospitalized for SARS.
CLINICAL CHARACTERISTICS
|
|
|
11/24/20
|
Zhang G, Wu Y, Xu R, et al. | J Med Virol
Aim: To explore whether the use of RAAS inhibitors was associated with severe disease and mortality in COVID?19 patients.
CANDIDATE THERAPEUTICS
|
|
|
11/24/20
|
France R, Vseteckova J, Lapwood S, et wood | Oxford COVID-19 Evidence Service
|
|
|
11/24/20
|
Novoa RH, Quintana W, Llancarí P, et al. | Travel Med Infect Dis
Aim: To review all cases from the current literature and provide up-to-date scientific evidence on the clinical characteristics, maternal outcomes, perinatal outcomes and the possibility of vertical transmission in the infected pregnant women. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/24/20
|
Perveen RA, Nasir M, Talha KA, et al. | Med J Malaysia
Aim: To evaluate the effectiveness of antiviral therapies in the treatment of COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
11/23/20
|
Bedrosian N, Mitchell E, Rohm E, et al. | Environ Sci Technol
Aim: To review the evidence on hygiene intervention effectiveness against SARS-CoV-2.
INFECTION CONTROL
|
|
|
11/23/20
|
Zhang J, Wang H, Wei M, et al. | Aging
Aim: To assess the incidence of cerebrovascular disease as a comorbidity in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
11/20/20
|
Ji P, Zhu J, Zhong Z, et al. | Medicine
Aim: To review the evidence on the potential association between inflammatory markers and severe COVID-19.
|
|
|
11/20/20
|
Takla M, Jeevaratnam K | Saudi Pharm J
Aim: To systematically identify and collate 24 studies describing the use of CQ and HCQ in human clinical trials and to provide a detailed synthesis of evidence of its efficacy and safety.
CANDIDATE THERAPEUTICS
|
|
|
11/20/20
|
Turkistani K & Turkistani K | J Int Soc Prev Community Dent
Aim: To provide dentists and dental auxiliary with insights regarding risk and precautions during COVID-19 crisis.
INFECTION CONTROL
|
|
|
11/20/20
|
Abdo C, Miranda EP, Santos CS, et al. | Indian J Psychiatry
Aim: To perform a systematic review of the literature regarding the consequences of severe acute respiratory syndrome-CoV-2 infection in terms of domestic violence and substance abuse, and compare incidences found.
MENTAL HEALTH
|
|
|
11/20/20
|
Rezapour A, Souresafil A, Peighambari MM, et al. | Int J Surg
Aim: To summarize economic evaluation evidence of preventing strategies, programs, and treatments of COVID-19.
|
|
|
11/20/20
|
Park S, Lee Y, Michelow IC, et al. | Open Forum Infect Dis
Aim: To systematically address the global seasonal patterns of human coronavirus (HCoV) infections.
INFECTION CONTROL
|
|
|
11/20/20
|
Bin Arif T, Khalid S, Siddiqui MS, et al. | Hong Kong Med J
Aim: To provide insight into the incidence, patterns, risk factors, histopathological findings, and relationship with disease severity of COVID-19-associated liver injury.
CLINICAL CHARACTERISTICS
|
|
|
11/20/20
|
Robertson LJ, Maposa I, Somaroo H, et al. | S Afr Med J
Aim: To understand which mental health conditions may occur in healthcare workers and which interventions could be considered during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
11/20/20
|
Liu D, Baumeister RF, Zhou Y | J of Psychiatric Res
Aim: To examine how the mental status of SARS survivors changed after infection and after hospital release.
MENTAL HEALTH
|
|
|
11/20/20
|
Nunes JPL | Porto Biomed J
Aim: To perform a systematic review on mortality associated to the use of ACEi in patients with COVID-19 disease.
CANDIDATE THERAPEUTICS
|
|
|
11/20/20
|
Vijenthira A, Gong IY, Fox TA, et al. | Blood
Aim: To perform a systematic review and meta-analysis to estimate the risk of death and other important outcomes for patients with hematologic malignancy infected with COVID-19 .
CLINICAL CHARACTERISTICS
|
|
|
11/20/20
|
Bwire GM, Njiro BJ, Mwakawanga DL, et al. | Med Virol
Aim: To determine the likelihood of vertical transmission among COVID?19 exposed infants and determine whether antibodies against SARS?CoV?2 were generated among COVID?19 vertically exposed but negative infants.
INFECTION CONTROL
|
|
|
11/20/20
|
Wang C, Zhang H, Zhou M, et al. | Eur Rev Med Pharmacol Sci
Aim: To explore the relationship between the prognosis of COVID-19 patients and thromboembolic events.
CLINICAL CHARACTERISTICS
|
|
|
11/20/20
|
Gómez-Durán EL, Martin-Fumadó C, Forero CG. | Occup Environ Med
Aim: To summarise the research evidence on the psychological impact of quarantine on healthcare workers.
MENTAL HEALTH
|
|
|
11/20/20
|
Faraone I, Labanca F, Ponticelli M, et al. | Molecules
Aim: To analyze preclinical and clinical studies on HCQ potential use in viral infection and chronic diseases.
CANDIDATE THERAPEUTICS
|
|
|
11/20/20
|
Younes S, Younes N, Shurrab F, et al. | Rev Med Virol
Aim: To compile and discuss all articles that describe experimental or natural infections with SARS-CoV-2.
INFECTION CONTROL
|
|
|
11/20/20
|
Tsankov BK, Allaire JM, Irvine MA, et al | Int J Infect Dis
Aim: To investigate the effects of pediatric comorbidities on COVID-19 severity.
CLINICAL CHARACTERISTICS
|
|
|
11/20/20
|
Dorantes-Acosta E, Ávila-Montiel D, Klünder-Klünder M, et al. | Bol Med Hosp Infant Mex
Aim: To analyze the available data associated with COVID-19 infection and mortality in pediatric cancer patients and to provide useful information to plan and design strategies in this group.
CLINICAL CHARACTERISTICS
|
|
|
11/20/20
|
Zreiq R, Haouas N, Khemakhem AM, et al. | J of Pharmaceutical Res
Aim: To review the "state-of-the-art" of treatment modalities and propose a practical therapeutic algorithm for the COVID-19 management.
CANDIDATE THERAPEUTICS
|
|
|
11/20/20
|
Zhao M, Lu J, Tang Y, et al. | Eur J Clin Pharmacol
Aim: To explore the effectiveness and safety of tocilizumab recently used for treating COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
11/20/20
|
Sánchez OR, Vale DB, Rodrigues L, et al. | Int J Gynaecol Obstet
Aim: To analyze the existing scientific literature on strategies and recommendations to respond to VAW during the implementation of social distancing measures in response to the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
11/20/20
|
National Collaborating Centre for Methods and Tools | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the risk of COVID-19 transmission across different indoor settings in the community.
INFECTION CONTROL
|
|
|
11/19/20
|
Mair M, Singhavi H, Pai A, et al. | Laryngoscope
Aim: To examine the pooled prevalence of symptoms, laboratory tests, and imaging of all COVID-19 infected patients.
|
|
|
11/19/20
|
Alves GS, Casali ME, Veras AB, et al. | Front Psychiatry
Aim: To discuss psychoeducation measures and brief psychosocial interventions designed in a home setting.
MENTAL HEALTH
|
|
|
11/19/20
|
Kashour T, Abdulhak AAB, Tlayjeh H, et al. | Am J Ther
Aim: To review the evidence on the association between prior use of ACEIs and ARBs and mortality due to COVID-19 disease.
CLINICAL CHARACTERISTICS
|
|
|
11/19/20
|
Ouyang L, Gong Y, Zhu Y, et al. | Am J Emerg Med
Aim: To explore the relationship of acute kidney injury (AKI) with the severity and mortality of coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
|
|
|
11/19/20
|
Kubjane M, McCreedy N, Cariou B, et al. | Endocrinol Metab
Aim: To investigate the association between diabetes and COVID-19 disease severity in patients hospitalized due to COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/19/20
|
Cheruiyot I, Kipkorir V, Ngure B, et al. | Am J Emerg Med
Aim: To evaluate whether malignancies are associated with a significantly enhanced odds of COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
|
|
|
11/19/20
|
Case Fatality Rates for COVID-19 Patients Requiring Invasive Mechanical Ventilation: A Meta-analysis
Lim ZJ, Subramaniam A, Reddy MP, et al. | Am J Respir Crit Care Med
Aim: To examine the case fatality rate of patients with COVID-19 receiving invasive medical ventilation.
CANDIDATE THERAPEUTICS
|
|
|
11/19/20
|
Udomsinprasert W, Jittikoon J, Sangroongruangsri S, et al. | J Clin Immunol
Aim: To determine associations of circulating levels of inflammatory cytokines with severity and mortality of COVID-19 by systematic review and meta-analysis.
CLINICAL CHARACTERISTICS
|
|
|
11/19/20
|
Sze S, Pan D, Nevill CR, et al. | EClinicalMedicine
Aim: To determine whether the risk of SARS-CoV-2 infection, COVID-19 intensive care unit (ICU) admission and mortality are associated with ethnicity. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/19/20
|
Meng M, Zhao Q, Kumar R, et al. | Aging
Aim: To review the evidence on the effects of coronary heart disease (CHD), hypertension and diabetes on the development of severe COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/19/20
|
Goldstein KM, Ghadimi K, Mystakelis H, et al. | VA Evidence Synthesis Program
Aim: To review the evidence on the risk of transmitting SARS-CoV-2, SARS, MERS, and influenza with administration of drugs via nebulizer UPDATED VA ESP
|
|
|
11/19/20
|
Beaudry G, Zhong S, Whiting D, et al. | BMJ Glob Health
Aim: To synthesise the evidence on outbreaks of highly contagious diseases in prison. UPDATED
INFECTION CONTROL
|
|
|
11/19/20
|
Liaw J, Saadi R, Patel VA, et al. | Otol Neurotol
Aim: To systematically review the available medical literature to investigate the viral load in the middle ear and mastoid cavity and the potential risk of exposure to airborne viruses during otologic surgery.
INFECTION CONTROL
|
|
|
11/19/20
|
Yang J, Tian C, Chen Y, et al. | J Med Virol
Aim: To explore the relationship between obesity and COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/19/20
|
Li X, Liu C, Mao Z, et al. | Crit Care
Aim: To evaluate the predictive values of NLR on disease severity and mortality in COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/19/20
|
Stegeman I, Ochodo EA, Guleid F, et al. | Cochrane Database Syst Rev
Aim: To assess the diagnostic accuracy of routine laboratory testing as a triage test to determine if a person has COVID?19. UPDATED
|
|
|
11/19/20
|
Mehraeen E, Salehi MA, Behnezhad F, et al. | Infect Disord Drug Targets
Aim: To review the current evidence of COVID-19 transmission modes.
INFECTION CONTROL
|
|
|
11/19/20
|
Wu T, Zou Z, Yang D, et al. | Age Aging
Aim: To explore the factors associated with prevalence of venous thromboembolism (VTE) in COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/18/20
|
Galli F, Pozzi G, Ruggiero F, et al. | Front Psychiatry
Aim: To provide evidence of the psychopathologic burden on health care workers (HCWs) of the first two deadly coronavirus outbreaks to get lessons for managing the current burden of COVID-19 outbreak.
MENTAL HEALTH
|
|
|
11/18/20
|
Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review
Serafim RB, Póvoa P, Souza-Dantas V, et al. | Clin Microbiol Infect
Aim: To describe the clinical course and outcomes of COVID-19 pneumonia in critically ill patients. UPDATED
|
|
|
11/18/20
|
Abdulla S, Hussain A, Azim D, et al. | Cureus
Aim: To draw generalized conclusions regarding impaired liver biochemistry and its potential relationship with COVID-19 disease severity.
CLINICAL CHARACTERISTICS
|
|
|
11/18/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence for transmission of COVID-19 in different settings, and to determine which settings are high risk.
|
|
|
11/18/20
|
Bansal A, Kumar A, Patel D, et al. | Am J Cardiol
Aim: To evaluate the association between cardiac injury and all-cause mortality, intensive care unit (ICU) admission, mechanical ventilation, acute respiratory distress syndrome, acute kidney injury and coagulopathy.
|
|
|
11/18/20
|
Spencer N, Nathawad R, Arpin E, et al. | BMJ Paediatr Open
Aim: To review the evidence on the impact of pandemics on existing inequities in routine vaccination coverage.
|
|
|
11/18/20
|
Fischer R, Bortolini T, Karl JA, et al. | Front Psychol
Aim: To provide a broad summary of the current evidence drawn from published meta-analyses in order to evaluate the effectiveness of self-guided therapeutic practices which can be implemented by individuals on their own, including during physical distancing and quarantine measures.
MENTAL HEALTH
|
|
|
11/18/20
|
Koshy AN, Murphy AC, Farouque O, et al. | Intern Med J
Aim: To investigate whether RAS inhibitors increased the likelihood of a positive test or death/severe illness in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/18/20
|
Kaye A, Siegel R | PeerJ
Aim: To investigate and synthesize existing evidence for the efficacy of TCZ in reducing COVID-19 mortality. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
11/18/20
|
Ramos CCR, Roque JLA, Sarmiento DB, et al. | Int J Health Sci
Aim: To review the literature on the use of ultraviolet-C (UV-C) sterilization to assess its clinical efficacy in reducing risk and transmission of nosocomial infections as well as its associated health safety or hazards.
INFECTION CONTROL
|
|
|
11/17/20
|
Yonas E, Alwi I, Pranata R, et al. | Diabetes Metab Syndr
Aim: To comprehensively study the various levels of immunological parameters in patients with COVID 19.
|
|
|
11/17/20
|
Hussein M, Toraih E, Elshazli R, et al. | Ann Surg
Aim: To systematically review and meta-analyze all literature reporting the basic reproductive number (R0), effective reproductive number (Re or Rt), and the serial interval (SI) values of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection.
|
|
|
11/17/20
|
Kansagara D, Mackey K, Vela K, et al. | Ann Intern Med
Aim: To synthesize evidence on the role of ACE inhibitor and ARB use on patient outcomes in COVID-19 as well as evidence on the benefits and harms of initiating these medications to treat patients with COVID-19. UPDATED WHO COLLABORATIVE VA ESP
|
|
|
11/16/20
|
Yoon YK, Lee J, Kim SI, et al | J Korean Med Sci
Aim: To derive suggestions for short-, mid-, and long-term strategies for medical resource management beyond the COVID-19 pandemic.
|
|
|
11/16/20
|
Raharja A, Tamara A, Kok LT | J Racial Ethn Health Disparities
Aim: To review the association between ethnicity and poor Covid-19 outcomes including all-cause mortality, hospitalisation, critical care admission, respiratory and kidney failure. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/16/20
|
Wong CKH, Wong JYH, Tang EHM, et al. | Sci Rep
Aim: To investigate the comorbidities, symptoms, clinical characteristics and treatment of COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/16/20
|
Joseph B, Dibas M, Evanson KW, et al. | Expert Rev Anti Infect Ther
Aim: To systematically review the clinical literature reporting the use of Lopinavir/ritonavir (LPV/r) for the treatment of patients with COVID-19 to assess the efficacy of LPV/r for the treatment of Cornonavirus disease 19 (COVID-19).
CANDIDATE THERAPEUTICS
|
|
|
11/16/20
|
Yang Q, Yang X | PLoS One
Aim: To evaluate the association of kidney impairment with the development of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/16/20
|
Juhasz MF, Ocskay K, Kiss S, et al. | World J Gastroenterol
Aim: To assess all the available evidence in the literature relating to coronavirus disease 2019 (COVID-19) and AP. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/16/20
|
Akin H, Kurt R, Tufan F, et al. | Diseases
Aim: Too present the currently available data regarding the GI symptoms of COVID-19 patients, and to compare the frequency of GI symptoms in early stage (Eastern) mostly Chinese data to the current stage (Western) non-Chinese data.
CLINICAL CHARACTERISTICS
|
|
|
11/16/20
|
Pant S, Perras C | CADTH
Aim: To describe the trial characteristics and estimated primary completion dates of the ongoing phase II, phase III, and phase IV studies evaluating drugs to prevent or treat COVID-19. UPDATED
|
|
|
11/16/20
|
Bustos R, Jaramillo-Bustamante JC, Vasquez-Hoyos P, et al. | Pediatr Emerg Care
Aim: To review the evidence on pediatric inflammatory multisystem syndrome associated with SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
11/16/20
|
Pinedo-Torres I, Flores-Fernandez M, Yovera-Aldana M, et al. | Clin Med Insights Endocrinol Diabetes
Aim: To determine the prevalence of diabetes comorbidity and its associated unfavorable health outcomes in patients with acute respiratory syndromes for coronavirus disease according to virus types. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/14/20
|
Zou H, Lu J, Liu J, et al. | Int J Infect Dis
Aim: To collect current evidence on pediatric PMIS and provide insights into pathogenesis, hopefully, providing possible clues for further research and treatment at this moment.
|
|
|
11/13/20
|
Haiduc AA, Ogunjimi M, Shammus R, et al. | Cardiol Young
Aim: To examine the literature to determine if both paediatric and adult patients diagnosed with congenital heart disease (CHD) are at a higher risk of poor outcomes if they have the coronavirus disease 2019 (COVID-19), compared to those without CHD.
CLINICAL CHARACTERISTICS
|
|
|
11/13/20
|
Kubota T, Kuroda N | Clin Neurol Neurosurg
Aim: To evaluate the severity of COVID-19 and its effect on neurological symptoms in patients with preexisting neurological disorder and COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/13/20
|
Bellos I, Pandita A, Panza R | Eur J Obstet Gynecol Reprod Biol
Aim: To evaluate maternal and neonatal outcomes in covid-19 pregnancies and identify factors associated with perinatal viral transmission.
|
|
|
11/13/20
|
Lin L, Wang X, Ren J, et al. | BMJ Open
Aim: To analyse the incidence, risk factors and impact of acute kidney injury (AKI) on the prognosis of patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/13/20
|
Li H, Hu Y, Tang H, et al. | Am J Chin Med
Aim: To systematically review evidence on the efficacy and safety of glycyrrhizin preparations for SARS and MERS for application to COVID-19.
|
|
|
11/12/20
|
Bellini D, Panvini N, Carbone I, et al. | J Comput Assist Tomogr
Aim: To perform a meta-analysis assessing the diagnostic yield of computed tomography (CT) for the identification of coronavirus disease 2019 (COVID-19) using repeated reverse transcriptase polymerase chain reaction testing or confirmed true-negative state as reference standard.
|
|
|
11/12/20
|
Wang K, Wu C, Xu J, et al. | EClinicalMedicine
Aim: To describe the clinical outcomes of operative patients with COVID-19, and the safety of medical staff during the perioperative period to take appropriate protective measures to avoid cross-infection.
|
|
|
11/12/20
|
Fredericks S, Miranda J, Sidani S, et al. | Brain Behav Immun Health
Aim: To inform evidence-based decision-making pertaining to the selection of effective strategies or therapies that this cohort could use to promote mental health and resilience both within the clinical practice and academic environment.
|
|
|
11/12/20
|
Hong TS, Gonzalez J, Nahass RG, et al. | Pharmacy
Aim: To evaluate the impact of HCQ exposure on mortality in hospitalized patients with COVID-19.
|
|
|
11/12/20
|
Vardhelli V, Pandita A, Pillai A, et al. | Eur J Pediatr
Aim: To summarize available literature on the clinical spectrum of COVID-19 in neonates and mothers and suggest a practical approach towards management of clinical scenarios.
|
|
|
11/12/20
|
Li P, Wang Y, Peppelenbosch MP, et al. | Int J Infect Dis
Aim: To comprehensively compare the clinical features of hospitalized COVID-19 patients with hospitalized 2009 influenza pandemic patients.
|
|
|
11/11/20
|
Kuswardhani RAT, Henrina J, Pranata R, et al. | Diabetes Metab Syndr
Aim: To assess the association between CCI and a composite of poor outcomes in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
11/11/20
|
Mahalingasivam V, Carik A, Tomlinson LA, et al. | Kidney Int Rep
Aim: To synthesise, analyse and appraise what has been learnt so far to help clinicians and policy makers better understand the risks to kidney transplant recipients, as well as identify gaps for future collaborative research for this global health challenge. UPDATED
INFECTION CONTROL
|
|
|
11/11/20
|
Zuin M, Guasti P, Roncon L, et al. | Int J Geriatr Psychiatry
Aim: To evaluate the mortality risk in elderly patients with dementia and COVID?19 infection.
|
|
|
11/11/20
|
Tleyjeh IM, Kashour Z, Damlaj M, et al. | Clin Microbiol Infect
Aim: To perform a living systematic review of the literature about the efficacy and toxicity of the IL-6 receptor antagonist, tocilizumab, in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
11/11/20
|
Oscanoa TJ, Vidal X, Kanters JK, et al. | Int J Antimicrob Agents
Aim: To conduct a meta-analysis of the frequency of LQT in patients with SARS-CoV-2 infection treated with HCQ.
CANDIDATE THERAPEUTICS
|
|
|
11/11/20
|
Aziz M, Haghbin H, Lee-Smith W, et al. | Ann Gastroenterol
Aim: To review the evidence on the gastrointestinal predictors of severe COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/11/20
|
Choi Y, Lee MK | Eur J Radiol
Aim: To comprehensively evaluate the incidences of abnormal neuroimaging findings in patients with COVID-19 via a systematic review and meta-analysis.
CLINICAL CHARACTERISTICS
|
|
|
11/11/20
|
Hellou MM, Gorska A, Mazzaferri F, et al. | Clin Microbiol Infect
Aim: To evaluate the diagnostic test accuracy (DTA) of nucleic acid amplification tests (NAATs) for the diagnosis of coronavirus infections.
|
|
|
11/11/20
|
Mudatsir M, Fajar JK, Wulandari L, et al. | F1000
Aim: To identify the predictors associated with poor clinical outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/11/20
|
Cachon-Zagalaz J, Sanchez-Zafra M, Sanabrias-Moreno D, et al. | Front Psychol
Aim: To learn about the research carried out on the child population in times of confinement, especially those dealing with the psychological and motor aspects of minors.
MENTAL HEALTH
|
|
|
11/11/20
|
Tleyjeh I, Kashour Z, Al Dosary O, et al. | Mayo Clin Proc Innov Qual Outcomes
Aim: To systematically review the literature and estimate the risk of cardiac toxicity in patients receiving CQ or HCQ for COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
11/11/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on monitoring wastewater as a surveillance strategy for COVID-19.
|
|
|
11/9/20
|
Ren L, Xu W, Overton JL, et al. | Front Pharmacol
Aim: To examine the safety profiles of these medications, we systematically evaluated the adverse events (AEs) of these medications from published randomized controlled trials (RCTs). UPDATED
CANDIDATE THERAPEUTICS
|
|
|
11/9/20
|
Alimohamadi Y, Sepandi M, Taghdir M, et al. | J Prev Med Hyg
Aim: To estimate the prevalence of clinical symptoms of COVID-19 in a systematic review and meta-analysis.
CLINICAL CHARACTERISTICS
|
|
|
11/9/20
|
Mekonnen D, Mengist HM, Derbi A, et al. | Rev Med Virol
Aim: To assess the diagnostic test accuracy (DTA) of severe acute respiratory syndrome coronavirus 2 (SARS?COV?2) serological test methods and the kinetics of antibody positivity.
DIAGNOSTICS
|
|
|
11/9/20
|
Ye L, Yang Z, Liu J, et al. | J Gastroenterol Hepatol
Aim: To highlight the gaps in our knowledge about the prevalence and clinical significance of GI symptoms in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
11/9/20
|
Jeevananthan C, Muhamed NA, Jafaar MH, et al. | BMJ Open
Aim: To identify the effects of temperature, humidity and air quality in the transmission of SARS-CoV-2 and to determine if the effects are linked to anthropic activities. UPDATED
INFECTION CONTROL
|
|
|
11/9/20
|
Lebrasseur A, Fortin-Bedard N, Lettre J, et al. | Disabil Health J
Aim: To review the impact of the COVID-19 pandemic, and associated isolation and protective measures, among people with physical disabilities. UPDATED
MENTAL HEALTH
|
|
|
11/9/20
|
Yue J, Yan W, Sun Y, et al. | Psychol Med
Aim: To review the available data on the benefits of interventions to reduce adverse mental health sequelae of infectious disease outbreaks, and to offer guidance for mental health service responses to infectious disease pandemic.
MENTAL HEALTH
|
|
|
11/9/20
|
Aggarwal K, Agarwall A, Jaiswal N, et al. | PLoS ONE
Aim: To evaluate the epidemiology and clinical features of ocular surface manifestations and complications related to COVID-19 infection, to assess the risk of transmission to patients and healthcare workers through ocular secretions and to determine whether ocular involvement has any correlation with the severity of respiratory symptoms and overall prognosis. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/9/20
|
Hasan I, Rashid T, Suliman S, et al. | Rom J Intern Med
Aim: To review the evidence on COVID-19 in kidney transplant recipients.
CLINICAL CHARACTERISTICS
|
|
|
11/9/20
|
Ssentongo A, Ssentongo P, Heilbrunn E, et al | Open Heart
Aim: To explore the association of RAAS inhibitors, including angiotensin-converting inhibitors (ACEi) and angiotensin II receptor blockers (ARBs) with COVID-19 mortality in patients with hypertension. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/9/20
|
Kiss P, Carcel C, Hockham C, et al. | Eur Heart J Qual Care Clin Outcomes
Aim: To assess the extent to which health services related to the care and management of acute cardiovascular events have been impacted during the COVID-19 pandemic.
|
|
|
11/9/20
|
Matsushita K, Ding N, Kou M, et al. | Glob Heart
Aim: To explore pre-existing CVD and its traditional risk factors as risk factors of severe COVID-19 (defined as death, acute respiratory distress syndrome, mechanical ventilation, or intensive care unit admission). UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/9/20
|
Sridharan GK, Vegunta R, Rokkam VRP, et al. | Am J Ther
Aim: To examine and appraise the incidence of VTE, major VTE, PE, and DVT in hospitalized COVID-19 patients by meta-analysis methods and, in particular, analyze whether the use of therapeutic anticoagulation decreased the odds of thromboembolic events compared with prophylactic anticoagulation.
CLINICAL CHARACTERISTICS
|
|
|
11/6/20
|
Santos M, Torres D, Cardoso PC, et al. | Braz Oral Res
Aim: To investigate the efficiency of cloth masks in reducing transmission and contamination by droplets and aerosols for the general population and healthcare workers.
|
|
|
11/6/20
|
Mallett S, Allen J, Graziadio S, et al. | BMC Med
Aim: To examine at what time points during SARS?CoV?2 infection it is detectable at different anatomical sites using RT?PCR based tests. UPDATED
|
|
|
11/6/20
|
Yadav R, Srivastava DK, Bajpai PK, et al. | J Neurosci Rural Pract
Aim: To determine the neurological involvement and its manifestations in COVID-19 patients.
|
|
|
11/6/20
|
Pereira M, Damascena AD, Azevedo LMG, et al. | Crit Rev Food Sci Nutr
Aim: To analyze the association between vitamin D deficiency and COVID-19 severity, via an analysis of the prevalence of vitamin D deficiency and insufficiency in people with the disease.
|
|
|
11/5/20
|
Mirza FN, Malik AA, Omer SB, et al. | Int J Dermatol
Aim: To collate the available information on the dermatologic manifestations in COVID?19 patients to inform current practice and further research. UPDATED
|
|
|
11/5/20
|
Cheruiyot I, Sehmi P, Ominde B, et al | Neurol Sci
Aim: To identify and consolidate evidence of ICH in COVID-19 patients.
|
|
|
11/5/20
|
Alamoodi AH, Zaidan BB, Zaidan AA, et al. | Expert Syst Appl
Aim: To review and analyse articles about the occurrence of different types of infectious diseases, such as epidemics, pandemics, viruses or outbreaks, during the last 10 years, understand the application of sentiment analysis and obtain the most important literature findings.
|
|
|
11/4/20
|
Wu Z, Yang D | Eur J Med Res
Aim: To explore the probable clinical severity and mortality of COVID-19 patients and their liver dysfunction.
|
|
|
11/4/20
|
Park R, Lee S, Kim SY, et al | Acta Oncol
Aim: To summarize the existing evidence for the effect of active oncologic treatment on COVID-19 outcomes. UPDATED
|
|
|
11/4/20
|
Zhang H, Han H, He T, et al. | J Natl Cancer Inst
Aim: To review the evidence on the reported fatalities in COVID-19 patients with cancer.
|
|
|
11/4/20
|
Hessami K, Romanelli C, Chiurazzi M, et al. | J Matern Fetal Neonatal Med
Aim: To evaluate the effect of the COVID-19 pandemic on anxiety and depression of women during pregnancy and perinatal period.
MENTAL HEALTH
|
|
|
11/4/20
|
Cao K, Kline B, Han Y, et al. | Biomed Res Int
Aim: To estimate the prevalence rate of ocular symptoms and the positive rate of conjunctival swab samples of patients diagnosed with 2019 Novel Coronavirus Disease (COVID-19).
|
|
|
11/4/20
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
11/4/20
|
Hoang T | J Med Virol
Aim: To summarize the current evidence of factors associated with the risk of disease recurrence.
|
|
|
11/4/20
|
Vizheh M, Qorbani M, Arzaghi SM, et al. | J Diabetes Metab Disord
Aim: To review all research carried out on the mental health status of health care workers (HCWs) to bring policymakers and managers’ attention.
MENTAL HEALTH
|
|
|
11/4/20
|
Khateri S, Mohammadi H, Khateri R, et al. | Arch Acad Emerg Med
Aim: To determine the prevalence of underlying diseases and associated comorbidities in COVID-19 patients using a systematic review and meta-analysis.
|
|
|
11/4/20
|
The Prognostic Value of Thrombocytopenia in COVID-19 Patients; a Systematic Review and Meta-Analysis
Bashash D, Hosseini-Baharanchi FS, Rezaie-Tavirani M, et al. | Arch Acad Emerg Med
Aim: To provide a well-conceptualized viewpoint demonstrating the prognostic value of thrombocytopenia in COVID-19.
|
|
|
11/3/20
|
Zhou Y, Ren Q, Chen G, et al. | Front Med
Aim: To review the evidence on the clinical characteristics of COVID-19 patients, with a focus on the prevalence of CKD and AKI, as well as their association with poor prognosis.
CLINICAL CHARACTERISTICS
|
|
|
11/3/20
|
Lakbar I, Luque-Paz D, Mege J, et al. | PLoS One
Aim: To systematically review the literature relating to men versus women on SARS-CoV-2 in order to seek differences in disease characteristics (e.g. infectivity, severity) and outcomes (e.g. mortality).
|
|
|
11/3/20
|
O'Neil M, Veazie S, LaFavor B | VA Evidence Synthesis Program
Aim: To compare the prevalence of mental health disorders among adults who have been hospitalized for COVID-19 to relevant comparison groups, assess whether the prevalence of mental health disorders varies by patient and disease characteristics, and ascertain mental health care utilization and resource needs for adults following hospitalization for COVID-19. UPDATED VA ESP
MENTAL HEALTH
|
|
|
11/3/20
|
Mesas AE, Cavero-Redondo I, Alvarez-Bueno C, et al. | PLoS One
Aim: To synthesize the results of primary studies and provide pooled effect size estimators for a comprehensive set of potential predictors of in-hospital mortality in patients with confirmed COVID-19. UPDATED
|
|
|
11/3/20
|
Lane MY, Winters N, Fregonese F, et al. | PLoS One
Aim: To conduct a systematic review and meta-analysis on the proportion of asymptomatic infection among coronavirus disease 2019 (COVID-19) positive persons and their transmission potential. UPDATED
|
|
|
11/2/20
|
Boregowda U, Perisetti A, Nanjappa A, et al. | Front Med
Aim: To compare the efficacy of tocilizumab in severe COVID-19 cases vs. standard of care alone. UPDATED
|
|
|
11/2/20
|
Dawoud DM, Soliman KY | Value Health
Aim: To review published economic evaluations of antiviral treatment for pandemics and outbreaks of respiratory illnesses.
|
|
|
11/2/20
|
Saad MA, Alfishawy M, Nassar M, et al. | Curr Rheumatol Rev
Aim: To review the evidence on reported COVID-19 cases with asociated autoimmune manifestations.
|
|
|
11/2/20
|
Palaiodimos L, Chamorro-Pareja N, Karamanis D, et al. | Hormones
Aim: To systematically review and synthesize with a meta-analysis the available observational studies reporting the effect of diabetes in mortality among hospitalized patients with COVID-19. UPDATED
|
|
|
11/2/20
|
Elsawah H, Elsokary M, Abdallah MS, et al. | Rev Med Virol
Aim: To systematically review the use of remdesivir in Covid?19 among the available clinical trials and summarise remdesivir efficacy. UPDATED
|
|
|
11/2/20
|
Hariyanto TI, Kristine E, Jillian C, et al. | Infect Disord Drug Targets
Aim: To review the evidence on the use of lopinavir/ritonavir as a potential treatment candidate against COVID-19.
|
|
|
11/2/20
|
Megnin-Viggars O, Carter P, Melendez-Torres GJ, et al. | PLoS One
Aim: To identify facilitators and barriers to uptake of, and engagement with, contact tracing during infectious disease outbreaks.
|
|
|
11/2/20
|
Prasitlumkum N, Chokesuwattanaskul R, Thongprayoon C, et al. | Diseases
Aim: To explore the incidence of acute myocardial injury among COVID-19 patients.
|
|
|
11/2/20
|
Ren L, Yu S, Xu W, et al. | J Cardiol
Aim: To address whether there is an association of antihypertensive medications and the incidence and severity of COVID-19.
|
|
|
11/2/20
|
Cagnazzo F, Arquizan C, Derraz I, et al. | J Neurol
Aim: To perform an updated review of the literature on the neurological manifestations of COVID-19-infected patients
|
|
|
11/2/20
|
Trypsteen W, Van Cleemput J, Van Snippenberg W, et al. | PLoS One
Aim: To review the current (pre)published SARS-CoV-2 literature with a focus on the evidence concerning SARS-CoV-2 distribution in human tissues and viral shedding in body fluids.
|
|
|
11/2/20
|
Shrestha DB, Budhathoki P, Syed N, et al. | Life Sci
Aim: To conduct a systematic review and meta-analysis on remdesivir use for COVID-19.
|
|
|
11/2/20
|
Ciaffi J, Meliconi R, Ruscitti P, et al. | BMC Rheumatol
Aim: To assess the prevalence of rheumatic manifestations in patients affected by COVID-19, as initial symptom or during disease course.
|
|
|
11/2/20
|
Lee KW, Khan AHKY, Ching SW, et al. | Front Neurol
Aim: To perform a systematic review and meta-analysis of currently available epidemiological, clinical, and laboratory data related to both stroke and COVID-19 infection.
|
|
|
11/2/20
|
Violante T, Violante FS | Med Lav
Aim: To summarize the available studies which have compared the respective effectiveness of surgical masks and filtering facepiece respirators for the prevention of infections caused by viruses that are transmitted by the respiratory tract.
|
|
|
11/2/20
|
Antony AR, Haneef Z | Seizure
Aim: To synthesize the data on EEG findings in COVID-19.
|
|
|
11/2/20
|
Kolcun JPG, Ryu WHA, Traynelis VC | J Neurosrug Spine
Aim: To examine the current utilization of TM for spine surgery.
|
|
|
11/2/20
|
Del Riccio M, Lorini C, Bonaccorsi G, et al. | Int J Environ Res Public Health
Aim: To review the association between seasonal influenza vaccination and the risk of SARS-CoV-2 infection or complicated illness or poor outcome (e.g. severe disease, need for hospitalization or ventilatory support, or death) among COVID-19 patients. UPDATED
|
|
|
11/2/20
|
Chen J, Wu C, Wang X, et al. | Front Endocrinol
Aim: To summarize available data on the association between glycemic parameters and severity of COVID-19.
|
|
|
11/1/20
|
Wen W, Zhang H, Zhou M, et al. | Eur Rev Med Pharmacol Sci
Aim: To evaluate arrhythmia in patients with severe and non-severe COVID-19 during the current COVID-19 pandemic.
|
|
|
11/1/20
|
Lim JL, Reddy MP, Afroz A, et al. | Resuscitation
Aim: To evaluate the influence of the COVID-19 pandemic on the incidence, process, and outcomes of OHCA. UPDATED
|
|
|
10/31/20
|
Sanghera J, Pattani N, Hashmi Y, et al. | J Occup Health
Aim: To determine the impact of SARS?CoV?2 on mental health outcomes of hospital?based HCWs and formulate recommendations for future action. UPDATED
|
|
|
10/30/20
|
Ghayda RA, Li H, Lee KH, et al. | J Clin Med
Aim: To synthesize the most up-to-date and relevant available evidence on the outcomes of pregnant women with laboratory-confirmed infection with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/30/20
|
Ebrahimi M, Malehi AS, Rahim F | Osong Public Health Res Perspect
Aim: To compare coronavirus disease 2019 (COVID-19) laboratory findings, comorbidities, and clinical outcomes in patients from the general population versus medical staff to aid diagnosis of COVID-19 in a more timely, efficient, and accurate way.
DIAGNOSTICS
|
|
|
10/30/20
|
D'Errico S, Zanon M, Montanaro M, et al. | Microorganisms
Aim: To summarize all autopsy studies up to February 2020 in which a complete post-mortem investigation in patients with COVID-19 disease was performed, focusing on histopathological features.
CLINICAL CHARACTERISTICS
|
|
|
10/30/20
|
Dong Z, Xiang B, Jiang M, et al. | Clin Gastroenterol
Aim: To investigate the prevalence of GI symptoms, abnormal liver function, digestive system disease and liver disease in patients with COVID-19 by a systematic review and meta-analysis.
CLINICAL CHARACTERISTICS
|
|
|
10/30/20
|
Arora T, Grey I, Ostlundh L, et al. | J Health Psychol
Aim: To examine the overall prevalence of psychological health outcomes during COVID-19. UPDATED
MENTAL HEALTH
|
|
|
10/29/20
|
Munteanu C, Paun D, Suta A, et al. | Balneo Research Journal
Aim: To identify the main possible interferences between DM and COVID-19's pathological mechanisms, and to discuss the value of physical and rehabilitation medicine and balneotherapy in the post-acute COVID-19 recovery of the surviving patients
CLINICAL CHARACTERISTICS
|
|
|
10/29/20
|
Aggarwal G, Lippi G, Lavie CJ, et al. | J Diabetes
Aim: To evaluate the potential assocations between diabetes mellitus and infection severity outcomes in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
10/29/20
|
Patel U, Malik P, Mehta D, et al. | J Glob Health
Aim: To evaluate epidemiological characteristics, needs of resources, outcomes, and global burden of the disease.
|
|
|
10/29/20
|
Khan M, Khan N, Mustagir G, et al. | J Glob Health
Aim: To summarize pre-existing comorbidities in patients with COVID-19, and to estimate the likelihood of mortality from COVID-19 with each category of pre-existing comorbidities. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/29/20
|
Kumar R, Nedungalaparambil NM, Mohanan N | J Family Med Prim Care
Aim: To review the evidence on emergency and primary care collaborations during the COVID-19 pandemic.
|
|
|
10/29/20
|
PHAC Emerging Science Group | Public Health Agency of Canada
Aim: To review the evidence on whether hosptialized SARS-CoV-2 patients that successfully recover with no subsequently positive RT-PCR tests present with SARS-CoV-2 antibody levels or seropositivity rates differ from those that do retest positive?
|
|
|
10/29/20
|
Ramos-Lopez O, Daimiel L, de Molina AR, et al. | Int J Genomics
Aim: To systematically explore genetic polymorphisms associated with the clinical outcomes in SARS-CoV infection in humans.
CLINICAL CHARACTERISTICS
|
|
|
10/29/20
|
Mohammadi M, Rajabnia M, Abdehagh M | Sci J Kurd Univ Med Sci
Aim: To review the gastrointestinal manifestations in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
10/29/20
|
Hasan I, Saif-Ur-Rahman KM, Hayat S, et al. | J Peripher Nerv Syst
Aim: To summarize and meta?analyze the salient features and prognosis of SARS?CoV?2?associated GBS.
CLINICAL CHARACTERISTICS
|
|
|
10/29/20
|
Asghar M, Hussan N, Shoaib H, et al. | J Community Hosp Intern Med Perspect
Aim: To assess hematological changes seen in COVID-19 infection and their association with the severity of the disease.
|
|
|
10/29/20
|
Ling XC, Kang EY, Lin J, et al. | Taiwan J Ophthalmol
Aim: To provide general guidance for ophthalmologists to understand the prevalence of ocular presentation in COVID 19 patients and to reduce the risk of transmission during practice.
INFECTION CONTROL
|
|
|
10/29/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of fit testing and fit checking for testing the protection of a respirator.
|
|
|
10/29/20
|
Milby KM, Atallah AN, Rocha-Filho CR, et al. | Sao Paulo Med J
Aim: To understand and summarize the evidence relating to clinical manifestations, disease severity and prognoses among patients coinfected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and arboviruses. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/29/20
|
Jahrami H, BaHammam AS, Bragazzi NL, et al. | J Clin Sleep Med
Aim: To assess the impact and prevalence of sleep problems among the general population, healthcare workers, and COVID-19 patients.
MENTAL HEALTH
|
|
|
10/28/20
|
Comber L, Murchu EO, Drummond L, et al. | Rev Med Virol
Aim: To synthesise the evidence for the potential airborne transmission of SARS-CoV-2 via aerosols.
INFECTION CONTROL
|
|
|
10/28/20
|
Mora-Ramirez M, Melgoza-Hernandez P, Toledo-Ramirez SE, et al. | Curr Med Chem
Aim: To review the main adverse effects regarding the most prescribed drugs and, specifically, the efficacy and potential risk of each pharmacological therapy, during hospital care for COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
10/28/20
|
Cano EJ, Fuentes XF, Campioli CC, et al. | Chest
Aim: To review the evidence on the impact of corticosteroids in mortality, ICU admission, mechanical ventilation, and viral shedding in COVID-19 patients.
|
|
|
10/28/20
|
Chou R, Dana T, Jungbauer R, et al. | Ann Intern Med
Aim: To examine the effectiveness of N95, surgical, and cloth masks in community and health care settings for preventing respiratory virus infections, and effects of reuse or extended use of N95 masks. UPDATED
|
|
|
10/28/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the contributing factors of a second spike in COVID-19 cases.
|
|
|
10/28/20
|
Amanullah S, Shankar RR | Healthcare
Aim: To analyse and summarise the current knowledge on factors/potential factors contributing to burnout amongst healthcare professionals amidst the pandemic.
MENTAL HEALTH
|
|
|
10/27/20
|
Wijeratne T, Sales C, Karimi L, et al. | Front Neurol
Aim: To review the clinical data on all published cases of COVID-19 and concomitant AIS, with a view to understanding the pertinent clinical, laboratory and imaging features.
CLINICAL CHARACTERISTICS
|
|
|
10/27/20
|
Lu Q, Wang Z, Yin Y, et al. | Front Med
Aim: To investigate the evidence on the association between peripheral lymphocyte levels and the progression and mortality of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/27/20
|
Budhathoki P, Shrestha DB, Rawal E, et al. | SN Compr Clin Med
Aim: To assess the rationality on the use of corticosteroids in COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
10/27/20
|
Nannoni S, de Groot R, Bell S, et al. | Int J Stroke
Aim: To characterize the incidence, risk factors, clinical-radiological manifestations and outcome of COVID-19-associated stroke.
CLINICAL CHARACTERISTICS
|
|
|
10/27/20
|
Hojaij FC, Chinelatto LA, Boog GHP, et al. | Int Arch Otorhinolaryngol
Aim: To provide an easy access to and a trustful review of the main aspects that have changed in the head and neck surgery and otorhinolaryngology practice due to the COVID-19 pandemic.
INFECTION CONTROL
|
|
|
10/27/20
|
Mehraeen E, Karimi A, Barzegary A, et al. | Eur J Integr Med
Aim: To systematically review the assessment of risk and model the predictors of mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
10/27/20
|
Chen X, Zhang G, Hao SY, et al. | Chin Med Sci J
Aim: To compare the similarities and differences of early CT manifestations of three types of viral pneumonia induced by SARS-CoV-2 (COVID-19), SARS-CoV (SARS) and MERS-CoV (MERS) using a systemic review.
CLINICAL CHARACTERISTICS
|
|
|
10/27/20
|
Szegedi I, Orbán-Kálmándi R, Csiba L, et al. | J Clin Med
Aim: To summarize the available literature on COVID-19-associated coagulopathy and thrombosis and to identify the characteristics of stroke in COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/27/20
|
Pranata R, Supriyadi R, Huang I, et al. | Clin Med Insights Circ Respir Pulm Med
Aim: To evaluate the association between chronic kidney disease (CKD) and new onset renal replacement therapy (RRT) with the outcome of Coronavirus Disease 2019 (COVID-19) in patients.
CLINICAL CHARACTERISTICS
|
|
|
10/27/20
|
Bansal A, Singh AD, Jain V, et al. | Heart & Lung
Aim: To determine if D-dimers are elevated in individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who have adverse clinical outcomes including all-cause mortality, intensive care unit (ICU) admission or acute respiratory distress syndrome (ARDS).
CLINICAL CHARACTERISTICS
|
|
|
10/27/20
|
Valencia-Enciso N, Ortiz-Pereira M, Zafra-Sierra MP, et al. | J Stroke Cerebrovasc Dis
Aim: To assess the temporal relationship between COVID-19 severity and stroke onset. To determine if characteristics such as presentation of the stroke, younger age, involvement of large vessel occlusion and pattern of paraclinical markers could be distinct from the no-COVID-19 population.
CLINICAL CHARACTERISTICS
|
|
|
10/26/20
|
Comber L, Walsh KA, Jordan K, et al. | Rev Med Virol
Aim: To synthesise the available evidence for detection of SARS?CoV?2 RNA using RT?PCR tested saliva or nasal specimens compared with RT?PCR tested nasopharyngeal specimens.
DIAGNOSTICS
|
|
|
10/26/20
|
Weatherald J, Solverson K, Zuege DJ, et al. | J Crit Care
Aim: To quickly identify and synthesize studies examining the effect of awake prone positioning on patients with hypoxemic respiratory failure (including those with ARDS and/or COVID-19). UPDATED
CANDIDATE THERAPEUTICS
|
|
|
10/26/20
|
Zeng L, Wang S, Cai J, et al. | Epidemiol Infect
Aim: To determine the potential risk factors for cardiac injury complicated COVID-19 virus infection.
CLINICAL CHARACTERISTICS
|
|
|
10/26/20
|
Yee JY, Kim WK, Han JMH, et al. | Sci Rep
Aim: To evaluate the impact of COVID-19 on pregnant women. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/26/20
|
Mirzaie H, Vahidi M, Shokoohi M, et al. | medRxiv
Aim: To summarize the evidence on COVID-19 patients with HBV or HCV co-infections.
|
|
|
10/26/20
|
Mch SA, Baishya M, Singh A, et al. | Trends Anaesthesia Crit Care
Aim: To conduct a systematic review of the available literature to highlight the effect of awake proning on the need for intubation, improvement in oxygenation and mortality rates in COVID-19 patients with ARDS.
CANDIDATE THERAPEUTICS
|
|
|
10/26/20
|
Hu C, Liang M, Gong F, et al. | Evid Based Complement Alternat Med
Aim: To investigate and compare the therapeutic effect of Lianhua Qingwen with conventional drugs on pneumonia symptoms.
CANDIDATE THERAPEUTICS
|
|
|
10/26/20
|
Chaabna K, Doraiswamy S, Mamtani R, et al. | Int J Infect Dis
Aim: To inform policymakers and stakeholders by examining and synthesizing available evidence on the effectiveness of cloth and medical facemasks for preventing transmission of respiratory infections in community settings and pointing out the gaps in evidence.
INFECTION CONTROL
|
|
|
10/26/20
|
Gu ZC, Zhang C, Kong LC, et al. | Cardiovasc Diagn Ther
Aim: To summarize all available evidence for a comprehensive and rigorous systematic review focused on myocardial injury incidence in COVID-19. In addition, to state the case-fatality rate related to cardiac injury, variations of myocardial injury incidence were also examined by disease severity (non-survivors, severe patients, and non-severe patients).
CLINICAL CHARACTERISTICS
|
|
|
10/26/20
|
Wang H, Ai J, Loeffelholz MJ, et al. | Emerg Microbes Infect
Aim: To evaluate the diagnostic accuracy of serologic methods for COVID-19 based on assay design and post-symptom-onset intervals.
DIAGNOSTICS
|
|
|
10/26/20
|
Malik P, Patel U, Patel K, et al. | J Med Virol
Aim: To assess the effect of obesity on outcomes in the COVID-19 hospitalizations.
CLINICAL CHARACTERISTICS
|
|
|
10/26/20
|
Javanmardi F, Keshavarzi A, Akbari A, et al. | PLoS One
Aim: To evaluate the prevalence of underlying disease in died people with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/26/20
|
Vazzana N, Dipaola F, Ognibene S | Acta Clin Belg
Aim: To review the prognostic value of procalcitonin for severe disease and adverse outcome events in COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/26/20
|
de Labry-Lima AO, Bermudez-Tamayo C, Martinez-Olmos J, et al. | Enferm Infecc Microbiol Clin
Aim: To compile the available evidence on the use of masks in relation to respiratory infections.
INFECTION CONTROL
|
|
|
10/26/20
|
Wang Y, Chen B, Li Y, et al. | J Med Virol
Aim: To investigate the effects of ACEI/ARB on COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
10/25/20
|
Kotak S, Khatri M, Malik M, et al. | Cureus
Aim: To assess the safety and efficacy of tocilizumab as compared to the standard regimen in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
10/23/20
|
Bwire GM, Nijiro BJ, Mwakawanga DL, et al. | J Med Virol
Aim: To determine the likelihood of vertical transmission among COVID-19 exposed infants and to determine whether antibodies against Severe Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/ COVID-19 virus exist among COVID-19 vertically exposed but negative infants.
CLINICAL CHARACTERISTICS
|
|
|
10/23/20
|
La Distia Nora R, Putera I, Khalisha DF, et al. | BMJ Open Ophthalmol
Aim: To review and critically appraise the ocular manifestation and the presence of SARS-CoV-2 through PCR positivity from ocular samples in COVID-19-related patients. Moreover, to evaluate the time and severity association of ocular manifestation to systemic disease of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/23/20
|
Yamakawa M, Kuno T, Mikami T, et al. | J Stroke Cerebrovasc Dis
Aim: To depict the frequency and clinical characteristics of COVID-19 patients with stroke.
CLINICAL CHARACTERISTICS
|
|
|
10/23/20
|
Guo L, Shi Z, Zhang Y, et al. | Diabetes Res Clin Pract
Aim: To assess the association of comorbid diabetes with COVID-19 severity or mortality in China.
CLINICAL CHARACTERISTICS
|
|
|
10/23/20
|
Wang JG, Cui HR, Tang HB, et al. | Sci Rep
Aim: To understand the clinical manifestations and incidence of gastrointestinal symptoms of Coronavirus disease (COVID-19) in children and discuss the importance of fecal nucleic acid testing. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/23/20
|
Favas TT, Dev P, Chaurasia RN, et al. | Neurol Sci
Aim: To estimate the proportion of COVID-19 patients developing neurological manifestations.
CLINICAL CHARACTERISTICS
|
|
|
10/23/20
|
Raymond C, Loshak H | CADTH
Aim: To describe the trial characteristics and estimated primary completion dates of the ongoing phase II, phase III, and phase IV studies evaluating IVIg and hyperimmune globulin to treat COVID-19. UPDATED
|
|
|
10/23/20
|
Wang C, Zhang H, Zhou Y, et al. | Eur Rev Med Pharmacol Sci
Aim: To explore the relationship between the prognosis of COVID-19 patients and thromboembolic events.
CLINICAL CHARACTERISTICS
|
|
|
10/22/20
|
Wijaya I, Andhika R, Huang I | Clin Appl Thromb Hemost
Aim: To explore the association between therapeutic-dose anticoagulation and its effect on mortality in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
10/22/20
|
Kurdi A, Abutheraa N, Akil L, et al. | Pharmacol Res Perspect
Aim: To provide a comprehensive/updated evaluation of the effect of ACEIs/ARBs on COVID?19?related clinical outcomes, including exploration of interclass differences between ACEIs and ARBs.
CANDIDATE THERAPEUTICS
|
|
|
10/22/20
|
Fong V, Iarocci G | J Pediatr Psychol
Aim: To evaluate the quality of existing studies on this topic, determine what is known about mental health outcomes and needs of children and families, and provide recommendations for how COVID-19 policies can best support children and families UPDATED
MENTAL HEALTH
|
|
|
10/22/20
|
Qadri SK, Ng P, Toh TSW, et al. | Pulm Ther
Aim: To describe the mechanisms of action of prone position, systematically appraise the current experience of prone position in COVID-19 patients, and highlight unique considerations for prone position practices during this pandemic.
CANDIDATE THERAPEUTICS
|
|
|
10/22/20
|
Sepandi M, Taghdir M, Alimohamadi Y, et al. | Iran J Public Health
Aim: To identify effective factors on the death among COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
10/22/20
|
Hernandez AV, Roman YM, Pasupuleti V, et al. | Ann Intern Med
Aim: To summarize evidence about the benefits and harms of hydroxychloroquine or chloroquine for the treatment or prophylaxis of coronavirus disease 2019 (COVID-19). UPDATED
CANDIDATE THERAPEUTICS
|
|
|
10/22/20
|
Ibrahim W | CNS Spectr
Aim: To systematically assess the neurological manifestations in patients diagnosed with COVID-19
CLINICAL CHARACTERISTICS
|
|
|
10/22/20
|
Chew QH, Wei KC, Vasoo S, et al. | J Clin Psychiatry
Aim: To learn from past infectious disease outbreaks to provide better psychological support for our frontline health care workers (HCW) by conducting a rapid review of extant studies that have reported on both psychological and coping responses in HCW during recent outbreaks.
MENTAL HEALTH
|
|
|
10/22/20
|
Perras C, Pohar S, Manoharan A, et al. | CADTH
Aim: To review the current scientific evidence on the potential benefits and harms of remdesivir. UPDATED
|
|
|
10/22/20
|
Haradaa G, Antonacio FF, Gongora AB, | Ecancermedicalscience
Aim: To address the question of whether to test asymptomatic cancer patients before initiating systemic cancer treatments.
CLINICAL CHARACTERISTICS
|
|
|
10/22/20
|
Andrews E, Berghofer K, Long J, et al. | Int J Nurs Adv
Aim: To examine current evidence on patient and healthcare provider's satisfaction with the use of telehealth during the COVID-19 pandemic
INFECTION CONTROL
|
|
|
10/22/20
|
Ayele Mega T, Feyissa TM, Dessalegn Bosho D, et al. | Can Respir J
Aim: To generate an up-to-date evidence for the clinical safety and efficacy of hydroxychloroquine (HCQ) with or without azithromycin (AZ) among patients treated for COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
10/21/20
|
Leisman DE, Ronner L, Pinotti R, et al. | Lancet Respir Med
Aim: To synthesise and describe the reported pattern of inflammatory cytokines in COVID-19-induced respiratory failure and to compare this profile with those of other acute inflammatory syndromes. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/21/20
|
Cheng L, Li H, Li L, et al. | J Clin Lab Anal
Aim: To determine the role of ferritin in COVID?19.
CLINICAL CHARACTERISTICS
|
|
|
10/21/20
|
Agstam S, Yadav A, Kumar MP, et al. | Indian Pacing Electrophysiol J
Aim: To study the risk of QTc prolongation and Torsades de pointes (TdP) by a well-defined criterion for HCQ, CQ alone, and in combination with Azithromycin in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
10/21/20
|
Kefale B, Tegegne GT, Degu A, et al. | Clin Appl Thromb Hemost
Aim: To investigate the extent and risk factors of thromboembolism among COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/21/20
|
Bhattacharyya A, Kumar S, Sarma P, et al. | Indian J Pharmacol
Aim: To evaluate the safety as well as efficacy of L/R combination therapy in the management of COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
10/21/20
|
Yang H, Lan Y, Yao X, et al. | Virol J
Aim: To summarize the characteristics of chest CT imaging in Chinese hospitalized patients with Coronavirus Disease 2019 (COVID-19) to provide reliable evidence for further guiding clinical routine.
DIAGNOSTICS
|
|
|
10/21/20
|
Xu J, Teng Y, Shang L, et al. | Clin Infect Dis
Aim: To provide a comprehensive summarization of current evidence to answer two major clinical questions: (1) Does the prior treatment of ACEI/ARB alter the susceptibility of SARS-CoV-2 infection in general population? (2) Does the prior treatment of ACEI/ARB affect risk of mortality and severe outcomes in COVID-19 patients? UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/20/20
|
da Silva PG, Nascimento MSJ, Soares RRG, et al. | Sci Total Environ
Aim: To review the evidence on the viability/stability of aerosols containing SARS-CoV and MERS-CoV viruses.
INFECTION CONTROL
|
|
|
10/20/20
|
Yonas E, Alwi I, Pranata R, et al. | Am J Emerg Med
Aim: To investigate the association between heart failure (HF) and poor outcome in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/20/20
|
Gungor B, Atici A, Baycan OF, et al. | Am J Emerg Med
Aim: To investigate the correlation of D-dimer levels measured on admission with disease severity and the risk of death in patients with coronavirus disease 2019 (COVID-19) pneumonia.
CLINICAL CHARACTERISTICS
|
|
|
10/20/20
|
Chou R, Dana T, Buckley D, et al. | Ann Intern Med
Aim: To examine the burden of SARS-CoV-2, SARS-CoV-1, and Middle Eastern respiratory syndrome (MERS)-CoV on HCWs and risk factors for infection, using rapid and living review methods. UPDATED WHO COLLABORATIVE
|
|
|
10/20/20
|
Tan E, Song J, Deane AM, et al. | Chest
Aim: To review the evidence on the global point estimate of mortality and risk factors for patients admitted to intensive care units (ICUs) with severe COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/20/20
|
Wassie GT, Azene AG, Bantie GM, et al. | Curr Ther Res Clin Exp
Aim: To estimate the pooled average incubation period of SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
10/20/20
|
Chua TH, Xu Z, King NKK | Brain Inj
Aim: To determine the clinical characteristics of neurological manifestations in COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/20/20
|
Kotecha P, Light A, Checcucci E, et al. | Panminerva Med
Aim: To evaluate the data currently available regarding the repurposing of different drugs for Covid-19 treatment. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
10/20/20
|
Sun C, Sun Y, Li X | Am J Emerg Med
Aim: To evaluate the clinical efficacy and safety of CM in the treatment of COVID-19 pneumonia.
CANDIDATE THERAPEUTICS
|
|
|
10/20/20
|
Hossein H, Ali KM, Hosseini M, et al. | Clin Transl Imaging
Aim: To answer to the question whether CT scan can be used in diagnosis of COVID-19 or not.
DIAGNOSTICS
|
|
|
10/19/20
|
Fram G, Wang D, Malette K, et al. | Curr Cardiol Rev
Aim: To evaluate the incidence of cardiotoxicity associated with hydroxychloroquine prior to onset of the COVID-19 pandemic.
CANDIDATE THERAPEUTICS
|
|
|
10/19/20
|
Liu Y, Lu H, Wang W, et al. | Expert Rev Anticancer Ther
Aim: To identify the risk factors for death in patients with cancer and COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/19/20
|
Mulchandani R, Lyngdoh T, Kakkar AK | Eur J Clin Invest
Aim: To quantify the differences in the circulating levels of major inflammatory and immunological markers between severe and non?severe COVID?19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/19/20
|
Ortega KL, Rech BO, El Haje GLC, et al. | J Hosp Infect
Aim: To review the evidence on whether hydrogen peroxide mouthwash has a virucidal effect. UPDATED
INFECTION CONTROL
|
|
|
10/19/20
|
Jena A, Kumar-M P, Singh AK, et al. | Dig Liver Dis
Aim: To study the elevations of fecal calprotectin in COVID-19 and if these elevations were different in patients with or without gastrointestinal symptoms.
|
|
|
10/19/20
|
Tasar R, Wiegand C, Elsner P | Contact Dermatitis
Aim: To review the evidence on the irritant effects of alcoholic hand rubs.
INFECTION CONTROL
|
|
|
10/19/20
|
Cantini F, Goletti D, Petrone L, et al. | Drugs
Aim: To assess the clinical impact of different therapies for COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
10/19/20
|
July J, Pranata R | J Stroke Cerebrovasc Dis
Aim: To evaluate the impact of the coronavirus disease (COVID-19) pandemic on stroke care, including the number of stroke alerts/codes, number of reperfusions, and number of thrombectomies during the pandemic compared to those during the pre-pandemic period.
INFECTION CONTROL
|
|
|
10/19/20
|
| CADTH
Aim: To review the various strategies being used to increase the availability of N95 masks.
|
|
|
10/19/20
|
Postoperative mortality among surgical patients with COVID-19: a systematic review and meta-analysis
Abate SM, Mantefardo B, Basu B | Patient Saf Surg
Aim: To provide the global prevalence of perioperative outcomes of patients with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/19/20
|
Chamseddine RS, Wahbeh F, Chervenak F, et al. | J Pregnancy
Aim: To review the evidence on preinatal and obstetric management in patients with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/19/20
|
Raschetti R, Vivanti AJ, Vauloup-Fellous C, et al. | Nat Commun
Aim: To clarify the main transmission route, clinical features and outcomes of neonatal SARS-CoV-2 infections UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/19/20
|
Ramaraj P, Super JT, Doyle R, et al. | BMJ Open
Aim: To review the evidence behind UK Government PPE guidance on surgical masks versus respirators for SARS-CoV-2 protection. UPDATED
INFECTION CONTROL
|
|
|
10/19/20
|
Pluddemann A, Aronson JK | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the role of T cells and antibodies in immunity to COVID-19 infection.
|
|
|
10/18/20
|
Walker C, Deb S, Ling H, et al. | J Pharm Pharm Sci
Aim: To assess the association between elevated cardiac biomarkers and the severity of COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
10/17/20
|
Zhang P, Shi L, Xu J, et al. | Immunogenetics
Aim: To evaluate the association of interleukin-6 (IL-6) level with the poor outcomes in coronavirus disease 2019 (COVID-19) patients.
CLINICAL CHARACTERISTICS
|
|
|
10/16/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on factors that may help protect Indigenous peoples and communities in Canada and internationally from the COVID-19 pandemic and its impacts.
|
|
|
10/16/20
|
Bhatia R, Pedapati R, Komakula S, et al. | J Stroke
Aim: To report the characteristics of stroke in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/15/20
|
Gonzalez-Rubio J, Navarro-Lopez C, Lopez-Najera E, et al. | Int J Environ Res Public Health
Aim: To review the evidence on the epidemiologic relationship between smoking and COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/15/20
|
Apostolopoulou A, Garrigos ZE, Vijayvargiya P, et al. | Diagnostics
Aim: To investigate the epidemiology, pathogenesis, risk factors, clinical manifestations, diagnosis, treatment and prognosis of COVID-19 associated pulmonary aspergillosis (CAPA).
CLINICAL CHARACTERISTICS
|
|
|
10/15/20
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
10/15/20
|
Akiyama S, Hamdeh S, Micic D, et al. | Ann Rheum Dis
Aim: To assess the prevalence and clinical outcomes of COVID-19 in autoimmune diseases.
CLINICAL CHARACTERISTICS
|
|
|
10/15/20
|
Du M, Lin Y, Yan W, et al. | World J Diabetes
Aim: To systematically evaluate the prevalence of diabetes among COVID-19 patients in China and its impact on clinical outcomes, including ICU admission, progression to severe cases, or death.
|
|
|
10/15/20
|
Chu IY, Alam P, Larson H, et al. | J Travel Med
Aim: To identify: 1) the social consequences of mass quarantine—community-wide movement restrictions—during previous and current infectious disease outbreaks, and 2) recommended strategies to mitigate the negative social implications of COVID-19 lockdowns. UPDATED
MENTAL HEALTH
|
|
|
10/15/20
|
Walsh KA, Spillane S, Comber L, et al. | J Infect
Aim: To summarise the evidence on the duration of infectiousness of individuals in whom SARS-CoV-2 ribonucleic acid is detected.
CLINICAL CHARACTERISTICS
|
|
|
10/14/20
|
Dehaghi BF, Ghodrati-Torbati A, Teimori G, et al. | Invest Educ Enferm
Aim: To assess the effectiveness of face masks against the novel coronavirus.
INFECTION CONTROL
|
|
|
10/14/20
|
Pang KW, Chee J, Subramaniam S, Ng CL | Curr Allergy Asthma Rep
Aim: To quantify the clinical utility of identifying OD in the diagnosis of COVID-19 and determine an estimate of the frequency of OD amongst these patients.
CLINICAL CHARACTERISTICS
|
|
|
10/14/20
|
Fung HF, Martinez L, Alarid-Escudero F, et al. | Clin Infect Dis
Aim: To review the evidence on the transmission of SARS-CoV-2 within households.
INFECTION CONTROL
|
|
|
10/13/20
|
Bansal A, Singh AD, Jain V, et al. | Heart Lung
Aim: To determine if D-dimers are elevated in individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who have adverse clinical outcomes including all-cause mortality, intensive care unit (ICU) admission or acute respiratory distress syndrome (ARDS). UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/13/20
|
Jackson T, Deibert D, Wyatt G, et al. | BMJ Open Respir Res
Aim: To review how official guidance documents and academic publications have classified procedures in terms of whether or not they are aerosol-generating.
INFECTION CONTROL
|
|
|
10/13/20
|
Pormohammad A, Ghorbani S, Khatami A, et al. | Rev Med Virol
Aim: To compare clinical symptoms, laboratory findings, radiographic signs and outcomes of COVID?19 and influenza to identify unique features.
CLINICAL CHARACTERISTICS
|
|
|
10/13/20
|
Chai KL, Valk SJ, Piechotta V, et al. | Cochrane Database Syst Rev
Aim: To assess whether convalescent plasma or hyperimmune immunoglobulin transfusion is effective and safe in the treatment of people with COVID?19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
10/13/20
|
Banakar M, Lankarani KB, Jafarpour D, et al. | BMC Oral Health
Aim: To examine the risk of the transmission of the COVID–19 during dental treatments and provides pathways and protective protocols to minimize them, bearing in mind the long-term necessity of actions and realistic, practical measures. UPDATED
INFECTION CONTROL
|
|
|
10/13/20
|
Singh H, Kaur H, Singh K, et al. | Adv Wound Care
Aim: To review the evidence on cutaneous manifestations reported in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
10/13/20
|
Aggarwal N, Garg M, Dwarakanathan V, et al. | J Travel Med
Aim: To review the evidence on the diagnostic accuracy of infrared thermal screening via handheld non-contact infrared thermometers and thermal scanners.
DIAGNOSTICS
|
|
|
10/13/20
|
Roshandel R, Nateqi M, Lak R, et al. | Cell Mol Biol
Aim: To review the evidence on the diagnostic and methodological evaluation of urinary shedding of SARS-CoV-2. UPDATED
DIAGNOSTICS
|
|
|
10/13/20
|
Kashour ZT, Riaz M, Garbati M, et al. | J Antimicrob Chemother
Aim: To systematically evaluate the effect of CQ and HCQ with or without azithromycin (AZ) on outcomes of COVID-19 patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
10/13/20
|
Nugroho J, Wardhana A, Mulia EP, et al. | Clin Hemorheol Microcirc
Aim: To determine the relationship between fibrinogen and FDP with poor outcome in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
10/13/20
|
Prodromos C, Rumschlag T | New Microbes New Infect
Aim: To review the efficacy of HCQ against COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
10/13/20
|
Sathian B, Asim M, Banerjee I, et al. | Nepal J Epidemiol
Aim: To assess the impact of the COVID-19 pandemic on the conduction of clinical trials and research.
INFECTION CONTROL
|
|
|
10/13/20
|
Sajid MI, Awais S, Salar K, et, al. | Biomedica
Aim: To evaluate the pathogenesis, risk factors, diagnosis and management strategies in pregnant women suspected or confirmed with COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
10/13/20
|
Han SM, Greenfield G, Majeed A, et al. | J Med Internet Res
Aim: To summarize evidence on the impact of remote consultation in primary care on antibiotic prescribing.
INFECTION CONTROL
|
|
|
10/13/20
|
Tamuzi JL, Ayele BT, Shumba CS, et al. | BMC Infect Dis
Aim: To review different studies on SARS-CoV, MERS-CoV or COVID-19 associated with HIV/TB co-infection or only TB and to understand the interactions between HIV, TB and COVID-19 and its implications on the burden of the COVID-19 among HIV/TB co-infected or TB patients, screening algorithm and clinical management. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/13/20
|
Malaty M, Kayes T, Amarasekera AT, et al. | Eur J Clin Invest
Aim: To examine the current incidence and available treatment for arrhythmias in hospitalized patients with SARS-CoV-2 infection. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/13/20
|
Gidari A, Nofri M, Saccarelli L, et al. | Eur J Clin Microbiol Infect Dis
Aim: To review the evidence on the recurrence of coronavirus disease 2019.
CLINICAL CHARACTERISTICS
|
|
|
10/13/20
|
Hariri LP, North CM, Shih AR, et al. | Chest
Aim: To review the evidence on the lung histopathology described in COVID-19 compared to SARS and H1N1 influenza.
CLINICAL CHARACTERISTICS
|
|
|
10/13/20
|
Nopp S, Moik F, Jilma B, et al. | Res Pract Thromb Haemost
Aim: To evaluate available data and estimating the prevalence of VTE in COVID?19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/13/20
|
Singh S, Desai R, Gandhi Z, et al. | SN Compr Clin Med
Aim: To identify COVID-19-associated TTS case reports and evaluate patient-level demographics, clinical attributes, and outcomes.
CLINICAL CHARACTERISTICS
|
|
|
10/13/20
|
Elsayed S, Reddy M, Murthy PM, et al. | Cureus
Aim: To identify the trends of COVID-19 relapse, the effects of co-morbidities on it, and associated mortality rates. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/13/20
|
Koh WC, Naing L, Chaw L, et al. | PLoS One
Aim: To estimate the secondary attack rate (SAR) in various settings and to examine whether household transmission differed by symptom status of index case, adult and children (< 18 years old), and relationship to index case.
INFECTION CONTROL
|
|
|
10/10/20
|
Yokoyama Y, Aikawa T, Takagi H, et al. | J Med Virol
Aim: To investigate the effect of ACEI and ARB on mortality and susceptibility to COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
10/9/20
|
Li Y, Li J, Zhang Y, et al. | Chin J Integr Med
Aim: To systematically review the clinical practice guidelines for the treatment of coronavirus disease 2019 (COVID-19) patients with Chinese herbal medicine (CHM), summarize their recommendations and evaluate their qualities.
CANDIDATE THERAPEUTICS
|
|
|
10/9/20
|
Toomey E, Conway Y, Burton C, et al. | Infect Control Hosp Epidemiol
Aim: To review the evidence on the extended use or re-use of single-use respirators and surgical masks by frontline healthcare workers.
INFECTION CONTROL
|
|
|
10/9/20
|
Abate BB, Kassie AM, Kassaw MW, et al. | BMJ Open
Aim: To assess the sex difference in the prevalence of COVID-19 confirmed cases.
CLINICAL CHARACTERISTICS
|
|
|
10/8/20
|
Maiese A, Manetti AC, La Russa R, et al. | Forensic Sci Med Pathol
Aim: To collect the currently available pathological data on COVID-19 and review the international literature on the postmortem findings of patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/8/20
|
Gianola S, Jesus TS, Bargeri S, et al. | PLoS One
Aim: To take a snapshot of the amount of scientific development devoted to COVID-19 and gain an idea of the current status of global research.
|
|
|
10/8/20
|
Quesada JA, López-Pineda A, Gil-Guillén VF, et al. | Rev Clin Esp
Aim: To provide a more accurate estimate of the incubation period of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/8/20
|
Ehaideb SN, Abdullah ML, Abuyssin B, et al. | Crit Care
Aim: To assess whether the newly created models reproduce the full spectrum of human COVID-19.
|
|
|
10/8/20
|
Oliveira CB, Lima CAB, Vajgel G, et al. | J Clin Pathol
Aim: To describe the incidence of AKI, need for renal replacement therapy (RRT) and mortality among patients with COVID-19-associated AKI.
CLINICAL CHARACTERISTICS
|
|
|
10/8/20
|
Henssler J, Stock F, van Bohemen J, et al. | Eur Arch Psychiatry Clin Neurosci
Aim: To assess the psychological effects in both quarantined and isolated persons compared to non-quarantined and non-isolated persons. UPDATED
MENTAL HEALTH
|
|
|
10/8/20
|
Choi GJ, Kim HM, Kang H, et al. | J Lipid Atheroscler
Aim: To analyze the available knowledge about the potential association between dyslipidemia and the severity of coronavirus disease 2019 (COVID-19) as reported in previous published systematic reviews. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/7/20
|
Leochico CFD, Espiritu AI, Ignacio SD, et al. | Front Neurol
Aim: To determine the challenges faced by telerehabilitation in the Philippines.
INFECTION CONTROL
|
|
|
10/7/20
|
Miller L, Bhattacharyya R, Miller AL | Medicine
Aim: To determine the mortality rate of hospitalized patients with Covid-19 in China and to identify factors that may potentially influence this rate.
CLINICAL CHARACTERISTICS
|
|
|
10/7/20
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
10/7/20
|
Ferner RE, Aronson JK | Oxford COVID-19 Evidence Service
|
|
|
10/7/20
|
Setiati S, Harimurti K, Safitri ED, et al | Acta Med Indones
Aim: To systematically review all relevant studies related to the risk factors and laboratory test results associated with severe illness and mortality in COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/7/20
|
Muacevic A, Adler JR | Cureus
Aim: To examine the association between smoking and mortality in COVID-19.
|
|
|
10/7/20
|
Betancourt JA, Rosenberg MA, Zevallos A, et al. | Healthcare
Aim: To review the evidence on the impact of the COVID-19 pandemic on the provision of care through telemedicine across unique health service lines that include dermatology, oncology, obstetrics/gynecology, and mental health.
INFECTION CONTROL
|
|
|
10/7/20
|
Magill E, Siegel Z, Pike KM | Psychiatr Serv
Aim: To review the evidence on the anticipated mental health sequelae for frontline health workers and best practices to address those mental health needs.
MENTAL HEALTH
|
|
|
10/7/20
|
Luo L, Fu M, Li Y, et al. | Clin Cardiol
Aim: To assess the association between underlying comorbidities and acute cardiac injury and the severity or the prognosis in COVID?19 patients.
CLINICAL CHARACTERISTICS
|
|
|
10/7/20
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
10/6/20
|
A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19
Yekeduz E, Utkan G, Urun Y | Eur J Cancer
Aim: To evaluate cancer treatment’s effect on the severity of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/6/20
|
Mandal A, Nandi S, Chhebbi M, et al. | Indian J Otolaryngol Head Neck Surg
Aim: To review the current guidelines and safety measures to be followed during tracheostomy in COVID-19 infected patients.
CLINICAL CHARACTERISTICS
|
|
|
10/6/20
|
Kamel AM, Sobhy M, Magdy N, et al. | Rev Med Virol
Aim: To investigate the association between AC and outcomes in hospitalized Covid?19 patients.
CLINICAL CHARACTERISTICS
|
|
|
10/6/20
|
Tu TM, Goh C, Tan YK, et al. | J Stroke Cerebrovasc Dis
Aim: To perform a systematic review of known cases of concomitant COVID-19 infection and CVT in the current literature.
CLINICAL CHARACTERISTICS
|
|
|
10/6/20
|
Olorunsaiye CZ, Yusuf KK, Reinhart K, et al. | Int J MCH AIDS
Aim: To review the evidence on the immunization landscape since the COVID-19 pandemic.
INFECTION CONTROL
|
|
|
10/6/20
|
Cheng W, Li Y, Cui L, et al. | Front Pharmacol
Aim: To evaluate the efficacy and safety of corticosteroid therapy in patients with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
10/6/20
|
Sharma SK, Mishra M, Mudgal SK | J Educ Health Promot
Aim: To update the available most recent evidences on efficacy of cloth face masks in prevention of viral infection transmission.
|
|
|
10/6/20
|
Cheong KX | Curr Ophthalmol Rep
Aim: To summarise and discuss the current literature regarding ocular involvement of SARS-CoV-2 in COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/6/20
|
Jena A, Singh AK, Kumar-M P, et al. | Dig Liver Dis
Aim: To identify the frequency and reasons for the disruption of care for IBD patients and attempted to identify regional differences in patterns of adherence to IBD therapies.
|
|
|
10/5/20
|
Meyerowitz-Katz G, Merone L | Int J Infect Dis
Aim: To review the evidence on infection-fatality rates for COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/5/20
|
Noorimotlagh Z, Mirzaee SA, Jaafarzadeh N, et al. | Environ Sci Pollut Res Int
Aim: To collect all available studies concerning inactivation methods, environmental survival, and control and prevention strategies related to SARS-CoV-2.
INFECTION CONTROL
|
|
|
10/5/20
|
Tlayjeh H, Mhish O, Enani M, et al. | J Infect Public Health
Aim: To systematically review the literature about the association between systemic corticosteroid therapy (CST) and outcomes of COVID-19 patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
10/5/20
|
Moutchia J, Pokharel P, Kerri A, et al. | PLoS One
Aim: To assess clinical laboratory parameters which may serve as markers or predictors of severe or critical COVID-19. UPDATED
DIAGNOSTICS
|
|
|
10/5/20
|
Soeroto AY, Soetedjo NN, Purwiga A, et al. | Diabetes Metab Syndr
Aim: To evaluate the association between obesity and composite poor outcome in coronavirus disease 2019 (COVID-19) patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/5/20
|
Chaudhry H, Nadeem S, Mundi R | Clin Orthop Relat Res
Aim: To review the evidence on patient and surgeon satisfaction with the use of telemedicine, differences in outcomes compared to in-person visits and the difference in time commitment.
INFECTION CONTROL
|
|
|
10/5/20
|
Huang Y, Yao L, Huang Y, et al. | Metabolism
Aim: To review the evidence on the effects of obesity with the risk of severe disease among patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/5/20
|
Wilt TJ, Kaka AS, MacDonald R, et al. | Ann Intern Med
Aim: To evaluate the effectiveness and harms of remdesivir for COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
10/5/20
|
Simons D, Shahab L, Brown J, et al. | Addiction
Aim: To estimate the association of smoking status with rates of i) infection, ii) hospitalisation, iii) disease severity, and iv) mortality from SARS?CoV?2/COVID?19 disease.
CLINICAL CHARACTERISTICS
|
|
|
10/5/20
|
Jarrom D, Elston L, Washington J, et al. | BMJ Evid Based Med
Aim: To identify evidence on: (1) the clinical effectiveness of tests that detect the presence of severe acute respiratory syndrome coronavirus 2 (SARS?CoV?2) to inform COVID?19 diagnosis? and (2) the clinical effectiveness of tests that detect the presence of antibodies to the SARS?CoV?2 virus to inform COVID?19 diagnosis. UPDATED
DIAGNOSTICS
|
|
|
10/5/20
|
Deng J, Zhou F, Hou W, et al. | Ann N Y Acad Sci
Aim: To assess the prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
10/2/20
|
Simoni P, Bazzocchi A, Boitsios G, et al. | J Med Imaging Radiat Oncol
Aim: To describe the chest CT features reported in children with confirmed COVID?19 infection.
CLINICAL CHARACTERISTICS
|
|
|
10/2/20
|
Jahangir M, Nawaz M, Nanjiani D, et al. | Hong Kong Med J
Aim: To review the characteristics and presentation of COVID-19 among children and describe any subtle characteristics that may strengthen the clinical suspicion of infection and prompt further testing.
CLINICAL CHARACTERISTICS
|
|
|
10/2/20
|
Carrillo-Larco RM, Altez-Rodriguez C, Ravaglia S, et al. | Wellcome Open Res
Aim: To understand the characteristics of patients with COVID-19 and GBS, and to identify potential patterns. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/2/20
|
Mhango M, Dzobo M, Chitungo I, et al. | Saf Health Work
Aim: To map available evidence on Covid-19 risk factors among HWs to guide future research and policy.
CLINICAL CHARACTERISTICS
|
|
|
10/2/20
|
Rostami M, Mansouritorghabeh H | Expert Rev Hematol
Aim: To analyze the levels of D-dimer in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
10/2/20
|
Oliviera Silva DF, Cunha Lima SC, Mauricio Sena-Evangelista KC, et al. | Nutrients
Aim: To identify the screening instruments that can be used to assess nutritional risk in older adults with COVID-19, and to clarify their measurement properties. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
10/2/20
|
Flumignan RLG, de Sa Tinoco JD, Pascoal PIF, et al. | Cochrane Database Syst Rev
Aim: To assess the effects of prophylactic anticoagulants versus active comparator, placebo or no intervention, on mortality and the need for respiratory support in people hospitalised with COVID?19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
10/2/20
|
Yang S, Li A, Eshaghpour A, et al. | BMJ Evid Based Med
Aim: To review the trends and quality of evidence in early SARS-CoV-2 publications.
|
|
|
10/2/20
|
Leaune E, Samuel M, Oh H, et al. | Prev Med
Aim: To systematically review the evidence on the association between EVDOs and suicidal behaviors and/or ideation.
MENTAL HEALTH
|
|
|
10/2/20
|
Salari N, Khazaie H, Hosseinian-Far A, et al. | Global Health
Aim: To investigate the prevalence of sleep disturbances in hospital nurses and physicians facing the COVID-19 patients.
MENTAL HEALTH
|
|
|
10/2/20
|
Antikchi MH, Neamatzadeh H, Ghelmani Y, et al. | J Gastrointest Cancer
Aim: To estimate the risk and prevalence of COVID-19 infection in CRC patients using all available data.
INFECTION CONTROL
|
|
|
10/2/20
|
Li WT, Ma J, Shende N, et al. | BMC Med Inform Decis Mak
Aim: To investigate correlations between clinical variables, cluster COVID-19 patients into subtypes, and generate a computational classification model for discriminating between COVID-19 patients and influenza patients based on clinical variables alone.
DIAGNOSTICS
|
|
|
10/1/20
|
Chetty T, Daniels BB, Ngandu NK, et al. | S Afr Med J
Aim: To evaluate the effectiveness of different point-of-entry screening strategies in achieving a reduction in imported COVID-19 transmission.
|
|
|
9/29/20
|
Hussain N, Chung E, Heyl JJ, et al. | Cureus
Aim: To assess the effects of HCQ on patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/29/20
|
Uygun-Can B, Acar-Bolat B | Biomed Res Int
Aim: To summarize reliable medical evidence by the meta-analysis of all published retrospective studies that examined data based on the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by clinical symptoms, molecular (RT-PCR) diagnosis, and characteristic CT imaging features in pregnant women.
CLINICAL CHARACTERISTICS
|
|
|
9/29/20
|
Oliveira LV, Silva C, Lopes LP, et al. | Rev Assoc Med Bras
Aim: To review the current scientific evidence of vertical transmission related to coronavirus disease 2019 (COVID-19).
|
|
|
9/29/20
|
Bhattacharjee S, Banerjee M | SN Compr Clin Med
Aim: To analyze the clinical profile and outcomes in a total of 45 cases of new-onset ITP in COVID-19 patients described in literature until date.
|
|
|
9/29/20
|
Morone G, Palomba A, Iosa M, et al. | Front Med
Aim: To correlate the presence and the relevant temporal patterns of SARS-CoV-2 viral RNA in biological specimens (stool, urine, blood, and tears) of the transmission with clinical/epidemiological features in patients with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/29/20
|
Abuelgasim E, Dona ACM, Sondh RS, et al. | Dermatol Ther
Aim: To review the current literature on urticaria in COVID-19 patients and to provide insight into urticarial pathogenesis and management in such patients.
|
|
|
9/29/20
|
de Araujo LA, Veloso CF, de Campos Souza M, et al. | J Pediatr
Aim: To examine the impact of epidemics or social restriction on mental and developmental health in parents and children/adolescents.
MENTAL HEALTH
|
|
|
9/28/20
|
Sheleme T, Bekele F, Ayela T | Infect Dis
Aim: To summarize clinical presentations of this newly emerging coronavirus disease.
|
|
|
9/28/20
|
Shrestha DB, Pudhathoki P, Khadka S, et al. | Virol J
Aim: To review the efficacy and safety of favipiravir triphosphate as a treatment for COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/28/20
|
Malik P, Patel U, Patel K, et al. | J Med Virol
Aim: To assess the association of obesity and outcomes in COVID?19 hospitalized patients.
|
|
|
9/28/20
|
Rios P, Radhakrishnan A, Williams C, et al. | Syst Rev
Aim: to examine the current guidelines for infection prevention and control (IPAC) of coronavirus disease-19 (COVID-19) or other coronaviruses in adults 60 years or older living in long-term care facilities (LTCF). UPDATED
INFECTION CONTROL
|
|
|
9/28/20
|
| Public Health Agency of Canada
Aim: Not provided
|
|
|
9/28/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the potential for COVID-19 re-infection, including new transmission after recovery.
|
|
|
9/28/20
|
de Assis GG, Murawksa-Cialowicz E, Cieszczyk P, et wl. | Front Neurol
Aim: To review the evidence on the implications and mechanisms of infections by respiratory CoVs.
|
|
|
9/28/20
|
Viner RM, Mytton OT, Bonell C, et al. | JAMA Pediatr
Aim: To review the evidence on the susceptibility to and transmission of SARS-CoV-2 by children and adolescents compared with adults. UPDATED
INFECTION CONTROL
|
|
|
9/25/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence that CPR is aerosol generating and current advice for CPR in patients with suspected or confirmed COVID-19.
|
|
|
9/25/20
|
Singh B, Gornet M, Sims H, et al. | Am J Reprod Immunol
Aim: To analyze the available evidence on SARS-CoV-2 infection, early pregnancy, and reproductive tissues.
CLINICAL CHARACTERISTICS
|
|
|
9/24/20
|
Bennett S, Tafuro J, Mayer J, et al. | Int J Clin Pract
Aim: To identify the symptoms, comorbidities present, radiological features and outcomes for adults testing positive for COVID?19 admitted to hospital.
CLINICAL CHARACTERISTICS
|
|
|
9/24/20
|
Lim MA, Pranata R | J Clin Orthop Trauma
Aim: To evaluate the prevalence of coronavirus disease 2019 (COVID-19) and its impact on mortality in patients with hip fracture. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/24/20
|
Malgie J, Schoones JW, Pijls BG | Clin Infect Dis
Aim: To review the evidence on the use of IL-6 (receptor) antagonist therapy in reducing mortality in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
9/24/20
|
Does asthma increase the mortality of patients with COVID-19?: A systematic review and meta-analysis
Wang Y, Chen J, Chen W, et al. | Int Arch Allergy Immunol
Aim: To explore the literature and collate data comparing the mortality of coronavirus disease 2019 (COVID-19) patients with and without asthma.
CLINICAL CHARACTERISTICS
|
|
|
9/24/20
|
Wang M, Wu T, Zuo Z, et al. | BMJ Support Palliat Care
Aim: To summarize the efficacy and safety of antiviral agents currently in use for COVID-19 treatment. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/24/20
|
Berling I, King JD, Shepherd G, et al. | J Am Soc Nephrol
Aim: To determine the effect of and indications for extracorporeal treatments in cases of poisoning with chloroquine, hydroxychloroquine, and quinine.
|
|
|
9/24/20
|
Murchu EO, Byrne P, Walsh KA, et al. | Rev Med Virol
Aim: To summarize the evidence on the immune response and reinfection rate following SARS?CoV?2 infection.
CLINICAL CHARACTERISTICS
|
|
|
9/24/20
|
Roncon L, Zuin M, Barco S, et al. | Eur J Intern Med
Aim: To perform a systematic review and meta-analysis of the in-hospital incidence of acute PE among COVID-19 patients based on studies published within four months of COVID-19 outbreak.
CLINICAL CHARACTERISTICS
|
|
|
9/24/20
|
Goncalves LF, Gonzales AI, Patatt FSA, et al. | Rev Assoc Med Bras
Aim: To present scientific evidence evaluating the association of Kawasaki Disease (DK) and COVID-19 in children.
CLINICAL CHARACTERISTICS
|
|
|
9/24/20
|
Buitrago-Garcia D, Egli-Gany D, Counotte MJ, et al. | PLoS Med
Aim: To review the evidence on asymptomatic SARS-CoV-2 transmission.
CLINICAL CHARACTERISTICS
|
|
|
9/24/20
|
Nogueira SAR, de Oliveira SCS, de Carvalho AFM, et al. | Rev Assoc Med Bras
Aim: To present a review of renal changes in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/24/20
|
Ibekew TS, Fasunla AJ, Orimadegun AE | OTO Open
Aim: To estimate prevalence of smell and taste loss among COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
9/24/20
|
Gulsen A, Yigitbas BA, Uslu B, et al. | Pulm Med
Aim: To determine the relationship between smoking and clinical COVID-19 severity via a systematic meta-analysis approach. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/24/20
|
Cabarkapa S, Nadjidai SE, Murgier J, et al. | Brain Behav Immun Health
Aim: To explore the main findings from the literature examining the psychological impact on HCWs in times of severe epidemics, and to identify strategies to address this.
MENTAL HEALTH
|
|
|
9/23/20
|
O'Reilly A, Tibbs M, Booth A, et al. | Ir J Psychol Med
Aim: To summarise existing evidence on the potential impact of a pandemic on the mental health of 12-25-year-olds. UPDATED
MENTAL HEALTH
|
|
|
9/23/20
|
Navarro P | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the medium-term and long-term health impacts of COVID-19 on infection survivors.
|
|
|
9/22/20
|
Li X, Xu Z, Wang T, et al. | Clin Epidemiol Glob Health
Aim: To identify clinical characteristics of severe patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/22/20
|
van Boekel L, Stoop A, Luijkx KG | Tijdschr Gerontol Geriatr
Aim: To understand what we can learn from previous crises or disasters worldwide to optimize the care for older adults in long term care facilities during the outbreak of COVID-19.
|
|
|
9/22/20
|
| CADTH
Aim: To review evidence related to airflow transmission of SARS-CoV-2 and the risk associated with the use of heating, ventilation, and air conditioning (HVAC) systems.
|
|
|
9/22/20
|
Melo-Oliveira ME, Sa-Caputo D, Bachur JA, et al. | Expert Rev Respir Med
Aim: To summarize effects of the COVID-19 in the QoL of the studied populations.
CLINICAL CHARACTERISTICS
|
|
|
9/22/20
|
Boyce L, Nicolaides M, Hanrahan JG, et al. | J Plast Reconstr Aesthet Surg
Aim: To identify all published literature on plastic surgery and COVID-19, in an effort to summarise the evidence for future reference.
INFECTION CONTROL
|
|
|
9/21/20
|
Huang AT, Garcia Carreras B, Hitchings MDT, et al. | Nat Commun
Aim: To review the scientific literature on antibody immunity to coronaviruses, including SARS-CoV-2 as well as the related SARS-CoV, MERS-CoV and endemic human coronaviruses (HCoVs). UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/21/20
|
Marinaki S, Tsiakas S, Korogiannou M, et al. | J Clin Med
Aim: To analyze the data of studies reporting on adult KTx recipients with confirmed COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/21/20
|
Lo KB, Bhargav R, Salacup G, et al. | Expert Rev Cardiovasc Ther
Aim: To investigate the impact of ACEI/ARB on COVID-19 associated disease severity and mortality through a systematic review and meta-analysis of existing literature.
CLINICAL CHARACTERISTICS
|
|
|
9/21/20
|
Moosavi MS, Aminishakib P, Ansari M | J Oral Microbiol
Aim: To review the evidence on the effects of different types of mouthwashes to reduce viral load.
INFECTION CONTROL
|
|
|
9/21/20
|
Chen J, See KC | J Med Internet Res
Aim: To review AI applications for COVID-19.
DIAGNOSTICS
|
|
|
9/21/20
|
Yoon S, Li H, Lee KH, et al. | Medicina
Aim: To compare characteristics among: (1) asymptomatic versus symptomatic and (2) less than 10 versus greater or equal to 10 years old pediatric COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
9/21/20
|
Cabrera MA, Karamsetty L, Simpson SA | Psychosomatics
Aim: To provide a critical synthesis of the scientific literature on the pandemic's implications for psychiatric practice.
INFECTION CONTROL
|
|
|
9/21/20
|
Trevisanuto D, Cavallin F, Cavicchiolo ME, et al. | Arch Dis Child Fetal Neonatal Ed
Aim: To summarise currently reported neonatal cases of SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
|
|
|
9/21/20
|
Singh S, Fong HK, Mercedes BR, et al. | Resuscitation
Aim: To review the evidence on the change in out-of-hospital cardiac arrest indicence and mortality during the COVID-19 outbreak in various countries.
|
|
|
9/21/20
|
Mecenas P, da Rose Moreira Bastos RT, Vallinoto ACR, et al. | PLoS One
Aim: To describe current knowledge about the emergence and replicability of the virus and its connection with different weather factors such as temperature and relative humidity. UPDATED
INFECTION CONTROL
|
|
|
9/21/20
|
Acheampong DO, Barffour IK, Boye A, et al. | Biomed Pharmacother
Aim: To review the evidence on the possible biological reasons which underpin the differences observed in the outcome of COVID-19 among males and females.
CLINICAL CHARACTERISTICS
|
|
|
9/21/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the effect of the COVID-19 pandemic on opioid and substance use and related harms.
|
|
|
9/21/20
|
Luigi B, Francesco B, Giovanni B, et al. | Oral Dis
Aim: To review the evidence on surfaces decontamination and protection masks for SARS-CoV-2 in dental practice.
INFECTION CONTROL
|
|
|
9/21/20
|
Yang T, Chou C, Yang Y, et al. | J Chin Med Assoc
Aim: To address not only the benefits and safety issues of HCQ in COVID-19 treatment and to evaluate the effects in combination with the use of macrolide, especially AZI in therapy.
CANDIDATE THERAPEUTICS
|
|
|
9/21/20
|
Khalaj K, Figueira RL, Antounians L, et al. | J Extracell Vesicles
Aim: To analyse whether EV-based therapies could be effective in treating severe pulmonary conditions that affect COVID-19 patients and to understand their relevance for an eventual therapeutic application to human patients.
CANDIDATE THERAPEUTICS
|
|
|
9/21/20
|
Hamedani S, Farshidfar N, Ziaei A, et al. | European Oral Research
Aim: To review relevant current evidence in literature that has addressed the role of saliva and the threats that may be inherent in transmission of the disease during dental procedures.
INFECTION CONTROL
|
|
|
9/18/20
|
WHO REACT Working Group | JAMA
Aim: To estimate the association between administration of corticosteroids compared with usual care or placebo and 28-day all-cause mortality. WHO COLLABORATIVE
CANDIDATE THERAPEUTICS
|
|
|
9/18/20
|
Malik P, Patel U, Mehta D, et al. | BMJ Evid Based Med
Aim: To evaluate association between biomarkers and outcomes in COVID-19 hospitalised patients.
CLINICAL CHARACTERISTICS
|
|
|
9/18/20
|
Zahra SA, Iddawela S, Pillai K, et al. | Brain Behav
Aim: To investigate the diagnostic value of symptoms of anosmia and dysgeusia for COVID?19.
DIAGNOSTICS
|
|
|
9/18/20
|
Bornstein S | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the effectiveness of reducing prison populations to reduce the spread of COVID-19.
|
|
|
9/18/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on whether domestic animals can become infected with and transmit COVID-19.
|
|
|
9/18/20
|
Pranata R, Huang I, Lim MA, et al. | J Stroke Cerebrovasc Dis
Aim: To evaluate the latest evidence on the association between cerebrovascular, and cardiovascular diseases and poor outcome in patients with Coronavirus Disease 2019 (COVID-19) pneumonia.
CLINICAL CHARACTERISTICS
|
|
|
9/18/20
|
Mojtabavi H, Saghazadeh A, Rezaei N | Eur Cytokine Netw
Aim: To investigate whether the circulating levels of IL-6 is a reliable indicator of disease severity among patients affected with COVID-19.
DIAGNOSTICS
|
|
|
9/18/20
|
Lagzian M, Dadkhah M, Mehraeen A | Eur J Clin Invest
Aim: To recognize the challenges policymakers have typically experienced during pandemic diseases, including Covid-19, and, accordingly, new information technology capabilities to encounter with them.
|
|
|
9/18/20
|
Orru G, Conversano C, Malloggi E, et al. | Int J Environ Res Public Health
Aim: To review the evidence on the neurological complications of possible neuroinvasion related to SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
9/18/20
|
Paknahad Z, Moravejolahkami AR | Endocr Metab Immune Disord Drug Targets
Aim: To review the evidence on the effects of probiotics on incidence, severity, duration, and other clinical manifestations of viral infections especially SARS-CoV-2-induced.
CANDIDATE THERAPEUTICS
|
|
|
9/18/20
|
Campbell CM, Guha A, Haque T, et al. | J Clin Med
Aim: To characterize the current state of immunotherapy trials in COVID-19, and focuses on associated cardiotoxicities, given the importance of pharmacovigilance.
CANDIDATE THERAPEUTICS
|
|
|
9/18/20
|
Leung T, Chan A, Chan EW, et al. | Emerg Microbes Infect
Aim: To summarize the current evidence on the short-term adverse health outcomes and assess the risk of potential long-term adverse outcomes of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/18/20
|
Fridman S, Bullrich MB, Jimenez-Ruiz A, et al. | Neurology
Aim: To investigate the hypothesis that strokes occurring in patients with COVID-19 have distinctive features.
CLINICAL CHARACTERISTICS
|
|
|
9/18/20
|
Rajan MB, Kumar P, Bhardwaj A | Int J Dermatol
Aim: To estimate the prevalence of cutaneous manifestations in COVID?19 patients.
CLINICAL CHARACTERISTICS
|
|
|
9/17/20
|
Pastick KA, Nicol MR, Smyth E, et al. | Open Forum Infect Dis
Aim: To review the available evidence on COVID-19 cases during pregnancy and summarize clinical trials enrolling this population.
CLINICAL CHARACTERISTICS
|
|
|
9/17/20
|
McLane P | Alberta Health Services
Aim: To review the evidence on the factors impacting attitudes toward or adherence to COVID-19 public health guidelines and interventions to create more positive attitudes towards following guidelines.
|
|
|
9/17/20
|
Macaluso FS, Orlando A | Dig Liver Dis
Aim: To review the evidence on published COVID-19 cases ocurring in patients with IBD.
CLINICAL CHARACTERISTICS
|
|
|
9/17/20
|
Dambha-Miller H, Albasri A, Hodgson S, et al. | BMJ Open
Aim: To review evidence on routinely prescribed drugs in the UK that could upregulate or downregulate ACE2 and potentially affect COVID-19 disease. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/17/20
|
Chang T, Chou C, Chang L | Obes Rev
Aim: To examine the effects of body mass index (BMI) and obesity (BMI ? 30 kg/m2) on coronavirus disease 2019 (COVID?19).
CLINICAL CHARACTERISTICS
|
|
|
9/17/20
|
Juul S, Nielsen N, Feinberg J, et al. | PLoS Med
Aim: To compare the effects of all treatment interventions for participants in all age groups with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/17/20
|
Lasheras I, Gracia-Garcia P, Lipnicki DM, et al. | Int J Environ Res Public Health
Aim: To investigate the prevalence of anxiety in medical students during this pandemic.
MENTAL HEALTH
|
|
|
9/17/20
|
Wang Y, Ao G, Qi X, et al | Clin Exp Allergy
Aim: To review the evidence on the association of asthma with risk of severe or fatal COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/17/20
|
Christophers B, Marin BG, Oliva R et al. | Pediatr Res
Aim: To describe the clinical presentation and outcomes of pediatric patients using an individual patient data approach to visualize trends by age. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/16/20
|
Du Y, Lv Y, Zha W et al. | Metabolism
Aim: To explore the association between BMI and COVID-19 severity and mortality
CLINICAL CHARACTERISTICS
|
|
|
9/16/20
|
| CADTH
Aim: To provide information on ongoing randomized controlled trials of drugs being investigated to treat or prevent COVID-19.
|
|
|
9/15/20
|
da Silva ML, Rocha RSB, Buheji M, et al. | J Health Psychol
Aim: To assess the prevalence of generalized anxiety disorder (GAD) in pandemic survivors and the general population.
MENTAL HEALTH
|
|
|
9/15/20
|
Cheruiyot I, Henry B, Lippi G, et al. | Acta Biomed
Aim: To assess whether AKI may be associated with worse prognosis and increased mortality in COVID-19 patients UPDATED
|
|
|
9/15/20
|
Peres KC, Riera R, Martimbianco ALC, et al. | Front Endocrinol
Aim: To investigate a possible association between body weight and prognosis among patients diagnosed with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/15/20
|
Muhammad SZ, Ahmed A, Shahid I, et al. | Infez Med
Aim: To systematically review these studies and to conduct a meta-analysis of their results to provide a well-powered assessment of chest CT findings in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/15/20
|
Ciuca IM | Risk Manag Healthc Policy
Aim: To describe the current knowledge about coronavirus disease 2019 (COVID-19, which is caused by severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) in children, from epidemiological, clinical, and laboratory perspectives, including knowledge on the disease course, treatment, and prognosis.
CLINICAL CHARACTERISTICS
|
|
|
9/15/20
|
Bizzoca ME, Campisi G, Lo Muzio L | Int J Environ Res Public Health
Aim: To illustrate the most accepted models of safety protocols in dentistry and oral medicine, and to propose an easy view of the problem and a comparison (pre- vs post-COVID19) for the most common dental procedures.
INFECTION CONTROL
|
|
|
9/15/20
|
Fiorillo L, Cervino G, Matarese M, et al. | Int J Environ Res Public Health
Aim: To highlight all the sources currently present in the literature concerning the persistence of the different coronaviruses in the environment as well as in medical and dental settings.
INFECTION CONTROL
|
|
|
9/15/20
|
Yamamoto V, Bolanos JF, Fiallos J, et al. | J Alzheimers Dis
Aim: To provide a comprehensive review of SARS-CoV-2-induced disease, its mechanism of infection, diagnostics, therapeutics, and treatment strategies, while also focusing on less attended aspects by previous studies, including nutritional support, psychological, and rehabilitation of the pandemic and its management.
CANDIDATE THERAPEUTICS
|
|
|
9/15/20
|
Aziz H, Lashkari N, Yoon YC, et al. | Transplant Proc
Aim: To assess currently published literature relating to the management, clinical course and outcomes of SARS-Cov-2 infection in liver, kidney and heart SOT recipients.
CLINICAL CHARACTERISTICS
|
|
|
9/15/20
|
Roberto KT, Espiritu AI, Fernandez MLL, et al. | Seizure
Aim: To review the EEG findings in patients diagnosed with COVID-19 infection through a systematic review of published articles.
CLINICAL CHARACTERISTICS
|
|
|
9/15/20
|
| Health Information and Quality Authority, Ireland
Aim: To review the evidence on the duration of infectiousness in those that test positive for SARS-CoV-2 RNA.
|
|
|
9/15/20
|
Siepmann T, Sedghi A, Simon E, et al. | Eur J Neurol
Aim: To define the risk of acute stroke in patients with severe and non-severe COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/15/20
|
Zhang A, Leng Y, Zhang Y et al. | Int J Infect Dis
Aim: To figure out whether abnormal coagulation parameters are associated with disease severity and poor prognosis in patients with 2019 Corona Virus Disease (COVID-19)
CLINICAL CHARACTERISTICS
|
|
|
9/15/20
|
Ahmed M, Advani S, Moreira A, et al. | EClinicalMedicine
Aim: To describe the typical presentation and outcomes of children diagnosed with this hyperinflammatory condition. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/15/20
|
| Quebec National Institute of Public Health
Aim: To review the evidence on risk factors for severe infections and potential for transmission in children.
|
|
|
9/15/20
|
Sharpe H | Alberta Health Services
Aim: To review the evidence on different methods, completion rates, and costs for self-collected samples for SARS-CoV-2 RT-PCR.
|
|
|
9/15/20
|
Ricco M, Ranzieri S, Peruzzi S, et al. | Acta Biomed
Aim: To conduct a meta-analysis on the sensitivity and specificity of SARS-CoV-2 viral RNA detection through RT-qPCR based on salivary specimens compared to conventional nasopharyngeal swabs.
DIAGNOSTICS
|
|
|
9/15/20
|
Banerjee I, Robinson J, Kashyap A, et al. | Nepal J Epidemiol
Aim: To assess the impact of COVID-19 on the younger age group in terms of the Global mortality of COVID-19 in comparison to Nepal.
CLINICAL CHARACTERISTICS
|
|
|
9/15/20
|
Aronoff SC, Hall A, Del Vecchio MT | J Pediatric Infect Dis Soc
Aim: To provide a detailed clinical description and natural history of MIS-C.
CLINICAL CHARACTERISTICS
|
|
|
9/15/20
|
Viswanathan M, Kahwati L, Jahn B, et al. | Cochrane Database Syst Rev
Aim: To assess (1) the effectiveness of universal screening for SARS?CoV?2 infection compared with no screening and (2) the accuracy of universal screening in people who have not presented to clinical care for symptoms of COVID?19.
INFECTION CONTROL
|
|
|
9/14/20
|
Lee JC, Nallani R, Cass L, et al. | Am J Rhinol Allergy
Aim: To synthesize the existing primary literature related to olfactory dysfunction secondary to viral infection, detail the underlying pathophysiological mechanisms, highlight relevance for the current COVID-19 pandemic, and identify high impact areas of future research.
CLINICAL CHARACTERISTICS
|
|
|
9/14/20
|
Mark EG, Golden WC, Gilmore MM, et al. | J Pediatr
Aim: To summarize and evaluate current reports on community-onset severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in young infants.
CLINICAL CHARACTERISTICS
|
|
|
9/14/20
|
Jimenez-Ruiz CA, Lopez-Padilla D, Alonso-Arroyo A, et al. | Arch Bronconeumol
Aim: To review the evidence on the association between tobacco use in patients with COVID-19 and negative progression and adverse outcome of the disease.
CLINICAL CHARACTERISTICS
|
|
|
9/14/20
|
Klein MG, Cheng CJ, Lii E, et al. | Disaster Med Public Health Prep
Aim: To highlight models that project both caseload and hospital capacity requirements over time.
|
|
|
9/14/20
|
Williams N, Radia T, Harman K, et al. | Eur J Pediatr
Aim: To identify and describe which underlying comorbidities may be associated with severe SARS-CoV-2 disease and death in children.
CLINICAL CHARACTERISTICS
|
|
|
9/14/20
|
Aziz M, Haghbin H, Sitta EA, et al. | J Med Virol
Aim: To compare the efficacy of addition of TOC to standard of care (SOC) versus SOC in patients with COVID?19.
CANDIDATE THERAPEUTICS
|
|
|
9/14/20
|
Di Maria E, Latini A, Borgiani P, et al. | Human Genomics
Aim: To review the evidence on genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS, and COVID-19). UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/14/20
|
Fernandez R, Lord H, Halcomb E, et al. | Int J Nurs Stud
Aim: To synthesize and present the best available evidence on the experiences of nurses working in acute hospital settings during a pandemic.
|
|
|
9/14/20
|
Hasan SS, Kow CS, Hadi MA, et al. | Am J Cardiovasc Drugs
Aim: To critically examine the association of RAS inhibitors use with mortality and disease severity in COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
9/14/20
|
Panda PK, Sharawat IK, Panda P, et al. | J Trop Pediatr
Aim: To review the evidence on the neurological manifestations of COVID-19 in children. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/14/20
|
Amorim dos Santos J, Normando AGC, Carvalho da Silva RL, et al. | J Dent Res
Aim: To provide a comprehensive up-to-date summary of oral manifestations in patients with COVID-19.
|
|
|
9/14/20
|
Nino G, Zember J, Sanchez-Jacob R, et al. | Pediatr Pulmonol
Aim: To provide the first comprehensive summary of the findings of published studies thus far describing COVID-19 lung imaging data in the pediatric population.
CLINICAL CHARACTERISTICS
|
|
|
9/14/20
|
Cozzupoli GM, Savastano MC, Galsini B, et al. | J Ophthalmol
Aim: To review and analyze previous studies conducted on ritonavir administration and retinal impairment in a narrative synthesis.
CANDIDATE THERAPEUTICS
|
|
|
9/14/20
|
Nussbaumer-Streit B, Mayr V, Dobrescu AI, et al. | Cochrane Database of Systematic Reviews
Aim: To assess the effects of quarantine (alone or in combination with other measures) of individuals who had contact with confirmed cases of COVID19, who travelled from countries with a declared outbreak, or who live in regions with high transmission of the disease. UPDATED WHO COLLABORATIVE
INFECTION CONTROL
|
|
|
9/14/20
|
Florez-Perdomo WA, Serrato-Vargas SA, Bosque-Varela P, et al. | Clin Neurol Neurosurg
Aim: To evaluate and summarize the level of evidence on past history of stroke in COVID19 patients.
CLINICAL CHARACTERISTICS
|
|
|
9/14/20
|
Patoulias D, Katsimardou A, Stavropoulos K, et a. | Curr Hypertens Rep
Aim: To evaluate the association between the use of either ACE inhibitors or ARBs and the risk for major clinical endpoints (infection, hospitalization, admission to ICU, death) in adult patients during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
|
|
|
9/14/20
|
Elhabyan A, El Yaacoub S, Sanad E, et al. | Virus Res
Aim: To identify the candidate genes that are likely to aid in explaining severe COVID-19 and provide insights to understand severe COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/14/20
|
Zeng M, Li L, Wu Z | PLoS ONE
Aim: To review the evidence on the clinical efficacy and safety of the traditional Chinese medicine Lianhua Qingwen in the treatment of new coronavirus pneumonia (COVID-19).
CANDIDATE THERAPEUTICS
|
|
|
9/12/20
|
Noor FM, Islam MM | J Community Health
Aim: To find the prevalence of mortality among hospitalized COVID-19 infected patients and associated risk factors for death.
CLINICAL CHARACTERISTICS
|
|
|
9/12/20
|
Hussain N, Yoganathan A, Hewage S, et al. | Expert Rev Anti Infect Ther
Aim: To identify studies pertaining to antivirals, both as sole and combined therapies, in COVID-19 patients and review the clinical outcomes of these treatment methods.
CANDIDATE THERAPEUTICS
|
|
|
9/11/20
|
Usman AS, Siddiqi TJ, Khan MS, et al. | Am J Cardiol
Aim: To conduct a meta-analysis of all available data on the relationship between renin-angiotensin aldosterone system of inhibitors and COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
9/11/20
|
Sun M, Xu Y, He H, et al. | Int J Infect Dis
Aim: To explore the effectiveness of treatment and predict the potential effects of CP with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
9/11/20
|
Sun Z, Zhang N, Li Y, et al. | Quant Imaging Med Surg
Aim: To analyze the currently available studies documenting radiologic findings and aim to clarify the role of CT imaging in the diagnosis of patients with COVID-19.
DIAGNOSTICS
|
|
|
9/11/20
|
Brienza N, Puntillo F, Romagnoli S, et al. | Blood Purif
Aim: To clarify the incidence and the impact of COVID-19-related AKI on mortality.
CLINICAL CHARACTERISTICS
|
|
|
9/11/20
|
Ng JJ, Luo Y, Phua K, et al. | J Infect
Aim: To quantitatively synthesized available literature and performed a single-arm meta-analysis of proportions to report the pooled incidence rate of AKI and renal replacement therapy (RRT) use in hospitalized patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/11/20
|
Patel U, Malik P, Usman MS, et al. | SN Compr Clin Med
Aim: To identify risk factors associated with poor outcomes (IMV and mortality) of COVID-19 hospitalized patients.
CLINICAL CHARACTERISTICS
|
|
|
9/11/20
|
Bakhtawar N, Usman M, Khan MMU | Cureus
Aim: To evaluate the efficacy of convalescent plasma (CP) therapy and its effects on COVID-19 patient outcomes.
CANDIDATE THERAPEUTICS
|
|
|
9/11/20
|
Paliogiannis P, Mangoni AA, Dettori P, et al. | Front Public Health
Aim: To investigate differences in serum D-dimer concentrations in patients with and without severe COVID-19 disease.
CLINICAL CHARACTERISTICS
|
|
|
9/11/20
|
Sant'Ana G, Imoto AM, Amorim FF, et al. | Acta Paul Enferm
Aim: To identify evidences regarding infection by SARS-CoV-2 and deaths of healthcare workers and related-risk factors.
INFECTION CONTROL
|
|
|
9/11/20
|
Pathak SK, Salunke AA, Thivari P, et al. | Diabets Metab Syndr
Aim: To evaluate the efficacy of hydroxychloroquine and its related formulations in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
9/11/20
|
Zhao G, Huang P, Du B, et al. | Nutr Metab Cardiovasc Dis
Aim: To 1) explore the prevalence of cardiac injury in different types of COVID-19 patients and 2) evaluate the association between cardiac injury and worse prognosis (severe disease, admission to ICU, and mortality) in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/11/20
|
Lenferink LIM, Meyerbroker K, Boelen PA | Psychiatry Res
Aim: To review the evidence on online Eye Movement Desensitization and Reprocessing (EMDR) treatment for PTSD.
|
|
|
9/11/20
|
Czumbel LM, Kiss S, Farkas N, et al. | Front Med
Aim: To conduct a meta-analysis on the reliability and consistency of SARS-CoV-2 viral RNA detection in saliva specimens. UPDATED
DIAGNOSTICS
|
|
|
9/11/20
|
Abdoul-Azize HT, El Gamil R | Glob Soc Welf
Aim: To explore the current implementation of social protection programs during the COVID-19 pandemic in the most affected countries as well as to provide learned lessons from countries that had not previously considered implementing social protection programs up until the COVID-19 crisis.
|
|
|
9/11/20
|
Heidary F, Gharebaghi R | Expert Rev Clin Immunol
Aim: To review the evidence on the antiviral effects of TRIM56.
|
|
|
9/11/20
|
Seidu S, Gillies C, Zaccardi F, et al. | Endocrinol Diabetes Metab
Aim: To determine whether people with overweight or obesity and with SARS?CoV?2 have different outcomes compared to those within normal weight thresholds. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/11/20
|
Rahman HS, Aziz MS,Hussein RH, et al. | Int J Surg Open
Aim: To review the evidence on the causative agent, the main modes of transmission, and sources of COVID-19.
INFECTION CONTROL
|
|
|
9/10/20
|
Neishaboori AM, Moshrefiaraghi D, Ali KM, et al. | Arch Acad Emerg Med
Aim: To investigate the current evidence regarding central nervous system (CNS) complications in patients with confirmed COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/10/20
|
Chastain DB, Stitt TM, Ly PR, et al. | Open Forum Infect Dis
Aim: To assess potential proinflammatory targets and review the safety and efficacy of immunomodulatory therapies in managing patients with acute respiratory distress syndrome associated with coronavirus disease 2019.
CANDIDATE THERAPEUTICS
|
|
|
9/10/20
|
Flumignan RLG, Nakano LCU, Pascoal PIF, et al. | Sao Paulo Med J
Aim: To identify and summarize the evidence from Cochrane systematic reviews (SRs) regarding measures for controlling the dissemination of COVID-19 infection.
INFECTION CONTROL
|
|
|
9/10/20
|
Housing for Health Project | University of Alberta
Aim: To review the evidence on the built environment factors associated with physical activity among older adults during the acute and recovery phases of the COVID-19 and future pandemics.
|
|
|
9/10/20
|
Tricco A | Drug Safety and Effectiveness Network
Aim: To review the evidence on the safety and effectiveness of using fractional dosing strategies to deliver intramuscular seasonal influenza vaccines.
|
|
|
9/10/20
|
Serban D, Smarandache CG, Tudor C, et al. | Diagnostics
Aim: To review the available evidence regarding the health risk of the aerosolization induced by laparoscopy induced and impact of the COVID-19 pandemic upon minimally invasive surgery.
INFECTION CONTROL
|
|
|
9/10/20
|
Liu C, Yang J, Wang W, et al. | Eur J Gastroenterol Hepatol
Aim: To compare liver injury in severe vs. non-severe or dead vs. surviving patients and investigate whether livery injury can help predict clinical severity and mortality in patients with coroanvirus disease 2019.
DIAGNOSTICS
|
|
|
9/10/20
|
Cyr G, Gabet M | Centre de Recherche en Sante Publique
Aim: To review the evidence on the best practices for managing a regional coordination center in a crisis situation.
|
|
|
9/10/20
|
Bondini CM, Sage S, Wilson BP, et al. | Int Wound J
Aim: To explore the existing evidence around alternative service delivery modalities for treating complex wounds.
INFECTION CONTROL
|
|
|
9/10/20
|
García Ron A, Cuéllar-Flores I | An Pediatr
Aim: To review the available evidence on the psychological impact of confinement in children, seeking to identify the main stressors and protective factors at play.
MENTAL HEALTH
|
|
|
9/10/20
|
Lester S, Khatwa M, Sutcliffe K | JAMA Intern Med
Aim: To gain a deeper understanding of the kinds of services that young people exposed to ACEs feel they need.
|
|
|
9/10/20
|
Seyedpour S, Khodaei B, Loghman AH, et al. | J Cell Physiol
Aim: To provide a systematic evaluation of the most recent in vitro and in vivo investigations targeting SARS?CoV?2 cell entry.
CLINICAL CHARACTERISTICS
|
|
|
9/10/20
|
Major R, Selvaskandan H, Makkeyah YM, et al. | J Am Soc Nephrol
Aim: To assess the CKD-related inclusion and exclusion criteria for COVID-19 trials.
|
|
|
9/10/20
|
Bornstein S | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the long-term impacts of COVID-19 on infection survivors.
|
|
|
9/9/20
|
Fu EL, Janse RJ, de Jong Y, et al. | Clin Kidney J
Aim: To review the evidence on incidence, mortality and risk factors for acute kidney injury in hospitalized COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
9/9/20
|
Razmi M, Hashemi F, Gheytanchi E, et al. | Int Immunopharmacol
Aim: To assess the available data regarding the efficacy of the immunomodulatory drugs used to manage COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/9/20
|
Kow CS, Hasan SS | J Med Virol
Aim: To explore whether the use of metformin was associated with decreased mortality in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
9/9/20
|
Chauhan N, Soni S, Gupta A, et al. | Expert Rev Mol Diagn
Aim: To review the evidence on diagnostic methods for COVID-19 detection.
DIAGNOSTICS
|
|
|
9/9/20
|
Gitterman LMT, Feris SNV, von Oetinger Giocoman A | Neurologia
Aim: To analyze the available evidence on patients with Guillain-Barre syndrome associated with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/9/20
|
Seyedpour S, Khodaei B, Loghman AH, et al. | J Cell Physiol
Aim: To provide a systematic evaluation of the most recent in vitro and in vivo investigations targeting SARS?CoV?2 cell entry.
CANDIDATE THERAPEUTICS
|
|
|
9/8/20
|
Wong Y, Tan M, Zheng Q, et al. | Ann Hepatol
Aim: To assess the prevalence and degree of liver injury between patients with severe and non-severe COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/8/20
|
Miller MA, Cappuccio F | Sleep Med Rev
Aim: To review the rapidly emerging COVID-19 literature to determine (a) the relationship between obstructive sleep apnoea (OSA) and adverse COVID-19 outcomes and, (b) potential causal mechanisms (c) what effect COVID-19 has had on OSA diagnosis and (d) what effect COVID-19 has had on treatment and management of OSA during this period.
CLINICAL CHARACTERISTICS
|
|
|
9/8/20
|
Kaushik A, Gupta S, Sood M, et al. | Pediatr Infect Dis J
Aim: To review the evidence on multisystem inflammatory syndrome in children (MIS-C).
CLINICAL CHARACTERISTICS
|
|
|
9/8/20
|
Hartmann-Boyce J, Gunnell J, Drake J, et al. | BMJ Evid Based Med
Aim: To assess the risks and management considerations of COVID-19 in people with asthma (PWA).
CLINICAL CHARACTERISTICS
|
|
|
9/8/20
|
Elavarasi A, Prasad M, Seth T, et al. | J Gen Intern Med
Aim: To synthesize the available data on the efficacy and safety of CQ and HCQ for the treatment of COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/8/20
|
Fraser J, Mousley J, Testro A, et al. | Transplant Proc
Aim: To review the evidence on the clinical presentation, treatments, and outcomes in liver transplant recipients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/8/20
|
Zang Y, Han X, He M, et al. | Naunyn Schmiedebergs Arch Pharmacol
Aim: To systematically assess the benefits and harms of HCQ for the treatment of COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
9/8/20
|
Vargas M, Servillo G, Einav S | Eur Rev Med Pharmacol Sci
Aim: To review the evidence on the use of lopinavir/ritonavir for the treatment of SARS, MERS, and SARS-CoV-2.
CANDIDATE THERAPEUTICS
|
|
|
9/8/20
|
Shoar S, Hosseini F, Naderan M, et al. | Am J Cardiol
Aim: To review the evidence on cardiovascular complications associated with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/8/20
|
Radia T, Williams N, Agrawal P, et al. | Paediatr Respir Rev
Aim: To evaluate reported cases of MIS-C in children and adolescents.
CLINICAL CHARACTERISTICS
|
|
|
9/8/20
|
Wittmeier K, Parsons J, Webber S, et al. | Phys Ther
Aim: To provide a review of the pandemic and physical disaster management literature to summarize physical therapy–specific operational considerations to assist hospital-based leadership teams in planning and response efforts during the COVID-19 pandemic.
INFECTION CONTROL
|
|
|
9/8/20
|
Barbosa MT, Sousa CS, Morais-Almeida M, et al. | COPD
Aim: To review the effectiveness of telemedicine to treat COPD during the COVID-19 pandemic.
INFECTION CONTROL
|
|
|
9/8/20
|
Diriba K, Awulachew E, Getu E | Eur J Med Res
Aim: To assess the effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and its possibility of vertical maternal–fetal transmission.
CLINICAL CHARACTERISTICS
|
|
|
9/8/20
|
Samaranayake LP, Fakhruddin KS, Ngo HC, et al. | Acta Odontol Scand
Aim: To review the data on the effectiveness and efficacy of facemasks and respirators, including protective eyewear, with particular emphasis on dental healthcare.
INFECTION CONTROL
|
|
|
9/8/20
|
Barello S, Falco-Pegueroles A, Rose D, et al. | Int J Public Health
Aim: To assess available literature on perceived stress and psychological responses to influenza pandemics in HCWs and identify implications for healthcare practice and future research.
MENTAL HEALTH
|
|
|
9/8/20
|
Kashi AH, De la Rosette J, Amini E, et al. | Urol J
Aim: To review the current literature on the presence of COVID-19 virus in the urine of infected patients and to explore the clinical features that can predict the presence of COVID-19 in urine.
INFECTION CONTROL
|
|
|
9/7/20
|
Simadibrata DM, Lubis AM | Epidemiol Infect
Aim: To review and evaluate currently available evidence to establish the association between D-dimer levels on admission and all-cause mortality risk in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/4/20
|
Sarkar S, Khanna P, Soni KD | J Med Virol
Aim: To evaluate the impact of glucocorticoid therapy in COVID-19 patients based on the publications reported to date.
CANDIDATE THERAPEUTICS
|
|
|
9/4/20
|
Keller KG, Reangsing C, Schneider JK | J Adv Nurs
Aim: To 1) determine the clinical presentation and 2) outcomes of adult hospitalized patients with COVID-19 to provide practicing nurses with a cogent and concise clinical impression of COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
9/4/20
|
Rees EM, Nightingale ES, Jafari Y, et al. | BMC Med
Aim: To review estimates of how long patients with COVID-19 need different levels of hospital care. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/4/20
|
Ghoda A, Ghoda M | Cureus
Aim: To ascertain whether liver enzyme derangement is a common feature in adult patients with confirmed COVID-19 infection, determine the relation of deranged liver enzymes with outcome or mortality in COVID-19, and determine if liver failure is a common feature of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/4/20
|
Stavridou A, Stergiopoulou A, Panagouli E, et al. | Psychiatry Clin Neurosci
Aim: To review the evidence on psychosocial consequences of COVID-19 in children, adolescents and young adults.
MENTAL HEALTH
|
|
|
9/3/20
|
Giorli A, Ferretti F, Biagini C, et al. | Curr Treat Options Neurol
Aim: To investigate the association between the olfactory dysfunction and the more typical symptoms (fever, cough, dyspnoea) within the Sars-CoV-2 infection (COVID-19) in hospitalized and non-hospitalized patients.
CLINICAL CHARACTERISTICS
|
|
|
9/3/20
|
Martin A, Blom IM, Whyatt G, et al. | Disaster Med Public Health Prep
Aim: To explore the involvement of medical students in past global health emergencies, to help inform current and future scenarios. UPDATED
|
|
|
9/3/20
|
Caldeira D, Alves M, Melo RGE, et al. | Int J Cardiol Heart Vasc
Aim: To systematically evaluate the risk of COVID-19 infection and the risk of severe COVID-19 disease associated with previous exposure to (ACEi) and/or ARB). UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/3/20
|
Liu C, He Y, Liu L, et al. | BMC Pediatr
Aim: To review the evidence on the characteristics of children with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/3/20
|
Zhang Z, Zhang L, Zha D, et al. | Ren Fail
Aim: To evaluate the clinical characteristics and possible risk factors affecting the progression of disease in COVID-19 patients with AKI.
CLINICAL CHARACTERISTICS
|
|
|
9/3/20
|
Allotey J, Stallings E, Bonet M, et al. | BMJ
Aim: To determine the clinical manifestations, risk factors, and maternal and perinatal outcomes in pregnant and recently pregnant women with suspected or confirmed coronavirus disease 2019 (covid-19). UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/3/20
|
de Camargo MC, Martinez-Silveira MS, Lima AA, et al. | Cien Saude Colet
Aim: To evaluate the effectiveness of non-woven face masks for the prevention of respiratory infections (MERS CoV, SARS-CoV, and SARS-CoV-2) in the population.
INFECTION CONTROL
|
|
|
9/3/20
|
Sergeant A, van Reekum EA, Sanger N, et al. | BMJ Open
Aim: To study the effect of pandemics and epidemics on mental health outcomes for people with premorbid mental disorders. UPDATED
|
|
|
9/3/20
|
de Andrade KRC, da Silva Carvalho VK, Farinasso CM, et al. | Cien Saude Colet
Aim: To evaluate the effects of drug therapies for coronavirus infections.
CANDIDATE THERAPEUTICS
|
|
|
9/3/20
|
Bendezu-Quispe G, Rodirquez-Zuniga MJM, Roman YM, et al. | Rev Peru Med Exp Salud Publica
Aim: To review the evidence on chloroquine/hydroxychloroquine, lopinavir/ritonavir, tocilizumab, oseltamivir, interferon, atazanavir and anti SARS-CoV-2 serum as therapeutic agents for COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
9/3/20
|
Bentlage E, Ammar A, How D, et al. | Int J Environ Res Public Health
Aim: To provide practical recommendations for maintaining active lifestyles during pandemics.
INFECTION CONTROL
|
|
|
9/3/20
|
| Health Information and Quality Authority, Ireland
Aim: To review guidance for residential care facilities in the context of COVID-19.
|
|
|
9/3/20
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the risk of adverse maternal or fetal outcomes in women diagnosed with COVID-19 during pregnancy.
|
|
|
9/3/20
|
de Barcelos Ubaldo Martins L, Jabour LGPP, Vieira CC, et al. | Curr Med Chem
Aim: To describe the particularities of the RAS and the immune system profile of particular subgroups of patients.
CLINICAL CHARACTERISTICS
|
|
|
9/3/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the volume-outcome relationship for surgical interventions.
|
|
|
9/3/20
|
Costenaro P, Minotti C, Barbieri E, et al. | Rev Med Virol
Aim: To review the current knowledge on SARS-CoV-2 cases in PLWHA. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/3/20
|
de Almeida-Pititto B, Dualib PM, Zajdenverg L, et al. | Diabetol Metab Syndr
Aim: To evaluate the association of diabetes, hypertension, cardiovascular disease and ACEI/ARBs exposure with severity–intensive care unit treatment or mechanical ventilation necessity or O2 saturation? UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/2/20
|
Cheruiyot I, Kipkorir V, Ngure B, et al. | Ann Vasc Surg
Aim: To identify and consolidate evidence of AT in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
9/2/20
|
Marasinghe KM | Int J One Health
Aim: To understand available evidence around the effectiveness or ineffectiveness of face mask use in limiting the spread of COVID-19 among individuals who have not yet been diagnosed with COVID-19
INFECTION CONTROL
|
|
|
9/2/20
|
Saini KS, Tagliamento M, Lambertini M, et al. | Eur J Cancer
Aim: To provide precise estimates of the mortality rate among patients with both cancer and COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/2/20
|
Cumpstey AF, Oldman AH, Smith AF, et al. | Cochrane Database of Systematic Reviews
Aim: To address how oxygen therapy should be targeted in adults with ARDS (particularly ARDS secondary to COVID?19 or other respiratory viruses) and requiring mechanical ventilation in an intensive care unit, and the impact oxygen therapy has on mortality, days ventilated, days of catecholamine use, requirement for renal replacement therapy, and quality of life.
CANDIDATE THERAPEUTICS
|
|
|
9/2/20
|
Chan CK, Huang YS, Liao HW, et al | Hypertension
Aim: To review the evidence on the impact of the use of ACEi or ARBs on SARS-CoV-2 infection.
CANDIDATE THERAPEUTICS
|
|
|
9/2/20
|
Gebru AA, Birhanu T, Wendimu E, et al. | Hum Antibodies
Aim: To identify and review a published level of risk, effects response to potential health emergencies, prevention, and control methods of Coronavirus Disease 2019 at the global level.
INFECTION CONTROL
|
|
|
9/1/20
|
Sakka M, Conners JM, Hekimian G, et al. | J Med Vasc
Aim: To review current available data on the association between D-Dimer levels and mortality in patients admitted to hospital for COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
9/1/20
|
Vafea MT, Atalla E, Kalligeros M, et al. | Clin Radiol
Aim: To determine the overall rate of chest imaging findings in asymptomatic cases, describe the most common patterns found, and determine the rate of later symptom development in these initially asymptomatic cases.
CLINICAL CHARACTERISTICS
|
|
|
9/1/20
|
Ahmed J, Rizwan T, Malik F, et al. | Cureus
Aim: To derive generalizable, well-powered estimates of liver injury prevalence in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
9/1/20
|
Gomez-Ochoa SA, Franco OH, Rojas LZ, et al. | Am J Epidemiol
Aim: To systematically review the evidence on the prevalence, risk factors, clinical characteristics, and prognosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among HCW.
|
|
|
9/1/20
|
Leal J, Gagnon H | Alberta Health Services
Aim: To review the evidence on transmission of COVID-19 in condos, apartments, and/or hotels.
|
|
|
9/1/20
|
Gagnon MP | Universite Laval
Aim: To review the evidence on effective digital health interventions to prevent, detect, and manage mental health problems in individuals with a pre-existing chronic diseases.
|
|
|
9/1/20
|
Liu M, Ya G, Yuan Y, et al. | Integr Med Res
Aim: To evaluate the efficacy and safety of LH for treating patients with COVID-19 by a systematic review and meta-analysis.
CANDIDATE THERAPEUTICS
|
|
|
9/1/20
|
Lapid MI, Seiner S, Heintz H, et al. | Am J Geriatr Psychiatry
Aim: To provide a consensus statement on the clinical practice changes in ECT specific to older adults based on expert group discussions of ECT practitioners across the country and a systematic review of the literature.
INFECTION CONTROL
|
|
|
9/1/20
|
Sharpe H | Alberta Health Services
Aim: To review the evidence on the harm of mask use in specific patient populations.
|
|
|
9/1/20
|
Allison P, de Souza RF, Aboud L, et al. | Public Health Agency of Canada
Aim: To review the evidence on safe dental practices during the COVID-19 pandemic.
|
|
|
9/1/20
|
Clements F | University of Calgary, Health Technology Assessment Unit
Aim: To review the evidence on the immunogenicity and safety of the influenza vaccine at reduced or regular intradermal doses compared with a full intramuscular dose.
|
|
|
9/1/20
|
Smale J | Timiskamig Health Unit
Aim: To review the harms being experienced by community dwelling low income populations from staying at home for long periods of time during current or past pandemics.
|
|
|
9/1/20
|
Baroutjian A, Sanchez C, Boneva D, et al. | Am J Emerg Med
Aim: To evaluate the safety and effectiveness of SARS-CoV-2 pharmacologic therapies as of August 2, 2020 according to study level of evidence.
CANDIDATE THERAPEUTICS
|
|
|
9/1/20
|
Park R, Chidharla A, Mehta K, et al. | EClinicalMedicine
Aim: To synthesize the evidence behind sex-bias within COVID-19 associated illness severity and death specifically within the cancer patient population.
CLINICAL CHARACTERISTICS
|
|
|
9/1/20
|
Erdmann R | Alberta Health Services
Aim: To review the evidence on the risk factors associated with the development of severe outcomes in COVID-19.
|
|
|
9/1/20
|
Carroll A, Hicks A, Saxinger L, et al. | Alberta Health Services
Aim: To review the evidence on the role of children in community SARS-CoV-2 transmission.
|
|
|
8/31/20
|
Usher K, Jackson D, Durkin J, et al. | Int J Ment Health Nurs
Aim: To systematically examine, synthesise and critically appraise the available evidence on the relationship between pandemic-related behaviours and psychological outcomes.
MENTAL HEALTH
|
|
|
8/31/20
|
McBane RD, Roldan VDT, Niven AS, et al. | Mayo Clin Proc
Aim: To synthesize current data on thrombosis risk, prognostic implications, and anticoagulation effects in COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/31/20
|
Ssentongo P, Ssentongo AE, Heilbrunn ES, et al. | PLoS ONE
Aim: To estimate the association of pre-existing comorbidities with COVID-19 mortality. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/31/20
|
Dhir SK, Kumar J, Meena J, et al. | J Trop Pediatr
Aim: To systematically synthesize the currently available literature on various modes of transmission (congenital, intrapartum, and postpartum), clinical features and outcomes of SARS-CoV-2 infection in neonates.
INFECTION CONTROL
|
|
|
8/31/20
|
Chi H, Chiu N, Tai Y, et al. | J Microbiol Immunol Infect
Aim: To investigate the outcomes of neonates born to mothers with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/31/20
|
Pal R, Banerjee M, Yadav U, et al. | Diabetes Metab Syndr
Aim: To conduct a systematic literature review and analyze the demographic/biochemical parameters and clinical outcomes of COVID-19 patients with diabetic ketoacidosis (DKA) and combined DKA/HHS (hyperglycemic hyperosmolar syndrome).
CLINICAL CHARACTERISTICS
|
|
|
8/31/20
|
Bakhtawar N, Usman M, Khan MHU | Cureus
Aim: To provide an insight into the clinical effectiveness of convalescent plasma as a potential therapy for COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
8/31/20
|
Mousavi E, Kananizadeh N, Martinello R, et al. | Environ Sci Technol
Aim: To review the evidence on the safety of air filtration and air recirculation in healthcare premises.
INFECTION CONTROL
|
|
|
8/31/20
|
Rego GNA, Nucci MP, Alves AH, et al. | Vaccines
Aim: To summarize the global race for vaccine development against COVID-19.
INFECTION CONTROL
|
|
|
8/31/20
|
Gordon M, Patricio M, Horne L, et al. | Med Teach
Aim: To synthesize published reports of medical educational developments in response to the pandemic, considering descriptions of interventions, evaluation data and lessons learned.
INFECTION CONTROL
|
|
|
8/31/20
|
Fiolet T, Guihur A, Rebeaud M, et al. | Clin Microbiol Infect
Aim: To assess whether chloroquine or hydroxychloroquine with or without azithromycin decreased COVID-19 mortality compared to the standard of care. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
8/31/20
|
Das RR, Jaiswal N, Dev N, et al. | Front Med
Aim: To review the evidence on the efficacy and safety of using anti-malarial drugs to treat COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
8/31/20
|
Del Sole F, Farcomeni A, Loffredo L, et al. | Eur J Clin Invest
Aim: To systematically review clinical and biochemical characteristics associated with the severity of the novel severe acute respiratory syndrome coronavirus 2 (SARS?CoV?2)?related disease (COVID?19).
CLINICAL CHARACTERISTICS
|
|
|
8/31/20
|
Uncini A, Vallat J, Jacobs BC | J Neurol Neurosurg Psychiatry
Aim: To clarify the clinical and electrophysiological phenotype, and to discuss, on the basis of the available data, whether the disease mechanism could be parainfective or postinfective and to speculate on the possible pathogenesis.
CLINICAL CHARACTERISTICS
|
|
|
8/31/20
|
Lei H, Xu X, Xiao S, et al. | J Infect
Aim: To assess the secondary attack rate of household COVID-19 transmission.
INFECTION CONTROL
|
|
|
8/31/20
|
Zhang C, Shen L, Le K, et al. | Front Cardiovasc Med
Aim: To summarize all available evidence for a comprehensive and rigorous systematic review focused on VTE incidence in hospitalized COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
8/31/20
|
Popkin BM, Du S, Green WD, et al. | Obes Rev
Aim: To review the evidence on the linkage between obesity and COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/31/20
|
El Boghdady M, Ewalds-Kvist B | Surgeon
Aim: To systematically review the literature regarding the safe use of laparoscopy during COVID-19.
INFECTION CONTROL
|
|
|
8/31/20
|
Shorey S, Chan V, et al. | Midwifery
Aim: To consolidate qualitative research studies that examined the experiences and needs of pregnant women, midwives, and nurses of maternity units to provide a way forward for future research and practices during the current pandemic and future epidemics and pandemics.
INFECTION CONTROL
|
|
|
8/31/20
|
Soklaridis S, Lin E, Lalani Y, et al. | Gen Hosp Psychiatry
Aim: To provide an up-to-date and robust synthesis of the evidence by reporting on implementation, evaluation, and outcomes regarding mental health interventions during medical pandemics within the last two decades.
MENTAL HEALTH
|
|
|
8/31/20
|
Almqvist J, Granberg T, Tzortzakakis A, et al. | Ann Clin Transl Neurol
Aim: To optimize diagnostic workup of the current severe acute respiratory syndrome coronavirus 2 (SARS?CoV?2) pandemic.
DIAGNOSTICS
|
|
|
8/31/20
|
Chi H, Chiu N, Peng C, et al. | Life
Aim: To investigate the prevalence of OGA in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
8/31/20
|
Daphine J, Hebert PC, Ziegler D, et al. | Crit Care Med
Aim: To identify and appraise articles describing criteria used to prioritize or withhold a critical care admission.
INFECTION CONTROL
|
|
|
8/31/20
|
Bueno-Notivol J, Gracia-Garcia P, Olaya B, et al. | Int J Clin Health Psychol
Aim: To systematically review community-based studies on depression conducted during the COVID-19 and estimate the pooled prevalence of depression.
MENTAL HEALTH
|
|
|
8/31/20
|
Derraik JGB, Anderson WA, Connelly EA, et al. | Int J Environ Res Public Health
Aim: To summarize the existing literature on the viability of SARS-CoV-2, the efficacy of key potential disinfection procedures against the virus (specifically ultraviolet light and heat), and the impact of these procedures on FFR performance, material integrity, and/or fit.
INFECTION CONTROL
|
|
|
8/31/20
|
Jani BD, Pell JP, McGagh D, et al. | BJGP Open
Aim: To collate a comprehensive list of symptoms, assessment items, demographics, and lifestyle and health conditions associated with COVID-19, with proposed corresponding SNOMED CT clinical terms.
CLINICAL CHARACTERISTICS
|
|
|
8/31/20
|
Duarte ML, Dos Santos LR, de Souza Contencas AC, et al. | Sao Paulo Med J
Aim: To compare accuracy between RT-PCR and computed tomography (CT) for detecting COVID-19 in the first week of its symptoms during the pandemic.
DIAGNOSTICS
|
|
|
8/31/20
|
Ullah W, Abdullah HM, Roomi S, et al. | J Clin Med Res
Aim: To review the evidence on the use of hydroxycholorquine to treat COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
8/31/20
|
Sawalha K, Abozenah M, Kadado AJ, et al. | Cardiovasc Revasc Med
Aim: To describe the clinical characteristics and management of currently published COVID-19 myocarditis patients.
CLINICAL CHARACTERISTICS
|
|
|
8/31/20
|
Nasir M, Perveen RA, Saha SK, et al. | Mymensingh Med J
Aim: To evaluate the role of favipiravir along with its safety and efficacy for the patients who are suffering from severe acute respiratory distress syndrome due to CoronaVirus-2 (SARS-CoV-2) as re-purposeful use.
CANDIDATE THERAPEUTICS
|
|
|
8/31/20
|
Hasani H, Mardi S, Shakerian S, et al. | Biomed Res Int
Aim: To assess the frequency of clinical, laboratory, and imaging featues of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/31/20
|
Copat C, Cristaldi A, Fiore M, et al. | Environ Res
Aim: To provide an update state of art relating the role of air pollution, in particular PM2.5, PM10 and NO2, in COVID-19 spread and lethality.
INFECTION CONTROL
|
|
|
8/31/20
|
Centeno-Tablante E, Medina-Rivera M, Finkelstein J, et al. | Ann N Y Acad Sci
Aim: To capture information that might necessitate changes in the guidance on breast milk and breastfeeding given the uncertainty in this area.
|
|
|
8/31/20
|
Porfidia A, Valeriani E, Pola R, et al. | Thromb Res
Aim: To evaluate the incidence of VTE in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/29/20
|
Kelada M, Anto A, Dave K, et al. | Cureus
Aim: To assess the role of sex in the risk of mortality from COVID-19 in adult patients through comparison of clinical markers and inflammatory indexes.? UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/28/20
|
Yu J, Wu B, Yang J, et al. | Biol Res Nurs
Aim: To explore whether cardio-cerebrovascular disease would increase the risk of COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
8/27/20
|
Braithwaite I, Callender T, Bullock M, et al. | Lancet Digit Health
Aim: To assess the effectiveness of automated and semi-automated digital tools for contact tracing, and identify key considerations for successful implementation, to inform the control of COVID-19. UPDATED
INFECTION CONTROL
|
|
|
8/27/20
|
Prodromos CC | New Microbes New Infect
Aim: To review the evidence on cardiac arrhythmic mortality caused by the use of hydroxychloroquine and azithromycin.
CANDIDATE THERAPEUTICS
|
|
|
8/27/20
|
Coomes EA, Haghbayan H | Rev Med Virol
Aim: To assess the evidence describing IL-6 response in patients with COVID-19 and the existing and planned studies investigating the efficacy of tocilizumab to guide patient management, clarify guideline development, and inform future trials in this field. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/27/20
|
Gertsman S, Agarwal A, O'Hearn K, et al. | J Hosp Infect
Aim: To collect and synthesize existing information on decontamination of N95 filtering facepiece respirators (FFRs) using microwave and heat-based treatments, with special attention to impact on mask function (aerosol penetration, airflow resistance), fit, and physical traits. UPDATED
INFECTION CONTROL
|
|
|
8/27/20
|
Laufs J, Waseem Z | Int J Disaster Risk Reduct
Aim: To explore the short- and long-term effects of epidemics on policing.
INFECTION CONTROL
|
|
|
8/26/20
|
Zou F, Qian Z, Wang Y, et al. | CJC Open
Aim: To conduct a comprehensive review and meta-analysis of the incidence, comorbidities, outcomes and possible mechanisms of acute cardiac injury in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
8/26/20
|
Pang W, Liu Z, Li Y, et al. | Integr Med Res
Aim: To evaluate the efficacy and safety of CMD for COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
8/26/20
|
Arentz S, Yang G, Goldenberg J, et al. | Adv Integr Med
Aim: To assess the effects of zinc on the incidence, duration and severity of acute upper or lower respiratory tract infections caused by SARS-CoV-2 infection in people of any age and of any zinc status when used as a preventive supplement or as a therapy.
CANDIDATE THERAPEUTICS
|
|
|
8/26/20
|
Schloss J, Lauche R, Harnett J, et al. | Adv Integr Med
Aim: To review the evidence on the effect of Vitamin C on acute respiratory tract infections in adults when administered at the onset of symptoms.
CANDIDATE THERAPEUTICS
|
|
|
8/26/20
|
Kaur N, Gupta I, Singh H, et al. | SN Compr Clin Med
Aim: To evaluate the epidemiological and clinical characteristics of COVID-19 patients while also highlighting the comorbidities and radiological findings.
CLINICAL CHARACTERISTICS
|
|
|
8/26/20
|
Rai B, Shukla A, Dwivedi LK | Clin Epidemiol Glob Health
Aim: To review the qualitative and quantitative synthesis of the currently available evidence for the serial interval of COVID-19.
INFECTION CONTROL
|
|
|
8/26/20
|
Abu-Rumeileh S, Abdelhak A, Foschi M, et al. | J Neurol
Aim: To provide a comprehensive and updated overview of all case reports and series of COVID-19-related GBS to identify predominant clinical, laboratory, and neurophysiological patterns and to discuss the possible underlying pathophysiology.
CLINICAL CHARACTERISTICS
|
|
|
8/26/20
|
Bansal A, Prasad JB | Z Gesundh Wiss
Aim: To quantify the overall risk of liver damage in COVID-19 patients and also find the overall variation in risk outcome.
CLINICAL CHARACTERISTICS
|
|
|
8/26/20
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the medium- and long-term health sequelae of COVID-19 infection among survivors.
|
|
|
8/26/20
|
Said M, Ngo V, Hwang J, et al. | Laryngoscope Investig Otolaryngol
Aim: To review applications of telemedicine for the evaluation of facial trauma to better direct utilization of these methods and technologies during times of limited access to clinical resources such as the COVID?19 pandemic.
INFECTION CONTROL
|
|
|
8/26/20
|
Correia AO, Feitosa PWG, Moreira JLS, et al. | Neurol Psychiatry Brain Res
Aim: To describe the main neurological manifestations related to coronavirus infection in humans.
CLINICAL CHARACTERISTICS
|
|
|
8/26/20
|
D'Ambrosi R | Indian J Orthop
Aim: To analyze all the articles related to COVID-19 and orthopedics and to shed light on the scientific evidence that has actually been found.
CLINICAL CHARACTERISTICS
|
|
|
8/26/20
|
Kotwal A, Yadav A, Kotwal J | Med J Armed Forces India
Aim: To assess correlation between predicted and actual values of cases in India.
|
|
|
8/26/20
|
Dinnes J, Deeks JJ, Adriano A et al. | Cochrane Database Syst Rev
Aim: To assess the diagnostic accuracy of point-of-care antigen and molecular-based tests to determine if a person presenting in the community or in primary or secondary care has current SARS-CoV-2 infection
DIAGNOSTICS
|
|
|
8/26/20
|
Frediansyah A, Nainu F, Dhama K, et al. | Clin Epidemiol Glob Health
Aim: To summarize the antiviral activities of remdesivir against SARS-CoV-2, the causative agent of COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
8/26/20
|
Khalil A, Kalafat E, Benlioglu C, et al. | EClinicalMedicine
Aim: To systematically review the available literature on COVID-19 and pregnancy, to provide comprehensive data to care-providers, pregnant women and their families, inform national and international guidelines, and direct the course of ongoing and future studies
CLINICAL CHARACTERISTICS
|
|
|
8/26/20
|
Hariyanto TI, Kurniawan A | Diabetes Metab Syndr
Aim: To analyze the association between statin use and in-hospital outcomes of COVID-19 infection.
CANDIDATE THERAPEUTICS
|
|
|
8/26/20
|
Siordia JA, Bernaba M, Yoshino K, et al. | SN Compr Clin Med
Aim: To compile the current data regarding human controlled COVID-19 treatment trials.
CANDIDATE THERAPEUTICS
|
|
|
8/26/20
|
Leeson CE, Ismail A, Hashad MM, et al. | SN Compr Clin Med
Aim: To review and summarize what is known about COVID-19 and the current implications of intravesical BCG with regard to the disease.
CANDIDATE THERAPEUTICS
|
|
|
8/26/20
|
Aucoin M, Cooley K, Saunders PR, et al. | Adv Integr Med
Aim: To review the role of quercetin in the treatment and recovery of COVID-19 and other respiratory tract infections.
CANDIDATE THERAPEUTICS
|
|
|
8/26/20
|
Aucoin M, Cooley K, Saunders PR, et al. | Adv Integr Med
Aim: To review the role of Echinacea in the prevention and treatment of COVID-19 and other respiratory tract infections.
CANDIDATE THERAPEUTICS
|
|
|
8/26/20
|
Nieto I, Navas JF, Vazquez C | Brain Behav Immun Health
Aim: To examine compliance with basic methodological quality criteria and open scientific research practices on the mental health effects of the COVID-19 pandemic.
|
|
|
8/26/20
|
Davis B, Rothrock AN, Swetland S, et al. | J Am Coll Emerg Physicians Open
Aim: To analyze the prevalence of respiratory pathogens (viruses and atypical bacteria) in COVID?19 patients.
CLINICAL CHARACTERISTICS
|
|
|
8/25/20
|